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ABSTRACT 
Radiation-induced DNA lesions lead to the activation of complex damage response pathways in 
mammalian cells. In one of these pathways the p21 protein, a well-characterized cyclin 
dependent kinase inhibitor, is induced by TP53 after DNA damage leading to cell cycle arrest in 
G1-phase. Independently of its transactivation by TP53, the p21 protein forms nuclear 
accumulations at heavy ion-induced DNA lesions [Jakob et al., 2000]. As shown in this study, 
p21 foci also arise after exposure of cells to sparsely ionizing X-rays. In an attempt to elucidate 
the functional role of these p21 foci, their dependence on the proliferating cell nuclear antigen 
(PCNA) is demonstrated here. In particular, the requirement for a functional interaction 
between p21 and PCNA is revealed. In addition, the kinetics of the PCNA- and p21- 
accumulations at heavy ion-induced DNA lesions is shown to be very similar, and both proteins 
are part of the chromatin-bound protein fraction after DNA damage induction by X-rays. A 
possible involvement of p21 in the DNA double- and/or single-strand break repair pathways is 
discussed. 
 
 
 
ZUSAMMENFASSUNG 
Durch ionisierende Strahlung induzierte DNA Schäden aktivieren ein komplexes Netzwerk an 
Signalwegen zur Erkennung und Reparatur der hierdurch hervorgerufenen DNA Schäden. Das 
Protein p21 ist ein bekannter CDK (cyclin dependent kinase) Inhibitor, der nach DNA-Schäden 
TP53 abhängig induziert wird und den Zellzyklus arretiert. TP53 unabhängig akkumuliert p21  
in Foci an Schwerionen-induzierten DNA Schäden [Jakob et al., 2000]. In dieser Arbeit wird 
gezeigt dass p21 auch nach DNA Schadensinduktion durch Röntgenbestrahlung Foci bildet. Bei 
der Erforschung einer möglichen Funktion dieser p21 Akkumulationen an strahleninduzierten 
DNA Schadensstellen zeigte sich die Interaktion von p21 mit dem Proliferierenden Zellulären 
Nucleären Antigen (PCNA) als essentiell. Zudem erwies sich die Kinetik des Erscheinens und 
des Auflösens der p21 und PCNA Foci nach Schwerionenbestrahlung als sehr ähnlich, und 
beide Proteine konnten nach DNA Schadensinduktion durch Röntgenbestrahlung in der 
Chromatin-gebundenen Proteinfraktion nachgewiesen werden. Eine mögliche Rolle für p21 in 
der DNA Doppel- oder Einzel-Strangbruchreparatur wird diskutiert. 
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h Hour 
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hMre11 Human homologue of yeast meiotic recombination 11 
HR Homologous recombination 
LET Linear energy transfer 
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N0 Seeded (attached) cell number 
NBS1 Protein expressed from NBS1, mutated in Nijmegen Breakage Syndrom 
NER Nucleotid excision repair 
NHEJ Non-homologous-end-joining 
p21 Cyclin dependent kinase inhibitor 1A (CDKN1A) 
PARP-1 Poly(ADP-ribose) polymerase-1 
PBS Phosphate buffered saline 
PCNA Proliferating cell nuclear antigen 
PD Population doublings 
PE Plating efficiency 
RBE Relative biological effectiveness 
rpm Rotations per minute 
RT Room temperature 
SDS Sodium dodecylsulfate 
SDS-PAGE SDS-polyacrylamidgel-electrophoresis 
SIS ‘Schwerionensynchroton’ 
SSB DNA single-strand break 
TP53 Tumour supressor protein p53 
U Units 
UNILAC Universal ion linear accelerator 
v/v Volume per volume 
w/v Weight per volume 
w/w Weight per weight 
wt Wild-type 
XRCC1 X-ray repair cross complementing 1 protein 
53BP1 Tumour supressor p53 binding protein 1 
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1 INTRODUCTION 
 
 
 
Cells have to cope with various kinds of DNA lesions, which lead to complex cellular reactions. 
Because of the importance of maintaining DNA integrity and genome stability, cells have 
evolved many pathways to detect damaged DNA sites and to repair the induced lesions. If a cell 
is not able to repair the DNA damage, it may undergo apoptosis or necrosis. In the worst case, 
the damage is misrepaired leading to mutations that may end in uncontrolled cell division, 
promoting carcinogenesis.  
 
DNA damage activates highly organised interactions between many different proteins. Some 
proteins are responsible for the DNA lesion detection (DNA damage sensors). Other proteins 
function as transducers which in their turn activate effector proteins. In parallel to the initiation 
of DNA repair pathways, the cell cycle has to be arrested, to get the time needed for the DNA 
repair. Many of the proteins involved have more than one function and with this, are active in 
several different pathways. 
 
Ionizing radiation induces severe DNA damages, which can lead to cell inactivation. In tumour 
therapy, this is the desired effect of the exposure of cancerous tissue to ionizing radiation. 
However, the line between cancerous cells and its surrounding healthy tissue is very narrow 
demanding highly precise radiotherapy. To better understand how ionizing radiation works on 
cellular level, experimental data are of great importance. 
 
In this thesis, the protein p21, also known as p21CIP1/WAF1 or CDKN1A, is the protein of interest. 
p21 participates in several cellular pathways. p21 was first described as a cyclin-dependent kinase 
inhibitor that interacts with the cell cycle cyclins to delay or arrest the cell cycle. After DNA 
damage detection, the protein TP53 (tumour suppressor protein 53) is stabilized by 
phosphorylation, leading to a higher concentration of this protein. TP53 can induce p21 directly 
on transcriptional level, leading to increased amounts of p21 within the cell. The protein p21 
then forms a complex with the cyclin A or E, resulting in cell cycle arrest. This cell cycle delay 
gives the cell the opportunity to repair the DNA damage. This was the first described function 
of p21, experimental data have shown many additional functions of this protein, most of them 
briefly mentioned in this thesis. Here, I try to elucidate the behaviour of p21 towards DNA 
lesions, as p21 accumulates directly at heavy ion-induced DNA lesions. The question came up, 
whether p21 is actively involved in the cellular response to DNA damage. A main topic within 
this thesis is the interaction with the proliferating cell nuclear antigen (PCNA). PCNA is known 
to be of importance for DNA replication as well as DNA repair. The p21/PCNA interaction is 
elucidated in response to irradiation-induced DNA lesions. With this thesis, even if p21 is only 
one protein from a huge amount of the cellular proteins, an additional role of this key player of 
the cellular response to irradiation-induced DNA damage is further clarified. 
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1.1 Ionizing radiation 
 
 
As unstable atoms decay, they release radiation in the form of electromagnetic waves and 
subatomic particles. If this radiation transfers enough energy to liberate electrons from target 
atoms and ionize the atoms as it passes through matter it is referred to as ionizing radiation. The 
basic unit for ionizing radiation is the dose, measured in Gray [Gy] and defined as the radiation 
energy absorbed per mass unit of the irradiated matter: 1 Gy = 1 J/kg [ICRU, 1970]. 
 
Depending on the energy deposition, ionizing radiation is either sparsely or densely ionizing 
with a low or high linear energy transfer (LET), respectively. The LET [keV/μm] gives the 
energy transfer of the radiation per unit distance as it traverses the matter. High-energy 
electromagnetic radiations such as X- and γ-rays release fast electrons having a low LET which 
makes them sparsely ionizing. Neutrons release low energy protons. Both low energy protons 
and heavy ions produce a dense track of secondary electrons that has a high LET and is 
therefore densely ionizing. 
 
The dose delivered to the irradiated matter is given by: 
 
D[Gy] = 1.602 × 10-9 × ⎥⎦
⎤⎢⎣
⎡
m
keV
dx
dE
μ  × F [ ]2−cm  × ⎥⎦
⎤⎢⎣
⎡
g
cm31
ρ  
 
The energy loss of a particle is specified by 
dx
dE , which is equivalent to the LET. F stands for 
the particle fluence, meaning the number of particles traversing one cm2 of the irradiated matter 
and ρ  is the mass density of the target material. 
 
DNA damage induced by exposure to radiation is induced by either the direct action or indirect 
action of the irradiation. With the direct action secondary electrons resulting from absorption of 
a photon interacts directly with the DNA, the dominant process for radiations with high LET.  
By the indirect action secondary electrons interact with another molecule, e.g. H2O leading to 
free radicals who induce the DNA damage (mainly process for low LET radiation). 
 
Ionizing radiation can create single damaged DNA sites and clustered damaged DNA sites, in 
which two or more lesions are formed within a few helical turns of the DNA, after the passage 
of a single radiation track. It has been estimated that low-LET radiation creates approximately 
1000 single-strand breaks (SSBs), 40 double-strand breaks (DSBs) and 2700 base damages per 
Gray in a mammalian cell [J. F. Ward, 1985, 1988, 1995]. 
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1.1.1 Sparsely ionizing radiation 
 
 
Photon irradiation, such as X-ray radiation and γ-radiation, are sparsely ionizing radiation types 
with a low LET (Fig. 1 A). With this kind of radiation, a part of the photon energy interacts with 
the electrons of the irradiated material. Electrons are knocked out of the atom and interact with 
surrounding electrons that result in a homogeneous deposition of secondary electrons (Fig. 1 B). 
The local energy desposition by sparsely ionizing radiation is given by the dose applied. Because 
of the statistic interaction of photons with the target material the beam of photons decreases in 
its intensity when penetrating through matter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Sparsely ionizing radiation gives a random homogeneous deposition of secondary electrons, 
which results in a homogeneous dose distribution in the irradiated area [Scholz, GSI].  
 
 
 
1.1.2 Densely ionizing radiation 
 
 
Particle radiation is densely ionizing radiation and has a high LET. Its interaction with matter 
generates secondary electrons with different energies along the particle track (Fig. 2 A). The 
energy deposition has a maximum in the centre of the particle track, decreasing quadratically 
with the distance from the track centre (Fig. 2 B).  
 
A 
 
 
     B 
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Fig. 2 Densely ionizing radiation leave many ionisations within the particle track. However, due to the 
particle track structure, it is very punctually localized and deposits a very high dose in the middle of the 
particle track.  
The dose deposition as well as the maximum of the track diameter, depends on the kind and 
energy of the particle used. For particles the energy loss is inverse to the velocity: For high 
velocities, i.e. high energies, the interaction time is short and therefore the energy loss low but 
gets larger with decreasing energy. The deposited dose rises slowly with the penetration depth 
until the so-called Bragg-Peak is reached with a sharp increase in dose deposition at the end of 
the particle range [Bragg and Kleemann, 1905]. Just after the Bragg-Peak, the dose decreases 
rapidly within 1 mm. The depth of the Bragg-Peak can be modified by varying the particle 
energy. The dose of particle irradiation can be calculated based on the fluence and the LET 
[Taucher-Scholz und Kraft, 1999]. The feature of this inverted and adjustable dose deposition 
makes particle radiation to a powerful tool in cancer treatment. Because of the minor increase in 
dose deposition with the penetration depth prior to the Bragg-Peak and the extreme fast 
decrease just after this point, normal tissue in the entrance channel or surrounding the tumour 
can be spared during therapy. Furthermore, heavy charged particles have a very small lateral and 
longitudinal scattering effect which makes it possible to irradiate deep-seated tumours with high 
precision. These characteristics, and the fact that heavy ions have a higher relative biological 
efficiency compared to sparsely ionizing radiation as written below, led to the development of 
the successful tumour therapy with heavy ions at the GSI [Kraft, 2000]. 
 
 
 
A   B 
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1.1.3 Relative biological efficiency  
 
 
The relative biological effectiveness (RBE) gives the effectiveness of densely ionizing radiation 
on living matter compared to sparsely ionizing radiation. It has been shown that densely ionizing 
radiation as carbon ions have an elevated RBE at the end of their range [Kraft, 1997]. This 
property allows a control of otherwise radioresistant tumourgenic tissue in tumour therapy. With 
the RBE it is possible to compare different radiation qualities in their biological efficiency. The 
RBE is defined as followed: 
 
RBE = 
ion
x
D
D  
 
Dx and Dion are the X-ray and ion doses, respectively that are necessary to achieve the same 
biological effect. RBE is one if both types of radiation have the same effectiveness. If the test 
radiation is more effective, the RBE is larger than 1. As the RBE varies, the biologically effective 
dose [De] to living matter is given in Gray-equivalent [Gye] as below: 
 
De [Gye] = D [Gy] × RBE 
 
With this knowledge, it is obvious, that it is very important to know the RBE for cell killing 
before any radiation is applied in therapy, to ensure that the desired level of radiation exposure is 
achieved. Furthermore, the maximum RBE value not only differs with the particle used, but also 
changes with the cell type and the absorbed dose [Kraft, 1997; Weyrather, 1999].  
 
Fig. 3 shows a schematic dose effect curve for cell survival after irradiation with X-rays 
compared with particle irradiation. For a survival of 10 % of the irradiated cells a smaller dose of 
particle irradiation (Dpart.) is required than for X-ray irradiation (DX-ray). The high cell killing effect 
of particle irradiation is due to the difference in the level of induced DNA damage as written in 
the next chapter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Schematic survival curve, demonstrating the RBE for cell killing. The difference 
in effectiveness is seen in the higher X-ray dose compared to the particle dose required to 
achieve the same outcome for cell inactivation [Kraft, 2002]. 
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1.2 DNA damage induced by ionizing radiation 
 
 
The most critical part in living matter when exposed to ionizing radiation is the DNA [Munro, 
1970]. Cells which are not able to repair the DNA correctly, cannot sustain the genomic stability 
and non-repaired or incorrectly repaired DNA lesions lead to mutation, transformation or 
apoptosis (programmed cell death). Ionizing irradiation induces various DNA lesions, such as 
base damages, DNA single-strand breaks (SSBs) or DNA double-strand breaks (DSBs), 
resulting from deoxyribose destruction or DNA-protein crosslinks (Fig. 4). Depending on the 
kind of irradiation, different types of DNA damages may occur. The DNA double-strand break 
is the more critical DNA damage than single strand breaks as the complementary DNA strand is 
broken too, which complicates the repair. 
 
It has been shown that sparsely and densely ionizing irradiation does not significantly differ in 
the amount DSBs they induce [Heilmann et al., 1995]. However, the quality of the induced DNA 
lesions has been shown to vary for these two types of radiation. The DSBs produced by high 
LET radiation are closer together ("clustered DNA damages") having a higher complexity of the 
lesions [Ward, 1994; Goodhead, 1994; Rydberg et al., 1994]. The repair of these clustered DNA 
damaged sites is shown to be more difficult [Taucher-Scholz et al., 1996]. Furthermore, DSBs 
induced by low energetic ions are repaired less complete than DSBs induced by X-rays or high 
energetic ions [Taucher-Scholz et al., 1996]. The ability of the cells to repair the irradiation 
induced DSBs appear to depend on the proximity, distribution and number of the ionisation 
events in the nucleus.  
 
 
Fig. 4 Schematic diagram of possible DNA lesions induced exogenously or spontaneously. 
DNA damages are induced by ionizing radiation, UV radiation or chemicals, but also occur 
spontaneously. Possible DNA lesions are for example DNA single-strand breaks (SSBs), DNA 
double-strand breaks (DSBs), base loss, base exchange, dimerisation of bases or crosslinks 
between the DNA and proteins. 
DNA double helix 
2 nm 
DNA-protein 
crosslink 
Single-
strand break
UV- radiationionizing radiaton
Chemicals
Double-strand break 
Base exchange
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Dimer
Base loss
34 nm 
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Not only the type of DNA damage influences a cell's ability to repair the lesion, but also the cell 
cycle stage in which the lesion is introduced plays a role for the ability to repair. A cell undergoes 
four different cell cycle phases, the G1-, S-, G2- and the M-phase (Fig. 5). In the G1-phase (gap1-
phase) the cell is preparing for the DNA synthesis. At the end of the G1-phase there is a G1/S 
cell cycle checkpoint which controls whether the cell is ready to enter the following S-phase 
(synthesis-phase). During S-phase, which includes an intra-S-phase cell cycle control point, the 
DNA is synthesised. The S-phase is followed by the G2-phase (gap2-phase) which allow the cell 
time for the preparation of the cell division, the mitosis (M-phase). A G2/M cell cycle 
checkpoint at the end of the G2-phase controls if the entire DNA has been replicated correctly 
before cell division. Additionally, certain cell type's can reversibly or irreversibly leave the cell 
cycle and enter a resting state referred to as the G0-phase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depending on the cell cycle phase at time of DNA damage, different repair pathways are 
preferred. This mainly due to the DNA structure the cell has at the time-point the DNA has to 
be repaired. For example, for repair processes which use the homologous DNA strand for 
repair, the cell has to be in the S- or G2-phase of the cell cycle where the sister chromatid is 
present. Controversially, the repair process non-homologous endjoining (NHEJ) was shown to 
operate throughout all cell cycle phases [Hinz et al. 2005]. The possible DNA repair pathways 
are briefly written in chapter 1.3 Mechanisms of DNA damage repair (page 9). 
 
 
Fig. 5 Model of the eukaryotic cell cycle. The cell cycle is divided in four different phases; 
the G1-, G2-, S- and the M-phase. Additionally, certain cells can enter the G0-phase. The cell 
cycle has three cell cycle control points controling whether the cell cycle can proceed or if the 
cell cycle has to be arrested: G1/S, intra-S-phase and G2/M checkpoint. 
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1.2.1 DNA damage induced by sparsely ionizing radiation 
 
 
As mentioned in Sect. 1.1.1 (page 3) above, sparsely ionizing radiation generates mostly isolated 
secondary electrons and the local energy desposition is given by these electrons. On the cellular 
level, the nucleus encounters a wide spread of ionisations which produce isolated lesions in the 
DNA and its structure (Fig. 6). Because of this distribution of the damaged DNA sites, the cells 
seem to be able to have better possibilities of correct repair than the more clustered DNA 
damages induced by densely ionizing irradiation. 
 
 
A 
 
B 
 
 
Fig. 6 Sparsely ionizing irradiation generates a homogeneous deposition of secondary 
electrons. Because of this, the DNA damages are distributed randomly in the genome; there are 
no highly clustered DNA lesions as with densely ionizing radiation as described below [Scholz, 
GSI].  
 
 
 
1.2.2 DNA damage induced by densely ionizing radiation 
 
 
DNA lesions induced by densely ionizing irradiation are more complex and with this appeared 
to be more difficult to repair. Many ionisations are produced along the particle trajectory, 
causing clustered DNA damage sites when passing the nucleus (Fig. 7). These clustered DNA 
lesions induced are the reason for the elevated RBE [Heilmann et al., 1996; Kraft, 2002]. 
Furthermore, particle irradiation with high LET has been shown to induce a high fragmentation 
of the irradiated genomic DNA [Lobrich et al., 1998], and the cell cycle is more extendedly 
delayed than after sparsely ionizing radiation [Fournier et al., 2004].  
 
 
  X-rays 
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Fig. 7 Densely ionizing irradiation such as carbon ions leaves massive ionisation events 
which results in clustered DNA damages as illustrated by the schematic DNA. Along one 
track, many ionisations occur, which leaves a huge amount of DNA lesions in close proximity. 
Because of these clustered DNA damages, the repair of the damaged DNA is more difficult than 
with the isolated DNA lesions induced by sparsely ionizing irradiation [Krämer and Scholz, GSI].  
 
 
 
1.3 Mechanisms of  DNA damage repair 
 
 
DNA repair is not only an issue after ionizing radiation, since cells also contain spontaneously 
induced DNA lesions due to radical attacks generated mainly by the oxidative energy 
metabolism. For example, a cell handles with about 10000 SSBs, 5000 base damages and 2 DSBs 
a day [Friedberg et al., 1995]. Therefore, mammalian cells possess many pathways to repair the 
different DNA damages and preserve the genomic stability [Kohn, 1999; review: Sancar et al., 
2004]. Proteins detect the DNA damage (DNA damage sensors) and initiate pathways by 
activation or stabilisation of other proteins. The type of DNA lesion and the time of damage 
induction (e.g. cell cycle phase) determines which pathway is used. The DNA can be repaired, 
mis-repaired or not repaired. If the cell is not able to repair the DNA lesion correctly, the way of 
the programmed cell death (apoptosis) is preferred, as if the DNA is mis-repaired or no repair 
takes place, mutations occur which in worst case may lead to cancer (Fig. 8).  
 
 
DNA 
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Fig. 8 Schematic diagram of possible outcome of DNA damage, here induced by ionizing 
radiation. The DNA lesion is detected by DNA damage sensors, which activate further 
pathways, depending on the DNA damage. 
 
The DNA damages introduced can be repaired by the excision repair pathways (i.e. base-
excision repair, nucleotide-excision repair or mismatch repair), or the DSB repair pathways (i.e. 
homologous recombination (HR) or non-homologous end-joining (NHEJ)) [review: Jeggo, 
1998; Hoejmakers, 2001; Jackson, 2002]. Damaged bases are repaired by the base-excision repair 
(BER) or nucleotide-excision repair (NER) that involve excision and replacement of the 
individual damaged bases or larger nucleotide fragments, respectively. SSBs are repaired in a 
similar process [review: Caldecott, 2001]. DSBs potentially involve a number of repair processes. 
Which process is used, is mainly dependent on the cell cycle phase at time when DNA is 
damaged. DSBs that occur during or after chromosome duplication and before chromosome 
segregation (S- and G2-phase of the cell cycle) are repaired by both NHEJ and HR. In HR the 
broken strand is repaired by non-crossover gene conversion events using the sister chromatid as 
a template, making it the main repair pathway in late S/G1-phase of the cell cycle [Johnson and 
Jasin, 2000]. During all stages of the cell cycle, DSBs can be repaired by NHEJ, but it is of major 
importance when HR is minimal in G0/G1-phase [Lee et al., 1997; Rothkamm et al., 2003; 
Lobrich et al., 2005; Hinz et al., 2005]. 
 
The main DNA repair processes are described in brief below.  
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1.3.1 Excision repair 
 
 
As the name implicates, the excision repair is a process whereby the damaged DNA is 
recognised and excised. The damaged DNA site, with either free bases or nucleotides, is 
removed and replaced by newly synthesized DNA, using the undamaged complementary DNA 
strand as a template. There are two types of excision repair, the base-excision repair (BER) and 
the nucleotide-excision repair (NER), both outlined in brief below (Fig. 9). 
 
 
Damaged base
3'5'
Glycosylase
APE1
Pol β and/or
Pol ε/δPol β
Short patch Long patch
PCNA, RFC
Pol β FEN1
Ligase III/XRCC1 Lig I
 
 
Base-excision repair 
DNA lesion
3'5'
Endonuclease
Helicase
XPB/XPD
Pol δ/ε
PCNA RFC
GGR TCR
Lig I
XPG/XPA, 
RPA, TFIIH
 
 
 
 
 
Nucleotide-excision repair 
Fig. 9 Schematic of BER and NER. BER: A glycosylase removes an altered base, leaving an 
apyrimidinic site which is removed by the AP endonuclease APE1. The single-base gap is filled 
by sequential action of DNA polymerase and ligase (see text for more detail). Adapted and 
modified from Wilson et al., 2006. NER: After DNA damage recognition by DNA damage 
sensing proteins, a nuclease cuts the DNA on each side of the lesion which is removed by a 
DNA helicase. By sequential action of DNA polymerase and ligase the removed fragment is 
filled in again. 
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1.3.1.1 Base excision repair 
 
The BER repairs a single damaged nucleotide (short patch) or 2–10 nucleotides (long patch) 
around the damaged nucleotide caused by oxidation, alkylation, hydrolysation or deamination 
[Hoeijmakers, 2001]. The altered base is removed by a DNA glycosylase, which specifically 
recognizes the base modification and cleaves the N-glycosidic bond between the base and the 
deoxyribose of the DNA, leaving a so called AP site (apyrinic/apyrimidinic site) [Nash et al., 
1996; Krokan et al., 1997; Pearl, 2000]. Bifunctional DNA glycosylases posses an AP lyase 
activity, making them capable to cleave the DNA at the 3'-side of deoxyribose, resulting in a 
single-strand break. Monofunctional glycosylases lack this lyase activity and the remaining 
ribose-phosphate group is excised by polymerase β [Matsumuto and Kim, 1995; Sobol et al., 
2000]. The AP site is recognised by an AP endonuclease, which recognises any deoxyribose 
sugar in the DNA with a missing base. The major mammalian AP endonuclease is termed APE1 
[Demple et al., 1991; Izumi et al., 2003]. It removes the damaged DNA site by cutting the DNA 
upstream of the AP site. The resulting gap in the DNA helix is filled by sequential action of a 
DNA polymerase and DNA ligase (see schematic in Fig. 9).  
 
In the case of short patch BER the excised lesion is filled by DNA polymerase β [Singhal et al., 
1995] and the nick sealed by DNA ligase I or DNA ligase III/XRCC1 (X-ray repair cross 
complementing 1 protein) complex [Wilson, 1998; Tomkinson and Mackey, 1998]. The long 
patch BER involves PCNA (proliferating cellular nuclear antigen) and the PCNA-dependent 
polymerases ε or δ together with the replication factor C (RFC) followed by excision activity of 
the flap endonuclease 1 (FEN1) [Dianova et al, 2001] and DNA ligation by DNA ligase I 
[Frosina et al., 1996; Beard and Wilson, 2000]. Additionally, Pol β is described to be able to take 
part in this long patch pathway [Prasad et al., 2000]. XRCC1 has been described to be a crucial 
factor for BER and single-strand break repair [review: Caldecott, 2003]. It has been shown to 
interact with several enzymes involved in these repair processes, such as pol β [Caldecott et al., 
1996], APE1 [Vidal et al., 2001], PARP-1 [Masson et al., 1998; Schreiber et al., 2002] and DNA 
ligase III [Caldecott et al., 1995]. 
 
 
 
 
1.3.1.2 Nucleotide excision repair 
 
The nucleotide-excision repair (NER) repairs DNA damage affecting 2–30 nucleotides. It 
recognizes a wide range of DNA damages, including bulky distortions in the DNA helix, 
pyrimidine dimers and 6–4 photoproducts caused by UV light and single-strand breaks [Wood, 
1996; Costa et al., 2003]. Two different sub-pathways of NER are known; the global genomic 
NER (GGR) and the transcription coupled NER (TCR). The GGR pathway can repair DNA 
lesions at any location in the genome with efficiency depending on the type of the lesion 
[Tornaletti and Hanawalt, 1999] and genome condensation [Moggs and Almounzi, 1999]. The 
TCR pathway specifically removes lesions that block RNA polymerases on the transcribed 
strand of active genes [Bohr et al., 1985; Mellon et al., 1987]. These two repair processes vary in 
their way of recognising the helix-distorting DNA damage. After DNA damage recognition, the 
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damaged strand is excised by sequential action of helicases and nucleases, leaving a 2–30 
nucleotide gap in the DNA helix. The resulting gap is restored by DNA polymerases δ and ε 
and ligase, using the intact strand as template (Fig. 9) [Nichols and Sancar, 1992; Shivji et al., 
1992].  
 
In GGR the XPC-hHR23B complex has been shown to be the first component recruited at 
UV-induced DNA lesions and is required for the recruitment of subsequent NER factors 
[Volker et al., 2001]. For the TCR, the first signal is the RNA polymerase II transcription arrest. 
If the RNA polymerase II detects a helix distorting structure during the transcription of a gene, 
it stalls the transcription and recruits NER proteins.  
 
 
 
 
1.3.2 DNA double-strand break repair 
 
 
As described above, most repair systems use the intact complementary DNA strand as template 
to fill in the resulted gap in the DNA. This makes the DSBs the most severe type DNA damage 
of the genome, as it leaves no intact template strand to use for the repair. If DSBs are not 
repaired correctly, chromosomal breakage, fragmentation and translocation may occur. DSBs 
can be caused exogenously by ionizing radiation and mutagenic chemicals but can also arise 
during replication or be induced by radicals from cellular metabolism. Two mechanisms have 
evolved to repair such DSBs, the non-homologous end-joining (NHEJ) and the homologous 
recombination (HR) [review: Kanaar et al., 1998; van Gent et al., 2001; Jackson, 2002; Lieber et 
al., 2003; Bassing and Alt, 2004], both described in brief below (Fig. 10). Single-strand annealing 
(SSA) is considered a special form of HR involving sequence repeats [Pastink et al., 2001]. Which 
of the pathway is used for the DSB repair appears to be largely influenced by the stage of the 
cell cycle at time of DNA damage induction [Jackson, 2002].  
 
 
 
1.3.2.1 Non-homologous end-joining 
 
With the NHEJ the two ends of the DSB are rejoined without the need of a homologous DNA 
strand as a repair template and by this can take place in all phases of the cell cycle [review: 
Critchlow and Jackson, 1998]. NHEJ is the predominant repair pathway in mammalian cells. 
The DNA termini are rejoined by a protein-DNA complex where DNA-PK and the ligase 
IV/XRCC4/XLF complex play a major role. DNA-PK binds to the DNA ends by the 
heterodimer Ku70/80 [Walker et al., 2001] and the gap is closed by the activity of the ligase 
IV/XRCC4/XLF complex [Ahnesorg et al., 2006]. See Fig. 10 for schematic model. 
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1.3.2.2 Homologous recombination 
 
The homologous recombination (HR) is most efficient in the late S- and G2-phase of the cell 
cycle, as it uses the sister chromatid as a repair template [Takata et al., 1998; Johnson and Jasin, 
2000]. A large number of proteins are involved in HR, such as RAD51, RAD52, RAD54, 
BRCA1, BRCA2, XRCC2, XRCC3 and the MRN complex [Karran, 2000; Thompson and 
Schild, 2001]. The DSB is recognised by ATM, ATR and DNA-PKcs [Durocher and Jackson, 
2001]. The free DNA ends are processed by the MRN complex and after finding a homologous 
repair template and DNA synthesis the newly synthesised DNA strands are ligated by the action 
of ligase I. See Fig. 10 for schematic model. Single-strand annealing (SSA) is considered as a 
subpathway of HR. It is dependent on repeated sequences flanking the DSB and the non-
homologous ends between these repeated sequences are lost during repair. 
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Fig. 10 Schematic symplified model for DNA DSB repair by NHEJ and HR. NHEJ: Ku70/80 binds 
to the DNA ends and recruits the DNA-PKcs, followed by the Ligase IV/XRCC4/XLF 
complex which seals the DNA ends. Adapted and modified from Helleday et al. (2007). HR: 
Schematic model of HR. A homologous DNA fragment is used as template. Free DNA ends are 
processed by the MRE11/Rad50/NBS1 complex. The single-stranded DNA interacts with 
RAD52, Rad 51, RPA and other proteins and searches for homologues DNA which is used as a 
template for DNA synthesis. Adapted from Sancar et al. (2004) 
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1.4 Accumulation of  protein p21 at heavy ion induced DNA lesions 
 
 
It was shown previously, that p21 accumulates at heavy ion (HI) induced DNA lesions. In 
studies performed by B. Jakob at the GSI [Jakob et al., 2000] p21 accumulated along the heavy 
ion track through the nucleus of human fibroblasts shortly after irradiation (Fig. 11). 
Interestingly, these focal accumulations (foci) of p21 could not be detected after X-ray 
irradiation. In addition, it was reported that the persistence of the HI-induced p21 foci increased 
with the LET of the ion [Jakob et al., 2002]. Furthermore, it was shown by Scholz et al. that the 
p21 foci correlate exactly with the heavy ion tracks, i.e. directly with the sites of severe DNA 
damage [Scholz et al., 2001]. Colocalisation of p21 with hMre11 (human meiotic recombination 
11) and PCNA (proliferating cell nuclear antigen) was detected at the heavy ion track [Jakob et 
al., 2002]. hMre11 is part of the MRE complex (hMre11/Rad50/NBS) that has an important 
role in the DSBs repair and is involved in the NHEJ as well as HR [review: Jackson, 2002; 
Hopfner et al., 2002]. PCNA, a subunit of DNA polymerase δ and ε, has been shown to take 
part in DNA replication, but is also active in the NER [Nichols and Sancar, 1992; Shivji et al., 
1995] and BER [Tom et al., 2000; Tom et al., 2001; review: Maga and Hübscher, 2003]. 
 
Furthermore has been stated that p21 foci formation induced by HI-irradiation occurred 
independently of NBS1 (Nijmegen breakage syndrome), ATM (Ataxia-telangiectasia mutated), 
XPA (Xeroderma pigmentosum group A) and TP53 [Jakob et al., 2002]. NBS1 is described to be 
recruited to DSBs by binding to MRE11 in an ATM-dependent manner [for review see 
Kobayashi et al., 2004]. The TP53 dependent p21 induction after IR induced DNA damage has 
been shown to be attenuated in NBS deficient cells but higher than the induction in AT cells 
[Matsuura et al., 1998] which would be in line with this finding, suggesting that p21 is not 
involved in the DSB repair pathway downstream of NBS1 recruitment. The independency of 
ATM for the p21 foci formation shows that it takes place in absence of specific ATM 
phosphorylation. Even if protein phosphorylation can be done by several kinases, ATM has 
been shown to be the major activator of the cellular response to DSBs [Shiloh, 2003; Shiloh, 
2006]. XPA plays an important role in the NER repair pathway as XPA deficient cells are not 
able to carry out NER [review: Vermeulen et al., 1997]. This would suggest that p21 is not 
involved in XPA dependent NER. However, the involvement of p21 in NER has been studied 
by several groups, leading to contradictory results. It has been reported that p21 does not 
significantly inhibit or play an important role in NER [Shivji et al., 1994; Sheikh et al., 1997; Shivji 
et al., 1998]. Opposite, studies with mutant forms of p21 showed that cells expressing p21 which 
is not able to interact with PCNA were deficient in NER, but wtp21 expressing cells could carry 
out NER [McDonald et al., 1996].  
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A 
 
B C 
 
Mock-irradiated 10 min post irr. 30 min post irr. 
Fig. 11 Foci formation of p21 and PCNA after exposure to chromium ions. Human 
fibroblasts fixed and extracted according to the GSI modified Streck method at indicated times 
after irradiation with chromium ions (2×106 p/cm2; 11.4 MeV/u; 2810 keV/μm). 
Immunostained proteins p21 (green) and PCNA (red); DNA visualised by ToPro-3 (blue). A: 
mock-irradiated. B: 10 min post irradiation. C: 30 min post irradiation. Bar: 10 μm. 
 
As the p21 foci become visible almost immediately after heavy ion irradiation, this response 
appeared to be independent of p21's transcriptional induction through the TP53 pathway 
[Waldman et al., 1995]. This assumption was supported by experiments carried out in HPV16 E6 
cells that express the human papilloma virus 16 making them express only very small amounts 
of instable TP53. In spite of their non-detectable TP53 level (by Western Blot analysis), HPV16 
E6 cells showed p21 foci shortly after HI irradiation [Jakob et al., 2002]. 
 
In line with these observations, I was able to show in my Diploma Thesis that p21 foci 
formation was independent of protein synthesis [Heede, 2002]. I further demonstrated that both 
p21 protein synthesised before and after exposure to heavy ions was able to accumulate at the 
damaged DNA sites. In addition to these findings, I showed that if intracellular p21 levels were 
elevated artificially, p21 foci formation as well as their resolution was not altered. Additionally, 
the experimental studies in my Diploma Thesis indicated that the p21 focus most likely is a 
dynamic entity with p21 turnover.  
 
 
 
 
1.5 Known functions of  the p21 protein 
 
 
The protein p21 has become a highly investigated protein, as it is involved in many different 
cellular events. The name p21 refers to its molecular weight, which is 18119 kDa and its running 
behaviour at 21 kDa in SDS-PAGE. p21 was first described by Harper et al. [1993] as a inhibitor 
of cyclin dependent kinases (CDKs) by its direct interaction and named CDK-interacting 
protein 1 (Cip1). Simultaneously, El-Deiry et al. [1993] identified this protein as a mediator of 
TP53-induced growth arrest, and named it wild-type p53-activated fragment (WAF1). Other 
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names for this protein are SDI1 (senescent cell-derived inhibitor 1), CAP20 (CDK2-associated 
protein 20), PIC1 or MDA6 (Melanoma Differentiation Associated protein 6). The p21 protein 
consists of 164 amino acids (aa.) and is primarily localized in the nucleus. Residues 140–143 
comprise its nuclear localisation sequence (NLS, Fig. 12). Together with p27Kip1 and p57Kip2, p21 
is member of the so called Cip/Kip family of cyclin dependent kinase inhibitors (CDKIs) whose 
actions affect the activities of cyclin D-, E-, and A-dependent kinases [Gu et al., 1993; Harper et 
al., 1993; El-Deiry et al., 1993; Xiong et al., 1993; Dulic et al., 1994]. These CDKis share some 
sequence homology in their amino-terminal domains, through which they are able to bind both 
to cyclin and CDK subunits [Chen et al., 1995, 1996; Nakanishi et al., 1995; Lin et al., 1996; Russo 
et al., 1996; review: Sherr and Roberts, 1999]. At the carboxy-terminal domain, p21 has a PCNA 
(proliferating nuclear antigen; a subunit of DNA polymerase delta and epsilon) binding site (Fig. 
12) [Xiong et al., 1993; Kelman and Hurwitz, 1998; Ando et al., 2001]. This site enables p21's 
direct interaction with PCNA, resulting in inhibition of PCNA's function in DNA replication 
[Waga et al., 1994] and, with minor effects, in the NER [Pan et al., 1995; Cooper et al., 1999] and 
BER [Tom et al., 2001] repair pathways. Recently, Perucca et al. [2006] showed that p21 is 
recruited to UV-C-induced DNA damaged sites and colocalizes with PCNA, Pol β, XPG and 
CAF-1, all proteins known to be involved in NER. Furthermore, these investigators showed a 
very fast recruitment of p21-GFP and RFP-PCNA to the regions of DNA damage induced by a 
405 nm laser with RFP-PCNA showing slightly faster mobility than p21-GFP. 
 
 
 
 
 
 
 
 
In addition to the above mentioned binding sites, p21 has a number of additional direct protein-
protein interactions [Dotto, 2000]. Depending on the protein partner p21 interacts with, 
different functions for p21 are described, such as cellular differentiation, DNA damage 
response, DNA repair, DNA replication or the mediation of TP53-dependent and -independent 
apoptosis (Fig. 13) [review: Gartel et al., 1996; Gartel et al., 2002]. Also, a possible role for p21 in 
the regulation of transcription has been described, as it interacts with proteins that regulate gene 
expression [Blagosklonny, 2002; Coqueret, 2003]. The function of p21 is mainly regulated by its 
expression level but also the subcellular localisation and the phosphorylation status of p21 have 
shown to be of importance [Child and Mann, 2006]. 
 
p21 has 2 phosphorylation sites at the carboxy-terminal domain through which different 
functions, such as PCNA binding ability or cyclin/CDK complex formation, of the protein can 
be mediated [Rossig et al., 2001; Zhou et al., 2001]. By specific phosphorylation of the protein its 
subcellular localisation can be influenced. Phosphorylation of Ser153 of p21 by PKC for 
example, contributes to its cytoplasmatic accumulation [Agell et al., 2006]. Depending on its 
cellular localization, very different functions of p21 have been described [Conqueret, 2003]. 
Nucleolar p21 correlates with tumour suppressor functions, as PCNA binding inhibits DNA 
replication, p21's interaction with the CDK2/cyclin E complex induces cell cycle arrest, and, as 
cyclin cyclincdk 
PCNA
NH2 COOH 
17-24 53-58 152-158
144-151 
Fig. 12 Cartoon to demonstrate the interaction sites of p21 with PCNA and 
cyclin/CDK complexes. 
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a transcriptional regulator, p21 induces cellular senescence and differentiation [Perkins, 2002]. 
Cytoplasmatic p21 however, shows proliferative influence by interacting with the CDK4/cyclin 
D1 complex which leads to the translocalisation of this complex into the nucleus and it inhibits 
apoptosis through binding to cytoplasmatic Ask1 and caspase 3 [Tanaka et al., 2002; Asada et al., 
1999].  
 
The carboxy-terminal domain furthermore includes a caspase cleavage site that is cleaved during 
apoptosis, leaving a protein unable to mediate growth arrest [Poon and Hunter, 1998; Zhang et 
al., 1999]. 
 
The different functions, relevant for this thesis, of p21 that are known are described in more 
detail below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.5.1 Role of  p21 in the cell cycle regulation 
 
As described in Sect. 1.2 (Page 6) the cell cycle consists of four phases, the G1-, S-, G2- and the 
M-phase (Fig. 5). The cell cycle is regulated and controlled by numerous proteins, ensuring that 
the DNA is fully replicated and distributed to the two resulting daughter cells. At different 
stages of the cell cycle, the cell cycle checkpoints, it is controlled whether the cell can continue 
cell cycle progression or not. If not, the cyclin dependent kinases (CDKs), which are needed for 
cell cycle progression, are inhibited. The protein p21 is one of the best described CDK 
inhibitors [Harper et al., 1993; Sherr et al., 1995; Gartel et al., 1996; Niculescu et al., 1998]. An 
elevated p21 level leads to G1- and S-phase cell cycle arrest [Ogryzko et al., 1997; Niculescu et al., 
1998; Radhakrishnan et al., 2004]. Upon DNA damage induction, the protein ATM (ataxia 
telangiectasia mutated; a serine/threonine protein kinase) is recruited to DSBs by the 
hMre11/Rad50/Nbs1 (MRN) complex [Falck et al., 2005; Lee and Paull, 2005]. The activated 
Cell-cycle 
Apoptosis 
DNA replication
DNA repair 
p21 
Fig. 13 Schematic to represent the different cellular events in which p21 has a 
biological function.  
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ATM phosphorylates other proteins, such as TP53, which leads to the stabilisation of TP53 
[review: Appella and Anderson, 2000; Kurz et al., 2004]. TP53 induces p21 directly on the 
transcriptional level, resulting in an increase of the p21 protein [review: Vogelstein et al., 2000] 
and leading to G1- and S-phase cell cycle arrest [Ogryzko et al., 1997; Niculescu et al., 1998] by 
inhibiting cyclin/CDK2 complexes [Brugarolas et al., 1999; Sherr et al., 1999]. It has been shown 
by Waldman et al. [1995] that p21-null cells fail to undergo cell cycle G1-arrest in response to 
DNA damage-induced TP53 stabilization, and both p21 and TP53 have been described to be 
essential to sustain the G2-phase cell cycle checkpoint after DNA damage in human cells as well 
[Bunz et al., 1998]. For an optimal inhibition of the cyclin/CDK complex, direct binding of both 
a cyclin and a CDK to p21 (aa. 17–24 and 53–58, respectively) is required [Chen et al., 1996]. 
 
Interestingly, cytosolic phosphomimetic p21, which is not able to interact with PCNA, has no 
inhibitory effect on the cell cycle function [Zhou et al., 2001]. Cytosolic localized p21, induced by 
the usage of a NLS-deficient construct however, was shown to lead to cell cycle progression 
[Dong et al., 2003]. This suggests that not only the subcellular localization (i.e. nuclear) of p21 
results in an inhibitory effect on the cell cycle, but also its interaction with PCNA is required to 
elicit G1-arrest. 
 
Different proteins can share sequence homologies due to which they compete in binding to the 
protein of interest. Protein p21 shares a sequence homology in its amino terminal domain (part 
of the cyclin binding site; aa. 17–24) with proteins such as p27, p57, positive regulators of 
cyclin/CDK complexes (for example Cdc25 phosphatase) and cyclin/CDK substrates (e.g. p107, 
p130 and E2F) [Saha et al., 1997]. It does not only compete with p107 and p130 for binding to 
cyclin/CDK complexes, as it has been shown by Shiyanov et al. [1996] that p21 is able to disrupt 
already formed complexes of p107 or p130 with cyclin/CDKs. By binding to other proteins, 
p21 furthermore seems to be able to lend its NLS that leads to the translocation of the bound 
complex from the cytoplasm to the nucleus, as is the case for the CDK4/cyclin D1 complex 
[Agell et al., 2006]. 
 
In contrast to its inhibitory effect on cell cycle progression, it has been stated that p21 is 
required for G1- to S-phase transition in some cell types and that p21 functions as an assembly 
factor for cyclin D1/CDK4 complexes [LaBaer et al., 1997; Weiss et al., 2000]. More recently 
studies also indicated a positive role for p21 toward cell proliferation [Dupont et al., 2003; Dong 
et al., 2004].  
 
 
 
 
1.5.2 p21 and DNA repair 
 
The role of p21 in DNA repair to date is unclear. In vitro studies by Pan et al. [1995] 
demonstrated that p21 negatively interferes with NER due to its interaction with PCNA and 
inhibiting DNA synthesis, which was supported by in vitro studies from Podust et al. [1995]. 
Cooper and colleagues [1999] showed by in vitro and in vivo studies, using purified N-terminal and 
C-terminal p21 fragments, that the C-terminus of p21 inhibits NER, while the N-terminus did 
not have any effect. Interestingly, addition of purified PCNA relieved the NER inhibition by the 
C-terminal fragment. Sheikh et al. [1997] found that p21 may modulate the NER process and 
Introduction 
 
 20 
that the clonogenic survival after UV-irradiation was increased when the p21 expression was 
artificially induced a few hours before and after UV exposure of DLD1 colorectal carcinoma 
cells. Contrarily, Shivij et al. [1994] suggested that p21 had no effect in NER, as supported by 
former in vitro findings of Li et al. [1994]. HCT116p21-/- cells showed no decrease in GGR or 
TCR, nor was the clonogenic survival after UV-irradiation altered by the absence of p21, 
suggesting that TP53-dependent NER does not require p21 [Adimoolam et al., 2001]. This was 
supported by experiments from Wani et al. [2002] who showed that p21-null HCT116 cells did 
not differ in their DNA repair response to UV-irradiation compared to wild type HCT116 
cells. Also studies with MEF cells lacking p21 only showed a minor effect on UV-induced 
DNA repair [Smith et al., 2000]. On the other hand, Bendjennat et al. [2003] has shown that 
ubiquitin-dependent proteolysis of p21 is required for PCNA recruitment at UV-induced 
DNA lesions. 
 
Recently, O'reilly et al. [2005] showed that the expression of BER repair enzymes was not altered 
in p21-deficient mice cells after exposure to oxidative stress although p21-wildtype cells showed 
an increased p21 level. This is contrary to former studies, where p21 was shown to decrease the 
BER ability in MEFs [Jaiswal et al., 2002]. Also, in vitro experiments by Tom et al. [2001] showed 
an inhibition of BER by p21, due to its interaction with PCNA. 
 
For DSB repair pathways, a direct role for p21 has not been shown. The results obtained during 
my Diploma Thesis [2002] showed no influence of p21 for the clonogenic survival or rejoining 
of DSB in HCT116 cells. When described in literature, it is as a part of the TP53 pathway where 
p21 is induced by TP53 following DSBs and p21 itself is not directly connected with DNA 
repair, as for example by Mirzayans and colleages [2004]. 
 
Furthermore, DNA-(cytosine-5) methyltransferase (MCMT; methylates newly replicated DNA) 
was shown to bind directly to PCNA and this PCNA-MCMT association was disrupted in 
human lung fibroblasts (MRC5 cells) by a peptide corresponding to aa. 141–160 of p21 [Chuang 
et al., 1997]. This suggests that p21 can control DNA methylation levels during replication as 
well as possibly DNA repair.  
 
 
 
 
1.5.3 Protein p21 and its role in apoptosis 
 
The function of p21 in apoptosis is also a main topic, as p21 can inhibit as well as induce 
apoptosis. It has been described that the anti- or pro-apoptotic character of p21 partly depends 
on its subcellular localization [Gartel and Tyner, 2002]. Nucleolar localized p21 was shown to be 
pro-apoptotic [Dotto, 2000; Gartel and Tyner, 2002], whereas cytosolic localized p21 has an 
anti-apoptotic character [Asada et al., 1999]. The exact pro-apoptotic function still has to be 
clarified, but for the anti-apoptotic role several models have been proposed. Due to the 
possibility to interact with proteins, such as c-IAP (inhibitor of apoptosis protein C) and 
procaspase-3, p21 is able to inhibit apoptosis [Asada et al., 1999]. Gartel and Tyner [2002] have 
described that by the translocation of p21 from the nucleus to the cytoplasm it interacts with the 
apoptosis signal-regulating kinase 1 (Ask1) through which cells are protected from apoptosis. 
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Furthermore, nuclear localize p21 permits DNA repair by arresting the cell cycle, whereby the 
cell does not undergo apoptosis as a result of DNA lesions [Raderschall et al., 2002]. 
 
 
 
 
1.5.4 Interactions of  p21 and PCNA 
 
PCNA has been shown to be required for NER [Shivji et al., 1994; Nichols and Sancar, 1992] 
and is involved in many other cellular DNA replication and repair activities [Prosperi, 2006; 
Maga and Hübscher, 2003; Warbrick, 2000]. PCNA encircles the DNA and functions as a 
sliding clamp, enhancing the processivity of replicative DNA polymerases. PCNA and p21 
physically interact through a PCNA binding site on p21 (aa. 144–151; see schematic Fig. 12) 
[Xiong et al., 1993; Kelman et al., 1998; Ando et al., 2001]. The p21 binding to PCNA was 
originally shown to suppress PCNA-dependent DNA replication, leaving NER unaffected [Li et 
al., 1994; Shivji et al., 1994; Waga et al., 1994; Chen et al., 1995; Luo et al., 1995; Sherr et al., 1999]. 
However, inhibition of PCNA-dependent NER by p21 has also been reported [Pan et al., 1995]. 
The fraction of p21 that is bound to active cyclin/CDK complexes in proliferating normal cells 
is also bound to PCNA [Zhang et al., 1994]. The binding of p21 to PCNA can be modulated by 
reversible phosphorylation of p21 at its C-terminal domain [Scott et al., 2000]. Neither the 
loading of PCNA onto DNA, nor the ability to move along DNA is affected by the p21 binding 
[Podust et al., 1995; Cazzalini et al., 2003], suggesting that the effects of p21 in inhibiting PCNA-
dependent DNA replication may depend on preventing interactions with other proteins. This 
has recently been proposed for the function of p21 in TLS, where the binding of p21 to PCNA 
causes release of polδ (the p21 bindingsite on PCNA overlaps the polδ bindingsite [Gulbis et al., 
1996; Zhang et al., 1998]) from the DNA lesion and PCNA [Livneh, 2006]. That p21 influences 
TLS is also supported by the results obtained from Avkin et al. [2006] who showed that p21, as 
TP53, are required for UV-induced mono-ubiquitination of PCNA. 
 
Fen 1 (Flap endonuclease 1) which is a 5'–3' exonuclease that is essential in DNA replication for 
the joining of Okazaki fragments and completion of the lagging strand DNA synthesis [Siegal et 
al., 1992; Waga et al., 1994] has been shown to bind to the same overlapping region of PCNA in 
competition with p21 [Warbrick et al., 1997; Chuang et al., 1997]. Through its interaction with 
PCNA its enzymatic activity is stimulated [Li et al., 1995; Wu et al., 1996].  
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2 RESULTS 
 
 
2.1 p21 and other DNA repair proteins accumulate along the tracks of  
heavy charged particles 
 
 
Several DNA repair-related proteins - in addition to p21 - have been shown to accumulate along 
the DNA lesions induced by the charged particle track throughout the nucleus. Due to the 
clustered nature of the DNA lesions produced by heavy charged particles, a strong and very 
distinct signal for the accumulating proteins is obtained. Particularly, with the conventional 
irradiation geometry where samples are irradiated perpendicular to the particle beam. With this 
set up, is has not been possible to discriminate the accumulations of SSB- from DSB-related 
proteins at the induced DNA lesions. Therefore, a different irradiation geometry was used to 
follow the accumulation of different proteins throughout the nucleus and along the particle 
trajectory. With this set-up, cells were irradiated while positioned at an angle of 5° or less 
towards the incoming particle beam. This idea and exposure unit was developed by Dr. B. Jakob 
(GSI) with the aim to discriminate between different proteins accumulating along the particle 
trajectory [Jakob et al., 2003]. I have used this new irradiation set-up to determine whether a 
distinct distribution of the various DNA lesions, especially DSBs and SSBs, and with this a 
distinct distribution of p21 and other proteins could be detected. 
 
The detection of DSBs was done by immunostaining for either γH2AX (γ-phosphorylated 
Histone 2AX) or 53BP1 (tumour suppressor p53 binding protein 1). Phosphorylation of the 
histone H2AX is induced in response to DSBs and has become a commonly used DSB marker 
[review: Fernandez-Capetillo et al., 2004]. 53BP1 is hyper-phosphorylated in response to DNA 
damage [Rappold et al., 2001] and is a more specific marker for two-ended DSBs (i.e. 
exogeneously induced DSBs) in most cell lines.  
 
For the detection of SSBs I decided to use indirect immunostaining of the XRCC1 protein (X-
ray repair cross complementing 1 protein). XRCC1 has been shown to be required for the repair 
of the SSB [Brem and Hall, 2005]. Furthermore, it interacts with several enzymes known to be 
involved in BER and SSB repair [Vidal et al., 2001]. 
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2.1.1 Detection of  p21 and 53BP1 at the heavy ion induced DNA 
lesions 
 
The response of both p21 and the DSB-related protein 53BP1 to heavy ion (HI) irradiation was 
investigated in confluent human fibroblasts (AG cells) by the detection of these proteins with 
the indirect immunostaining method. AG cells were irradiated with iron ions (6×106 p/cm2; 200 
MeV/u; 337 keV/μm) as described in Sect. 4.2.3 (page 95), fixed without extraction of the 
soluble proteins (Sect. 4.4.1, page 99) at the time-points indicated and immunostained for p21 
and 53BP1 (Sect. 4.4.4, page 100). Microscopic analyses were done as described in Sect. 4.5 
(page 101). 
 
Fig. 14 shows human fibroblasts at different times after irradiation. Overall mock-irradiated cells 
show no accumulation of p21 protein (Fig. 14 A). For 53BP1 however, a minority of the mock-
irradiated nuclei showed 1–3 53BP1 foci per nucleus. Also if the DSB marker protein γH2AX 
was visualized, as done in several experiments, this was observed. It must be noted, that the red 
fluorescence signal often is not very clear in the pictures shown below, however, during 
microscopic analysis, if not mentioned otherwise, a weak red signal is observed.  
 
A 
 
B 
 
C 
 
Mock-irradiated 2 min post-irradiation 1 h post-irradiation 
D E F 
3 h post-irradiation 5 h post-irradiation 16 h post-irradiation 
Fig. 14 Indirect immunostaining to visualize p21 and 53BP1 along the particle trajectory 
throughout the nuclei of the irradiated AG cells. Human fibroblasts were irradiated with the 
Fe ion beam (6×106 p/cm2; 200 MeV/u; 337 keV/μm) at an angle of less than 5° (Sect. 4.2.3) at 
the UNILAC facility at GSI. Cells were fixed at the indicated times post-irradiation without 
extraction of soluble proteins. The cells were stained for p21 (green) and 53BP1 (red), the nucleus 
is visualized by DNA staining using ToPro-3 (blue). A: mock-irradiated nuclei; B–F irradiated with 
Fe ions. Note: Panel E is without ToPro-3 staining. Bar: 10 μm. 
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As shown in Fig. 14 p21 and 53BP1 form distinct protein tracks throughout the nuclei after 
irradiation with Fe ions. Both proteins became visible as early as 2 min after exposure to HI 
(Fig. 14 B). At 1, 2, 3 and 5 hours after exposure, protein tracks are detected (Fig. 14 C–F). 16 h 
after irradiation, only few of the nuclei display particle-induced streaks of p21 and 53BP1 (not 
shown), and the majority of the irradiated cells did not show any detectable protein 
accumulations (Fig. 14 F). The pattern of the protein accumulations appears to change with an 
increase in incubation time after irradiation, with the early distinct and streaky accumulations for 
p21 and 53BP1 becoming more dispersed at longer times after irradiation (see discussion 3.1.2). 
Nonetheless, both p21 and 53BP1 still appear to be colocalizing at later times after irradiation (5 
h, Fig. 14 E). Note, that the protein tracks are discontinuous throughout the nucleus and appear 
to be localized in focal accumulations along the HI track.  
 
 
2.1.1.1 Colocalisation analysis of p21 and 53BP by Scion Image analysis 
 
To analyse whether two proteins, here p21 and 53BP1, colocalize the program Scion Image was 
used as outlined in Sect. 4.5.2. Employing Scion Image, it is possible to graphically display the 
intensity of the single channels from the microscopic analysis. Fig. 15 shows a representative 
graph obtained from the analysis by Scion Image.  
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Fig. 15 Representative analysis of the fluorescence intensities for p21 and 53BP1 accumulations 
along the particle trajectory. Displayed is the analysis of the nuclei shown in Fig. 14 panel D. A: For 
each channel, fluorescence is converted into grey scale. The track is manually marked and the enclosed 
area is analysed for intensity levels. B: Graph of the given intensities for each of the two proteins 
detected by immunofluorescence. As described in the text, the intensity maxima of both fluorescent 
signals are localised very similar. C: The fluorescence intensities of the immunostained proteins plotted 
together with the intensity of the DNA staining ToPro-3, showing that the reduced detectable intensity 
for both proteins corresponds to a lower level of DNA staining. 
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The nuclei analyzed (12, n = 31) give overlapping positions for the intensity maxima of p21 and 
53BP1, meaning that these proteins accumulate within the same region along the particle track. 
As obvious from Fig. 15, both the p21 and 53BP1 signals are reduced in some regions of the 
particle track. These discontinuous accumulations can not be explained by the physical 
distribution of ionisation events resulting from the HI track, as these shows a nearly continuous 
pattern along the ion trajectory (see Sect. 1.1.2 Fig. 2). It has been suggested that these 'gaps' in 
protein accumulation is due to the chromatin structure, i.e. the chromatin condensation [Jakob et 
al., 2003]. Even if the DNA dye ToPro-3 is not appropriate to analyse the level of chromatin 
condensation, the nucleoli with low DNA density are distiguishable [Martin et al., 2005]. The 
positions of low protein detection correlate with the area of reduced ToPro-3 staining, 
displaying the nucleoli (Fig. 15). The nucleoli were free of HI-induced accumulations of the 
immunostained proteins in all experiments done (data not shown). Only at the boundaries of the 
nucleoli, irradiation-induced focal accumulations of p21 and 53BP1 were detected in some cells 
(data not shown).  
 
 
 
 
2.1.2 XRCC1 colocalises with p21 along the heavy ion trajectory 
 
 
Due to the colocalization of p21 with the DSB-related protein 53BP1 along the HI tracks as 
shown above, I decided to study whether the structure of the detected foci results from a 
different distribution of the various DNA lesions. Here, p21 was immunostained (Sect. 4.4.4) in 
combination with the SSB-related protein XRCC1. Confluent fibroblasts were irradiated with 
iron ions (6×106 p/cm2; 200 MeV/u; 337 keV/μm) and fixed without extraction of the soluble 
proteins (Sect. 4.4.1) at 2 min, 30 min, 1 h, 2 h, 3 h, 5 h and 16 h after irradiation. 
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Fig. 16 Immunostaining for p21 and XRCC1 along the HI trajectories in human fibroblasts 
after exposure to Fe ions. Cells were irradiated with Fe ions (6×106 p/cm2; 200 MeV/u; 337 
keV/μm) and fixed at the times indicated without extraction of soluble proteins. p21 (green), 
XRCC1 (red), nucleus stained by ToPro-3 (blue). A: mock-irradiated AG cells; B–G: AG cells 
exposed to Fe ions. The accumulations of p21 mirror the particle trajectories. XRCC1 only show 
a weak signal, seen in panel C where the single channel is displayed. Note: Panel F no ToPro-3 
staining. Bar: 10 μm. 
 
Fig. 16 shows human fibroblasts nuclei and detection of p21 and XRCC1. The mock-irradiated 
cells (Fig. 16 A) do not show any protein accumulations, neither p21 nor XRCC1. Cells fixed 2 
min after HI irradiation, show clear protein tracks of p21 as well as weak signals for XRCC1 at 
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the damaged DNA sites induced by particle traversal (Fig. 16 B–D). Furthermore, the XRCC1 
accumulations show the same focal character as observed for p21 and 53BP1 (Fig. 14), giving 
colocalisation with the p21 accumulations. Five hours after irradiation, the protein tracks are still 
visible, but show a different pattern compared to earlier time-points (Fig. 16 F). The tracks 
become more dispersed with time, as also seen in the former experiment detecting p21 and 
53BP1 (Sect. 2.1.1.). Cells fixed 16 h post-irradiation showed neither visible protein tracks nor 
focal accumulations of p21 or XRCC1 (Fig. 16 G). Note, that some tracks continue from one 
nucleus to a neighbouring nucleus, displaying an ion trajectory traversing two nuclei (Fig. 16 E).  
 
 
 
2.1.3 Aprataxin accumulates at the HI-induced DNA lesions 
 
 
The previous experiments did not show differential accumulations for p21 and 53BP1 or p21 
and XRCC1, which made me study another protein called aprataxin. Aprataxin has recently been 
described to play a role in SSB repair and BER. Aprataxin deficient cells were shown to have an 
increased sensitivity to genotoxic agents but are not hypersensitive to IR [Gueven et al., 2004]. 
However, neither IR, MMS, MMC nor H2O2 exposure induced detectable aprataxin foci in 
HeLa cells transfected with EGFP-aprataxin [Gueven et al., 2004]. Due to the highly clustered 
DNA damage induction by HI irradiation, I investigated whether these clustered DNA lesions 
induced detectable aprataxin foci, maybe in a different pattern than the already studied proteins. 
For this, HeLa cells were transiently transfected with a plasmid encoding EGFP-aprataxin 
(transfected as described in Sect. 4.10.6) and irradiated with uranium ions (2×106 p/cm2; 11.4 
MeV/u; 14925 keV/μm) at a low angle (Sect. 4.2.3). The cells were fixed and stained for 
XRCC1 30 min after irradiation without extraction of the soluble proteins (Sect. 4.4.1). 
 
The mock-irradiated cells show the successful ectopical expression of the transfected EGFP-
aprataxin, with a high expression level in the nucleoli compared to the rest of the nucleus, but 
without any visible protein tracks (Fig. 17 upper panels, green fluorescence signal). In the 
irradiated cells, EGFP-aprataxin (green) as well as XRCC1 (red) form tracks across the nucleus, 
provoked by the HI traversals (Fig. 17 lower panels). Note that in this Fig. protein tracks are 
visible as if going through the nucleoli. This is obtained because the images shown represent the 
mean projection of the microscopically obtained stacks (12 planes). By displaying a single plane 
of the microscopically acquired stack, it is inferred that the protein tracks are either above or 
below the nucleolus (single planes not shown).  
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Fig. 17 Colocalisation of aprataxin and XRCC1 in HeLa cells post-irradiation with 
uranium ions. HeLa cells, ectopically expressing EGFP-aprataxin, 30 min post-irradiation (+) or 
mock-irradiated (-). XRCC1 visualized by red fluorescence (published: Gueven et al., Human 
Molecular Genetics, 2004). Right panels: merged pictures to demonstrate partial colocalisation of 
aprataxin and XRCC1 (yellow) after uranium ions only. Bar: 10 μm. 
 
 
 
2.1.4 DSBs and SSBs can not be differentiated by the new irradiation 
geometry. 
 
 
In the former experiments, the accumulation pattern of p21 at the HI-induced DNA lesions was 
shown to be very similar to the observed XRCC1 and aprataxin accumulations, both described 
to be involved in BER and SSB repair. Furthermore, the detected p21 also colocalized with the 
used DSB markers 53BP1 and γH2AX accumulations along the HI trajectories (Sect. 2.1.1, page 
23). This made me investigate, whether a differential distribution of γH2AX and XRCC1 can be 
visualized at the clustered HI-induced DNA lesions. However, the goal to differentiate between 
various DNA lesions induced by HI has not been obtained using an irradiation geometry that 
facilitates the analysis of the spatial distribution of the proteins accumulated at the DNA lesions 
along the particle trajectory, as written below. 
 
 
Fig. 18 display AG cells after irradiation with Fe ions and detection of γH2AX and XRCC1. 
γH2AX show clear HI-induced tracks throughout the nuclei at the taken time-points. The 
microscopic analysis also gave weak HI-induced fluorescence tracks for the detected XRCC1 
protein, the signal however is to low to be displayed in the figure. Very similar focal 
accumulations along the HI trajectory were obtained for both γH2AX and XRCC1 after Fe ions 
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exposure (6×106 p/cm2; 200 MeV/u; 337 keV/μm; Fig. 18). Analysis with Scion Image was 
performed to verify that both proteins accumulate at the same positions along the HI track. An 
example of this analysis is shown in Fig. 19 with two tracks throughout one nucleus at 5 h after 
irradiation. Each track is analyzed separately, giving the data for the green and red channels of 
the fluorescence signal along the track. Both channels show the maxima at the same position. At 
2 min and 1, 2, 3, and 5 hours after irradiation, γH2AX and XRCC1 tracks throughout the 
nuclei were detected and analysed (data not shown). Unlike for XRCC1, visible tracks for 
γH2AX were detected in some nuclei as late as 16 h post-irradiation (Fig. 18 D). Mock-irradiated 
cells did not show any protein accumulations (Fig. 18 A).  
 
 
A B 
mock-irradiated 2 h post-irradiation 
C 
 
5 h post-irradiation 
D 
16 h post-irradiation 
Fig. 18 Indirect immunoflourescence to visualize γH2AX and XRCC1 in human 
fibroblasts after Fe ion irradiation. γH2AX (green) and XRCC1 (red; detected by microscopic 
analysis, not clear visible in this figure), nucleus stained by ToPro-3 (blue). A: mock-irradiated 
AG cells. B–D irradiated with Fe ions. At early times post exposure the HI trajectory provokes 
streaky accumulations of both γH2AX and XRCC1. At 16 h post-irradiation only few nuclei 
show detectable protein tracks for γH2AX (D). Bar: 10 μm. 
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In summary, the results of these experiments show that p21 colocalises at the heavy ion tracks 
with γH2AX, 53BP1, XRCC1 and aprataxin. At the earliest time-point taken (2 min after 
irradiation) all proteins analyzed show detectable focal accumulations along the heavy ion tracks. 
In most experiments, the tracks of p21, 53BP1 and γH2AX are still visible in a few nuclei 16 h 
after DNA damage induction, XRCC1 however not. Here it must be noted though, that the 
obtained XRCC1 signal was weak compared to other stained proteins in all experiments done. 
Furthermore, I conclude that this experimental setup does not allow discriminating DSBs from 
SSBs after irradiation with heavy ions.  
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Fig. 19 γH2AX and XRCC1 accumulate with a similar pattern along the HI trajectory. 
Fluorescence intensities of γH2AX and XRCC1 are plotted for each track separately 
demonstrating colocalization of the intensity maxima within one track. Bar: 10 μm. 
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2.2 The accumulation of  p21 at heavy ion-induced DNA damaged sites 
is dependent on its interaction with PCNA 
 
 
Although p21 colocalises with PCNA at HI-induced DNA lesions and has a PCNA binding site, 
this does not prove an interaction of these two proteins at the DNA damaged site. To 
investigate whether one or both of the two proteins is dependent of the other for its foci 
formation at DNA lesions, the kinetics of p21 and PCNA accumulation was studied in more 
detail after HI irradiation. Furthermore, by the use of different p21 plasmids, I investigated 
whether p21 needs the intact PCNA binding site to accumulate at the HI-induced DNA lesions. 
Plasmids to elucidate this were kindly provided by Prof. Dr. S. Dimmeler (University of 
Frankfurt). 
 
To visualise PCNA with the available antibody by immunostaining a special extraction method 
became necessary (see Sect. 4.4.3). Chromatin-associated PCNA protein was detected by a 
method modified from Streck et al. [Mirzoeva and Petrini, 2001] referred to as the ‘GSI modified 
Streck method’ in further context. However, as p21 could not be detected using this method, 
the modified Streck method was altered slightly, such that chromatin-bound p21 could be 
visualized paralell with PCNA by immunostaining ('GSI-modified Streck method' see Sect. 
4.4.3). This adaptation led to both detectable PCNA and p21 foci after heavy ion irradiation. It 
should be mentioned though, that the PCNA as well as the p21 signal were proven to be fainter 
after extraction by the GSI-modified Streck method than after the original modified Streck 
method or the Hepes extraction method, respectively (data not shown). 
 
 
 
2.2.1 Kinetics of  p21/PCNA foci formation 
 
 
To investigate the kinetics of the p21/PCNA foci formation after exposure to heavy ions, 
confluent human fibroblasts were irradiated as described in Sect. 4.2.3 followed by extraction 
and fixation according to the GSI-modified Streck method (Sect. 4.4.3) and staining for p21 and 
PCNA (Sect. 4.4.4). After irradiation, the cells were incubated at 37°C as indicated. To 
investigate whether the kinetics of the foci formation is influenced by the incubation 
temperature, cells were incubated at two different temperatures during the experiment with 
chromium ion irradiation. The sample holders used for the irradiation were cooled or pre-
warmed at 4°C or 37°C, respectively and incubated at these temperatures for all samples fixed at 
5 min and 10 min post-irradiation. These two early time-points were chosen, as it was likely that 
if there was a temperature dependent difference in the foci formation for p21 and PCNA, this 
would be shortly after irradiation. For radiation safety reasons, the shortest time-point possible 
to fix the samples after irradiation was 2 min. In parallel to this experiment, cells were irradiated 
in pre-warmed medium and incubated at 37°C for 15 min, 30 min and 7 h. Table 1 shows the 
different types of heavy ions which were used for the experiments to elucidate the kinetics of 
the p21 and PCNA foci formation. 
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Ion 
Fluence 
[P/cm2] 
Energy 
[MeV/u] 
Energy on target 
[MeV/u] 
LET 
[keV/µm] 
Cr 2×106 11.4 5.6 281 
Ni 2×106 11.4 4.5 3790 
U 2×106 11.4 4.2 14925 
Table 1 Ions used to study the p21/PCNA kinetics. 
 
Immunostained nuclei to visualize the time-course of appearance for p21 (green) and PCNA 
(red) after exposure to Cr ions (2×106 p/cm2; 11.4 MeV/u; 2810 keV/μm) are shown in Fig. 20 
DNA is visualized by ToPro-3 staining (blue). At the first time-point taken, in this experiment 5 
min post-irradiation, p21 and PCNA foci were readily detectable (Fig. 20 B). Focal 
accumulations of both proteins were clearly visible at 5, 10, 15 and 30 min post-irradiation (Fig. 
20 B–E). However, 7 h after irradiation, hardly any p21 or PCNA foci could be detected (Fig. 20 
F). Sporadically, an S-phase cell was observed, showing a high level of PCNA staining (data not 
shown). 
 
 
A 
 
B C 
 
mock-irradiated 5 min post-irradiation 10 min post-irradiation 
D 
 
E F 
 
15 min post-irradiation 30 min post-irradiation 7 h post-irradiation 
Fig. 20 Early time-course of p21 and PCNA foci formation in human fibroblasts after 
irradiation with chromium ions. A: mock-irradiated cells. Soluble proteins were extracted 
according to the GSI-modified Streck method and the cells fixed at the indicated times at 37°C 
after irradiation. Focal accumulations for p21 (green) and PCNA (red) are seen 5, 10, 15, and 30 
min post-irradiation (B–E); 7 h after irradiation, only very few nuclei show focal protein 
accumulations (F). Mock-irradiated cells did not show any focal formation of either p21 or 
PCNA (A). DNA visualized by ToPro-3 staining (blue). Bar: 10 μm. 
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The influence of the temperature on the foci formation was analysed by manually counting 
visible p21 and PCNA foci in several nuclei. This was also done for the analysis of the kinetics 
of the focal formation of both proteins (Table 2). 
 
 
Incubation time 
post-irradiation 
Incubation 
temperature 
Cells with p21 
foci 
Cells with PCNA 
foci 
Number of nuclei 
analyzed (n) 
5 min 4°C 41% 98% 41 
5 min 37°C 54% 81% 81 
10 min 4°C 33% 100% 39 
10 min 37°C 69% 93% 67 
15 min 37°C 47% 99% 67 
30 min 37°C 79% 97% 78 
7 h 37°C 2% 5% 41 
Mock-irradiated 37°C 0% 0% 40 
Table 2 Analysis of early detectable p21/PCNA foci in human fibroblasts after irradiation with Cr. 
 
Independent of the temperature the majority of the cells showed PCNA foci at 5 min after 
exposure to chromium ions, while approximately half of the nuclei visualized p21 foci as 
summarized in Table 2 above. One third of the cells which were fixed 10 min post-irradiation 
showed p21 foci and all of the cells analyzed showed PCNA foci, if the medium was cooled 
compared to app. two third with p21 foci and almost all with PCNA foci in warm medium. 
After 15 min, app. half of the cells showed p21 foci and all of the cells were positive for PCNA 
foci when kept in 37°C medium. At 30 min post-irradiation, more of the cells irradiated in 37°C 
medium, had detectable p21 foci (79%) and nearly all cells showed PCNA foci. The cells that 
were fixed 7 hours after irradiation hardly showed any detectable foci formations for both 
proteins. Only in 2% of the cells p21 foci were seen and in 5% of the cells PCNA foci could be 
detected.  
 
The temperature at which the cells were kept during the experiment had a slight influence on the 
number of nuclei with detectable p21 foci in this experiment, giving more detectable p21 foci at 
37°C. With the PCNA foci however, the temperature did not seem to be of major importance. 
Also the early time-course of focal accumulations post HI exposure was not significantly 
changed. The same result was obtained in a second experiment (data not shown). Because of 
only the minor change in the detectable p21 foci, the following experiments were done in 37°C 
medium as the possibility of inducing cellular stress factors is assumed to be higher due to the 
cooling down to 4°C  
 
The time-course of protein accumulation of p21 and PCNA was investigated after HI irradiation 
with the ions displayed in Table 1. After irradiation with uranium ions (2×106 p/cm2; 11.4 
MeV/u; 14925 keV/μm) already 2 min post-irradiation nearly all nuclei showed detectable p21 
foci and all showed PCNA foci (supplement 6.1 Fig. 71 B). 15 min post-irradiation the majority 
of nuclei had visible p21 foci and all nuclei showed PCNA foci, compared to a slight reduction 
of p21 positive nuclei at 1 h after irradiation, where still all nuclei visualized PCNA foci 
(supplement 6.1 Fig. 71 D and E, respectively). 
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Incubation time 
Cells with p21 
foci 
Cells with PCNA 
foci 
Number of nuclei 
analyzed (n) 
2 min 95% 100% 76 
15 min 88% 100% 40 
1 h 78% 100% 27 
Mock-irradiated 0% 0% 40 
Table 3 Dectectable p21/PCNA foci after uranium ion irradiation in human fibroblasts. 
 
Both p21 and PCNA showed focal accumulations at the early times. Even if not all nuclei 
displayed p21 foci, approximately the half of them did after chromium ion irradiation and 
almost all after uranium ions irradiation. This shows that both proteins investigated are able to 
accumulate at the damaged DNA sites at a very early time-point after DNA damage induction 
by heavy ions. Furthermore, these results indicate a slightly slower recruitment of p21 at the HI-
induced DNA lesions compared to the PCNA recruitment. 
 
A possible role for p21 at DNA damaged sites following UV irradiation has been described 
discussing that p21 might loosen PCNA from the DNA damaged sites to help recycling the 
PCNA protein [Stivala et al., 2001]. Because of these findings, I decided to investigate the 
vanishing of the p21 and PCNA accumulations at the heavy ion induced DNA lesions after 
irradiation with nickel ions, in spite of the known problem of protein detection after the 
extraction of the soluble proteins as described above (Sect. 2.2, page 31). For this, human 
fibroblasts were irradiated with Ni ions followed by fixation and extraction according to the 
GSI-modified Streck method. Because hardly any foci were detectable 7 h after irradiation with 
chromium ions, and nickel has a very similar LET, I decided to take samples with an incubation 
time below 7 h after irradiation.  
 
Human fibroblasts irradiated with Ni ions and fixed 30 min, 1, 2, 3 or 5 h post-irradiation 
showed accumulations of p21 as well as PCNA (supplement 6.1 Fig. 72 B–F). Analysis showed, 
as summarized in Table 4 below, that within this chosen time frame, a maximum of cells 
showing p21 foci occurred 3 h post-irradiation (75%). However, 5 hours after irradiation, still 
many nuclei showed visible p21 foci (60%), with less nuclei displaying PCNA foci (40%). It 
must be noted that 5 h after irradiation the p21 level was quite high compared to the earlier 
taken time-points due to an induction of the p21 protein level and PCNA was hardly visible, 
making me analyze only 10 nuclei for a preliminary result. 
 
 
Incubation time 
Cells with  
p21 foci 
Cells with PCNA 
foci 
Number of nuclei 
analyzed (n) 
30 min 63% 95% 41 
1 h 31% 97% 29 
2 h 66% 100% 29 
3 h 75% 96% 28 
5 h 60% 40% 10 
Mock-irradiated 0% 0% 40 
Table 4 Analysis of the p21/PCNA dissolvement after nickel ion irradiation. 
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Even if the analysis by further investigation may support the described role for p21 after UV 
irradiation to loosen PCNA from the DNA lesion, the method used here seemed too limited to 
clarify the accumulation and resolution of p21 and PCNA and I did not expand these 
experiments. Live analysis of tagged proteins would be needed to clarify the exact kinetics.  
 
 
 
2.2.2 Transient expression of  mutant forms of  p21 in mammalian cells 
 
 
The results presented above (Sect. 2.1) demonstrate that p21 and PCNA colocalize after heavy 
ion irradiation. Furthermore, both proteins appear to form foci similarly fast after exposure to 
heavy ions. This made me investigate whether the p21 foci formation after HI irradiation is 
affected by p21's direct interaction with PCNA.  
 
It has been shown by Rossig et al. [2001] that the binding of p21 to PCNA is regulated by 
specific phosphorylation of the threonine 145 residue of p21 by the protein kinase Akt (Fig. 21). 
If this residue (Thr145) is phosphorylated, p21 can no longer interact with PCNA. I investigated 
whether ectopically expressed phospho-mimetic p21T145D abrogates p21 foci formation after 
HI irradiation. Prof. Dr. Dimmeler of the University of Frankfurt kindly provided three 
different expression plasmids for full-length human p21. The first plasmid carries the wild-type 
p21 (wtp21) open reading frame (ORF). Both of the other plasmids express p21 with a single-
site mutation each at Thr145 to either abrogate p21’s interaction with PCNA (p21T145D, 
phospho-mimetic) or to not inhibit p21’s interaction with PCNA (non-phosphorylatable, 
p21T145A). All cDNAs were expressed from a CMV promoter as (his)6- and c-myc-tagged C-
terminal fusions (pcDNA3.1; Rossig et al., 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The three different plasmids were transfected individually into HCT116p21-/- cells or HeLa cells. 
HCT116p21-/- cells lack endogenous p21 due to targeted integrations at both p21 alleles 
[Waldman et al., 1995] and HeLa cells express extremely low levels of their endogenous p21 
protein because of their instable TP53. Endogenous p21 in HeLa cells could not be detected by 
Western Blot analysis or by immunofluorescence (IF) (Fig. 23 and Sect. 2.2.5 Fig. 29, 
cyclin cyclincdk 
PCNA
NH2 COOH 
17-24 53-58 152-158
144-151 
Thr145
Fig. 21 Cartoon to demonstrate the interaction sites of p21 with PCNA and cyclin-CDK 
complexes. Arrow: Threonine145, Akt phosphorylation site, which is replaced by aspartic acid 
(D) or alanine (A). Mutant p21T145D is not able to bind PCNA. 
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respectively). Thus, if a p21 signal is detected with a p21 specific antibody in these two cell lines, 
transfected with one of the p21 expression plasmids, it will be the ectopically expressed p21 
protein. 
 
To test whether a normal cell system gives the same results with the ectopically expressed p21 
plasmids, I anticipated to transfect human fibroblasts, which I mainly use for other experiments 
in this thesis, as well. However, human fibroblasts are difficult to transfect, probably because of 
their extracellular matrix. Neither with Lipofectamine, nor with FuGene a positive signal for 
ectopic p21 could be detected by IF (data not shown). Only when a nucleofector (Amaxa, Köln, 
Germany) was used, transfection was possible, but the transfection efficiency for the human 
fibroblasts was below 10% (data not shown). For this reason, experiments with the p21 
expression plasmids in human fibroblasts were carried out solely to check whether the 
ectopically expressed p21 protein retains its wild-type functions that are relevant to this thesis.  
 
Ectopic expression and with this the successfully transfection of the plasmids was verified by 
Western Blot analysis (Sect. 4.9). Fig. 22 shows an example of the WB analysis of transfected 
HCT116p21-/- cells with the wtp21 or p21T145D plasmid by FuGene (Sect. 4.10.6). Twenty-
four hours after transfection of the HCT116p21-/- cells Laemmli lysates were made as described 
in Sect. 4.7.1. The lysates were analysed by Western Blot analysis for p21 and α-tubulin (see Sect. 
4.9). Tubulin detection verifies equal loading and transfer of the cell lysates across the gel (Fig. 
22 upper bands in lane 2–5; not shown in further displayed WB). The non-transfected 
HCT116p21-/- cells do not express p21 as expected (Fig. 22 lane 2). Lanes 3 and 4 display the 
HCT116p21-/- cells transfected with wtp21 or p21T145D, respectively. Clear bands are seen for 
these two transfected cell lysates using an antibody to detect p21. Additionally, HCT116p21+/+ 
cell lysate was loaded onto the SDS-PAGE, as a control for the WB analysis and to check the 
endogenous p21 expression of these cells (Fig. 22 lane 5). It is seen, that the endogenous p21 
expression level is only a fraction of the amount of the exogenous p21 expression levels. 
Furthermore, the ectopically expressed p21 runs at a higher molecular weight because of its C-
terminal tags (approximately 25 kDa versus 21 kDa). 
 
 
Lane           1    2          3          4           5 Exposure time: 30 sec. 
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p21his6-cmyc 
 
 
p21 
Lane  
1 Molecular weight marker RPN 800 
2 HCT116p21-/- cells non-transfected 
3 HCT116p21-/- cells transfected with wtp21 
4 HCT116p21-/- cells transfected with p21T145D 
5 HCT116p21+/+ cells 
Fig. 22 Representative example of the Western Blot analysis of the expression levels of 
transiently expressed wtp21 and p21T145D in HCT116p21-/- cells (lanes 3 and 4). Lane 1: 
Molecular weight marker RPN 800. Lane 2: non-transfected HCT116p21-/- cells. Lane 5: non-
transfected HCT116p21+/+ cells. WB: α-tubulin and p21. 
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The Western Blot analysis in Fig. 23 displays the expression of the ectopically expressed p21 
protein in HeLa cells. HeLa cells were transfected with the wtp21, p21T145A or p21T145D 
plasmid with Lipofectamine as described in Sect. 4.10.6. Twenty-four hours after transfection, 
protein lysates were prepared according to Laemmli (Sect. 4.7.1) and Western Blot analysis was 
done (Sect. 4.9). HeLa cells transfected with the p21T145A, p21T145D or wtp21 plasmid show 
a very high level of p21 (Fig. 23 lane 1, 2 and 4). At this exposure time (1 min), the p21 signal of 
the AG cells, used as a control for the Western Blot analysis and to show the position of 
endogenously expressed p21 protein, is not visible (Fig. 23 lane 6). After 5 min of exposure, the 
endogenous p21 of the AG cells was detected (Fig. 23 lane 6). Transfected HeLa cells show 
several bands in the Western Blot analysis, the main band running higher than the p21 band of 
the AG cells, because of the additional tag. The other detectable bands after the longer exposure 
time (5 min) are caused by degradation fractions and complexation with other proteins of the 
ectopically expressed p21 that are not fully denatured due to the very high expression level. 
Non-transfected HeLa cells do not express any detectable p21 (Fig. 23 lane 5). This verified the 
transfection and expression of the p21 expression plasmids in HeLa cells and showed that all 
three plasmids were expressed at very similar levels, meaning that the site-directed mutagenesis 
of T145 in p21 does not affect the protein expression level in HeLa cells (lanes 1, 2 and 4). 
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Exposure time: 5 min 
Lane: 
1 HeLa cells transfected with p21T145A 
2 HeLa cells transfected with p21T145D 
3 Molecular weight marker RPN 800 
4 HeLa cells transfected with wtp21 
5 Non-transfected HeLa cells 
6 AG lysate 
 
Fig. 23 Representative Western Blot to show extracts from HeLa cells transiently 
transfected with three different plasmids to express p21T145A (lane 1), p21T145D (lane 2) 
or wtp21 (lane 4). All plasmids show similarly high expression levels for p21. Lane 5: non-
transfected HeLa cells. Lane 6: non-transfected human fibroblasts (AG1522C). WB: p21.  
 
These results confirmed the successful transfection of plasmids and the ectopical expression of 
recombinant p21 in HCT116p21-/- cells and HeLa cells. Furthermore, ectopically expressed 
wild-type and mutant forms of p21 could be monitored by the same anti-p21 antibody 
(Cip1/Waf1 from Transduction Laboratories). 
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2.2.3 Recombinant wild-type p21 and p21T145A retain the interaction 
with both CDK and PCNA 
 
 
After establishing a method to detect a p21/PCNA complex by specific p21 pulldown from 
cells expressing p21 compared to no immunoprecipitated complex from Hela cells as described 
in Sect. 2.8, the effect of three different ectopically expressed p21 constructs was studied. The 
expressed protein from the p21T145A plasmid is a p21 plasmid with a point-mutation at Thr145 
to Ala145 which makes it non-phosphorylatable [Rossig et al., 2001] and with this able to interact 
continuously with PCNA (see schematic Sect. 2.2.2, Fig. 21). Herewith, immunoprecipitation of 
ectopically expressed p21T145A from HeLa cells should result in co-precipitation of 
endogenous PCNA. To investigate this, HeLa cells were transfected with the wtp21 or 
p21T145A plasmid by the use of Lipofectamine (Sect. 4.10.6). Cell lysates were prepared 24 h 
after transfection according to Sect. 4.8.1, followed by anti-p21 immunoprecipitation as 
described in Sect. 4.8. To verify the immunocomplex of the ectopically expressed p21, 
immunoprecipitations were done both with an anti-p21 antibody and with an anti-myc antibody. 
The immunoprecipitated complex was separated by SDS-PAGE and detected for p21 and 
PCNA by Western Blot analysis (Sect. 4.9).  
 
 
Lane                     1            2             3             4     5 Exposure time: 15 sec. 
   
 
 
PCNA 
 
p21his6-cmyc 
p21 
Lane 
1 Molecular weight marker RPN 800 
2 p21 IP non-transfected HeLa cells 
3 p21 IP HeLa cells transfected with wtp21 
4 p21 IP HeLa cells transfected with p21T145A 
5 Crude lysates: AG1522 cells laemmli lysate  
 
Fig. 24 Western Blot analysis of anti-p21 immunoprecipitates from HeLa cell lysates. The 
ectopically expressed wtp21 and p21T145A co-immunoprecipitate PCNA. WB: PCNA and p21. 
 
The WB analysis displayed above shows that no p21 complex is immunoprecipitated from the 
non-transfected HeLa cells (Fig. 24 lane 2). The anti-p21 complex obtained from the HeLa cells 
transfected with the wtp21 plasmid, shows clear p21 and PCNA signals in this WB analysis (Fig. 
24 lane 3). Importantly, the anti-p21 complex from the HeLa cells transfected with the 
p21T145A plasmid also contains PCNA (Fig. 24 lane 4). Lane 5 gives the signals for 
endogenous p21 and PCNA in crude lysates from AG cells, verifying the Western Blot analysis. 
Hela crude cell lysate is not loaded, as they were shown to have a non-detectable p21 level (Sect. 
2.2.2, Fig. 23). 
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The WB analysis of the immunoprecipitated complex with the myc antibody resulted in a p21 
and PCNA signal for the HeLa cells transfected with either wtp21 or p21T145A as shown in 
Fig. 25 (lanes 3 and 4, respectively). Anti-myc immunoprecipitation from non-transfected HeLa 
cells results in a slight background signal after PCNA detection, but does not show a clear p21 
or PCNA band (Fig. 25 lane 2). This signal is not observed after p21 immunodetection as seen 
in the former Fig. 24. Crude lysate from AG cells displays a weak PCNA signal, but no p21 due 
to the small amount of total protein loaded where p21 is only a minor fraction because of the 
confluent grown cells (G1-phase of the cell cycle) and the short exposure time (Fig. 25 lane 5). 
This verifies that the former immunoprecipitated p21 complex indeed is a result of specific 
immunoprecipitation of the ectopically expressed p21 as after the myc-pulldown the same result 
is obtained. 
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PCNA 
p21his6-cmyc 
Lane  
1 Molecular weight marker RPN 800 
2 myc IP non-transfected HeLa cells 
3 myc IP HeLa cells transfected with wtp21 
4 myc IP HeLa cells transfected with p21T145A 
5 Crude lysates: AG1522 cells Laemmli lysate 
Fig. 25 The anti-myc complex shows both precipitated exogenous p21 and co-precipitated 
PCNA in HeLa cells transfected with either the wtp21 or p21T145A plasmids. WB: PCNA 
and p21.  
 
The point-mutation at Thr145 should only affect the interaction of the expressed protein with 
PCNA, functional interactions with other proteins such as CDK2 which binding site is in the aa. 
53–58 region should be retained (see Fig. 21). To investigate whether the ectopically expressed 
p21 protein retains its ability to complex with CDK2, the Western Blot was probed for the 
presence of CDK2 as shown below in Fig. 26.  
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Lane                 1      2              3              4             5 Exposure time: 3 min 
   
 
 
CDK2 
PCNA 
p21his6-cmyc 
Lane 
1 Molecular weight marker RPN 800 
2 myc IP non-transfected HeLa cells 
3 myc IP HeLa cells transfected with wtp21 
4 myc IP HeLa cells transfected with p21T145A 
5 Crude lysates: AG1522C laemmli lysate 
 
 
Fig. 26 WB analysis of the immunoprecipitated anti-myc complex from HeLa cells 
transfected with the wtp21 or p21T145A plasmids results in a detectable CDK2 signal. 
WB: CDK2, PCNA and p21. 
 
As seen above, the wtp21 transfected HeLa cells show a detectable CDK2 signal on the Western 
Blot (Fig. 26 lane 3). A weak CDK2 signal is also obtained for the HeLa cells transfected with 
p21T145A which is in line with the weaker p21 signal obtained (Fig. 26 lane 4). The non-
transfected HeLa cells have no detectable CDK2 signal (Fig. 26 lane 2). The additional loaded 
crude lysate from AG cells show a weak CDK2 band (Fig. 26  lane 5). 
 
My results show that ectopically expressed wtp21 and p21T145A are able to form a complex 
with both PCNA and CDK2 in HeLa cells. 
 
 
 
 
2.2.4 Recombinant p21T145D no longer interacts with PCNA 
 
 
The p21T145D plasmid encodes a mutant p21 protein in which Thr145 was substituted by Asp, 
a phospho-mimetic residue. The protein expressed from this plasmid should not be able to 
interact with PCNA as described in Sect. 2.2.2 (page 35). To verify the lack of interaction, HeLa 
cells were transfected with the p21T145D plasmid as described in Sect. 4.10.6. Native cell lysates 
were prepared 24 h after transfection followed by specific anti-p21 or anti-myc pulldowns (Sect. 
4.8). Western Blot analysis was done to analyze components of the p21T145D complex (Sect. 
4.9). 
 
In Western Blot analysis, precipitated p21 is visible in HeLa cells transfected with wtp21 or with 
p21T145D (Fig. 28 lanes 3 and 4, respectively). Non-transfected HeLa cells do not show any 
detectable p21 signal after anti-p21 immunodetection and Western Blot analysis (Fig. 28 lane 2). 
In crude lysates from AG cells weak p21 signal migrating slightly below the recombinant tagged 
version of p21 is detected (Fig. 28 lane 5). When the same Western Blot was probed to an anti-
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PCNA antibody, a clear signal for HeLa cells expressing ectopic wtp21 and for crude lysates 
from AG cells is detected (Fig. 28 lanes 3 and 5, respectively), but no PCNA is detected in anti-
p21 immunoprecipitations from non-transfected HeLa cells or from HeLa cells expressing 
p21T145D (Fig. 28 lanes 2 and 4 respectively). These results confirm the inability of p21T145D 
to bind to PCNA, similarly to what has been observed in umbilical cord cells [Rossig et al., 
2001]. 
 
 
Lane           1           2           3           4           5  Exposure time: 15 sec. 
   
 
 
 
PCNA 
 
p21his6-cmyc 
p21 
Lane  
1 Molecular weight marker RPN 800 
2 p21 IP non-transfected HeLa cells 
3 p21 IP HeLa cells transfected with wtp21 
4 p21 IP HeLa cells transfected with p21T145D 
5 Crude lysates: AG1522C laemmli lysate 
 
Fig. 27 No PCNA is bound to the phospho-mimetic p21T145D when expressed in HeLa 
cells. Western Blot analysis of the anti-p21 complexes from the HeLa cells. HeLa cells 
transfected with the wtp21 plasmid give a clear PCNA and p21 band (lane 3). HeLa cells 
transfected to express p21T145D do not show PCNA in anti-p21 complexes (lane 4). Negative 
control: non-transfected HeLa cells (lane 2). Lane 5: crude cell lysates from AG cells. WB: PCNA 
and p21. 
 
Immunoprecipitations utilizing the anti-myc antibody were also carried out in order to only 
precipitate the tagged version of p21. The WB analysis for these immunoprecipitations is shown 
in Fig. 29. A weak non-specific signal is detected in the anti-myc complexes from non-
transfected HeLa cells, as well as in HeLa cells transfected with the p21T145D plasmid after 
PCNA immunodetection of the WB (supplement 6.2 Fig. 73 lane 2 and lane 4, respectively). 
However, a specific band for PCNA, as in lane 3 containing the anti-myc protein complex of 
HeLa cells expressing recombinant wtp21 is not detected. 
 
The same Western Blot was probed for anti-CDK2 to test whether p21T145D retains the ability 
to bind CDK2. As the p21T145D carries a single residue change within the PCNA binding site, 
the interaction of p21T145D with CDK2 should not be affected if the mutant form folds 
correctly (see Fig. 21). The WB analysis in Fig. 29 displays the result after CDK2 detection 
together with PCNA and p21. Crude lysates from AG cells show a signal for CDK2 and PCNA, 
p21 however is not visible (Fig. 28 lane 1). The anti-myc IP from the non-transfected cells 
shows background signal that results from the previous detected PCNA signal (supplement 6.2 
Fig. 73) but no CDK2 or p21 signal (Fig. 28 lane 2). Clear CDK2 and p21 bands, as well as the 
formerly detected PCNA band, are seen in precipitates from HeLa cells expressing ectopic 
wtp21 (Fig. 28 lane 3). The HeLa cells expressing p21T145D also display a CDK2 and p21 
band, without any detectable PCNA signal (Fig. 28 lane 4). This means, that the expressed 
p21T145D protein indeed is able to form a complex with other proteins such as CDK2 and is 
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likely to fold in wild-type conformation. However, its interaction specifically with PCNA is 
abrogated due to the amino acid substitution at Thr145. 
 
 
Lane               1            2        3       4        5    Exposure time: 5 min 
   
 
 
 
CDK2 
PCNA 
 
p21his6-cmyc 
 
Lane 
1 Crude lysates: AG1522 laemmli lysate  
2 Myc IP mouse Non-transfected HeLa cells 
3 Myc IP mouse HeLa cells transfected with wtp21 
4 Myc IP mouse HeLa cells transfected with p21T145D 
5 Molecular weight marker RPN 800 
 
Fig. 28 CDK2 is co-immunoprecipitated in anti-myc pulldowns from HeLa cells 
expressing p21T145D. Western Blot analysis to show the components of the p21 complex in 
HeLa cells, either non-transfected (lane 2), transfected with the wtp21 plasmid (lane 3) or with 
the p21T145D plasmid (lane 4). WB: PCNA, CDK2 and p21. WB: CDK2, PCNA and p21. 
 
Sequence analysis of the p21T145D plasmid was carried out and the single amino acid change 
from Thr to Asp at Thr145 was confirmed (see Sect. 4.10.5.4 page 122). 
 
 
 
 
2.2.5 The non-phosphorylatable p21T145A accumulates at the sites of  
particle traversal 
 
 
The non-phosphorylatable p21T145A protein was shown to interact with PCNA by 
immunoprecipitation experiments (Sect. 2.2.3, page 38). Whether the ectopically expressed 
p21T145A protein also is able to form HI-induced foci was investigated after irradiation with 
nickel and zinc ions. HeLa cells were transfected with the p21T145A or with the wtp21 plasmid 
as described in Sect. 4.10.6.2 (page 123). The cells were irradiated and fixed 30 min after 
irradiation without extraction of the soluble proteins to be able to detect the transfected cells 
(Sect. 4.4.1). Fig. 29 displays HeLa cells after immunostaining for p21 (green) in combination 
with 53BP1 (red) to visualise the sites of damaged DNA. Mock-irradiated cells show expression 
of p21 as seen by the green fluorescence throughout the nucleus, but no focal accumulations, as 
expected (Fig. 29 A and D). The 53BP1 protein accumulates to single foci in many of the mock-
irradiated cells as it has been observed in previous experiments (Sect. 2.1.1, page 23). p21T145A 
accumulates to foci in the irradiated nuclei 30 min after exposure to Ni ions, as does 53BP1 (Fig. 
29 B and C) and ectopically expressed wtp21 (Fig. 29 E and F). The experiments were repeated 
with both zinc and gold ion irradiations, leading to the same results (data not shown). 
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mock-irradiated 30 min post-irradiation 30 min post-irradiation plasmid 
A B C 
 
 
+p21T145A 
 
D E F 
 
 
+wtp21 
 
mock-irradiated 30 min post-irradiation 30 min post-irradiation  
Fig. 29 Ectopically expressed p21T145A and wtp21 accumulate at HI-induced DNA 
lesions. HeLa cells transfected with the p21T145A (A–C) or wtp21 (D–F) plasmid. A and D: 
mock-irradiated cells. B, C, E and D: 30 min post-irradiation with Ni ions (2×106 p/cm2; 11.4 
MeV/u; 3790 keV/μm); Immunostained for p21 (green) and 53BP1 (red), DNA counterstained 
by ToPro-3 (blue). Mock-irradiated cells show single 53BP1 foci. Bar: 10 μm. 
 
To make sure that only the ectopically expressed p21 proteins and not endogenous p21 is 
detected, HeLa cells transfected with wtp21 or p21T145A were immunostained for the myc-tag 
of the ectopically expressed protein. As seen in Fig. 30 focal structures of the myc-tagged p21 
forms and of 53BP1 are visible 30 min after irradiation with zinc ions (3×106 p/cm2; 11.4 
MeV/u; 4120 keV/μm; panels B, C, E and F). Mock-irradiated cells show expression of the 
ectopically expressed p21 in some of the nuclei, but no p21 accumulations (green fluorescence 
signal in panels A and D). 
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mock-irradiated 30 min post-irradiation 30 min post-irradiation plasmid 
A B C  
 
 
 
 
+p21T145A 
 
 
D E F  
 
 
 
 
+wtp21 
 
    
Fig. 30 Ectopically expressed wtp21 and p21T145A is detectable by anti-myc 
immunostaining. HeLa cells transfected with p21T145A, irradiated with Zn ions (3×106 p/cm2; 
11.4 MeV/u; 4120 keV/μm) and fixed 30 min post-irradiation. Clear irradiation-induced protein 
accumulations of the myc-tagged versions of p21 are detectable after irradiation (B and C). A: 
mock-irradiated cells. Anti-myc antibody (green) and 53BP1 (red). DNA counterstained with 
ToPro-3 (blue). Note: some cells express the p21 cytoplasmatically (B). Bar: 10 μm. 
 
Following detection of the myc tag by immunostaining, HeLa cells transfected with the wtp21 
plasmid show the same results as obtained for the HeLa cells transfected with the p21T1145A 
plasmid (Fig. 30, lower panels). In sum, these results demonstrate that the amino acid exchange 
from Thr to Ala at residue 145 does not affect the ability of p21 to accumulate at the HI-
induced damaged DNA sites. The same experimental results were gained after exposure to gold 
ions (data not shown). 
 
To exclude false-positive results non-transfected HeLa cells irradiated with zinc ions (3×106 
p/cm2; 11.4 MeV/u; 4120 keV/μm) were immunostained for p21 in combination with 53BP1 
(Sect. 4.4.4). Fig. 31 displays the non-transfected HeLa cells which were fixed without extraction 
of the soluble proteins 30 min after irradiation. No signal is detected for p21 in these cells, 
neither in the mock-irradiated, nor in the irradiated samples (Fig. 31) and in line with the results 
presented by Western Blot analysis (Sect. 2.2.2, Fig. 23). For 53BP1 however, irradiation-
induced protein accumulations are obtained, as expected (Fig. 31 C). 
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A 
 
B C 
mock-irradiated 30 min post-irradiation 30 min post-irradiation 
Fig. 31 In non-transfected HeLa cells p21 cannot be detected by immunofluorescence. 
Non-transfected HeLa cells irradiated with Zn ions (3×106 p/cm2; 11.4 MeV/u; 4120 keV/μm; 
B and C) and fixed 30 min post-irradiation. A: mock-irradiated cells. p21 (green) and 53BP1 
(red); ToPro-3 counterstained DNA: blue. Bar: 10 μm. 
 
The response of ectopically expressed wtp21 was also investigated in a p21-null cell line 
(HCT116p21-/-) which, in contrast to HeLa cells, should not express any endogenous p21 at all. 
The HCT116p21-/- cells were transfected to express wtp21 (Sect. 4.10.6) and fixed 30 min after 
irradiation with gold (3×106 p/cm2; 11.4 MeV/u; 13030 keV/μm) or uranium ions (3×106 
p/cm2; 11.4 MeV/u; 14925 keV/μm) without extraction of the soluble proteins (Sect. 4.4.1). 
Immunostaining was done for p21 or myc in combination with γH2AX or 53BP1 (Sect. 4.4.4). 
The HCT116p21-/- cells, as shown in Fig. 32, display detectable accumulations of the ectopically 
expressed wtp21 protein in response to HI irradiation (panels B, C, E, F, H and I). 
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mock-irradiated 30 min post-irradiation 30 min post-irradiation particle and staining 
A B C  
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p21/53BP1 
p21/53BP1 p21/53BP1 p21/53BP1  
D E F  
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p21/H2AX 
 
p21/ H2AX  p21/H2AX p21/H2AX  
G H I  
 
 
 
U 
 
 
myc/53BP
1 
myc/53BP1 myc/53BP1 myc/53BP1  
Fig. 32 In p21-null HCT116 cells ectopically expressed wtp21 accumulates to foci after HI 
irradiation. HCT116p21-/- cells were fixed and stained after irradiation with gold (3×106 p/cm2; 
11.4 MeV/u; 13030 keV/μm; B and C) or uranium ions (3×106 p/cm2; 11.4 MeV/u; 14925 
keV/μm; E, F, H and I). A, D and G: mock-irradiated cells. DNA: blue (ToPro-3). Bar: 10 μm.  
 
To verify that the behaviour of the ectopically expressed protein is comparable with the 
endogenous p21, cells from the wtp21 sister cell line, HCT116p21+/+ cells were immunostained 
for p21, γH2AX, 53BP1 or XRCC1 after irradiation with gold ions (3×106 p/cm2; 11.4 MeV/u; 
13030 keV/μm)). As seen in Fig. 33 (panel D and E) the HCT116p21+/+ cells show similar HI-
induced protein accumulations as do the HCT116p21-/- cells for ectopically expressed wtp21 
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and endogenously expressed γH2AX, 53BP1 and XRCC1 (Fig. 32). The anti-myc staining in 
HCT116p21+/+ cells however, did not give any signal, as expected (Fig. 33 F). 
 
 
A B C  
 
 
 
 
mock-
irradiated 
p21/53BP1 γH2AX/XRCC1 myc/53BP1  
D E F  
 
 
 
30 min 
post-irr. 
    
Fig. 33 Endogenous p21 in HCT116p21+/+ cells shows the similar focal accumulations as 
the ectopically expressed wtp21 in HCT116p21-/- cells (as seen in Fig. 32). HCT116p21+/+ 
cells irradiated with gold ions (3×106 p/cm2; 11.4 MeV/u; 13030 keV/μm) and immunostained for 
p21, γH2AX, myc, 53BP1 or XRCC1. A–C mock-irradiated cells; D–F: 30 min post-irradiation. 
green: p21, γH2AX or myc. red: 53BP1 or XRCC1. DNA: blue (ToPro-3). Bar: 10 μm. 
 
These results show that ectopically expressed wtp21 and p21T145A in HeLa cells and 
HCT116p21-/- cells act very similar to the endogenously expressed p21 in HCT116p21+/+ cells 
and that the tagged versions of p21 are able to form HI-induced focal accumulations at the 
damaged DNA sites independently of endogenous p21. 
 
 
 
 
2.2.6 The phospho-mimetic p21T145D does not accumulate at the sites 
of  particle traversal 
 
 
The previous section showed that ectopically expressed p21 protein, which is able to interact 
with PCNA forms foci at the HI-induced DNA lesions. If the accumulation of p21 at damaged 
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DNA sites is independent of its direct interaction with PCNA, the p21T145D protein should 
also be able to form irradiation-induced foci. The experiments described below elucidate the 
dependency of p21 on PCNA.  
 
HeLa cells transfected 24 hours before irradiation to express p21T145D as described in Sect. 
4.10.6 were irradiated with gold ions (2×106 p/cm2; 11.4 MeV/u; 13030 keV/μm) and fixed 
without extraction 30 min after irradiation (Sect. 2.4.1). Following fixation, the cells were 
immunostained for p21 and 53BP1 with counterstaining of the DNA by ToPro-3 (Sect. 4.4.4).  
 
Fig. 34 shows the successful expression of p21T145D in HeLa cells by immunostaining (green 
fluorescence). Mock-irradiated cells (Fig. 34 A and C) give a detectable p21 or myc signal 
dispersed throughout the nucleus. 53BP1 displays detectable foci in some of these non-
irradiated nuclei. After DNA damage induction by irradiation with gold ions, still no 
accumulations of p21T145D were detected either by using the anti-p21 or the anti-myc antibody 
(Fig. 34 B and D). An elevated amount of visible 53BP1 foci verifies the induction of DNA 
damage by the gold ion irradiation. The same results were obtained after irradiation with Ni and 
Zn ions (data not shown). 
 
 
mock-irradiated 30 min post-irradiation staining 
A 
 
B  
 
 
 
 
p21/53BP1 
   
C 
 
D  
 
 
myc/53BP1 
   
Fig. 34 The phospho-mimetic p21T145D protein does not accumulate to foci at the HI-
induced DNA lesions. HeLa cells transfected with the plasmid p21T145D, fixed and 
immunostained for the indicated proteins after irradiation with gold ions (2×106 p/cm2; 11.4 
MeV/u; 13030 keV/μm)). A and C: mock-irradiated cells; B and D: 30 min post irradiation. DNA: 
blue (ToPro-3). Bar: 10 μm. 
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Additionally, HCT116p21-/- cells were transfected with the p21T145D plasmid and irradiated 
with gold (3×106 p/cm2; 11.4 MeV/u; 13030 keV/μm)) or uranium ions (3×106 p/cm2; 11.4 
MeV/u; 14925 keV/μm). The immunostaining of p21 or myc and 53BP1 or γH2AX resulted in 
the same observations as described for the HeLa cells above. Also in this cell system, the 
phospho-mimetic p21T145D is not able to form foci at the HI-induced DNA lesions as seen in 
Fig. 35 below.  
 
 
mock-irradiated 30 min post-irradiation 30 min post-irradiation particle 
A B C  
 
 
 
 
Au 
p21/53BP1 p21/53BP1 p21/53BP1  
D E F  
 
 
 
 
U 
p21/h2ax p21/h2ax myc/BP  
Fig. 35 The phosphomimetic p21T145D does not form foci in HCT116p21-/- cells after 
exposure to heavy ions. HCT116p21-/- cells transfected with the p21T145D plasmid and 
stained for p21 or myc (green) and 53BP1 or γH2AX (red). B and C: nuclei irradiated with gold 
ions; E and F: nuclei irradiated with uranium ions; A and D mock irradiated. DNA: blue (ToPro-
3). Bar: 10 μm. 
 
With these experiments, I have shown that the accumulation of p21 at HI-induced DNA lesions 
is affected by its direct interaction with PCNA. The protein p21T145D that is not able to bind 
to PCNA does not form HI-induced foci as illustrated above; suggesting that p21 only 
accumulates at the induced DNA damaged sites if it can interact with PCNA. Furthermore, this 
shows that p21 and PCNA interact at the induced DNA lesions. The association of this 
complex with the chromatin was investigated on biochemical level as described in the following 
section. 
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2.3 PCNA and p21 are part of  the chromatin-bound protein fraction 
after DNA damage induction by X-ray irradiation 
 
 
In the previous section, I have been able to show that the accumulation of p21 at heavy ion-
induced DNA lesions is dependent on the interaction with PCNA. Here, I elucidate 
biochemically that the p21/PCNA complex associated with the induced DNA lesions after X-
ray exposure is chromatin-associated. 
 
The experiments described in Sect. 2.2 (page 31) were done with heavy ions to detect protein 
complexes at the induced DNA lesions by indirect immunostaining. To do so, single protein 
tracks throughout the irradiated nuclei were visualized along the damaged DNA sites induced by 
the heavy ion trajectories. The amount of accumulated protein to these distinct tracks is 
comparatively small and not expected to be detectable with the established protocols to assess 
the chromatin-associated protein fraction. Therefore, I decided to induce homogenously 
distributed DNA lesions by a high dose of X-ray irradiation, to gather as much DNA damage-
induced chromatin-associated proteins as possible. To analyze chromatin-associated proteins, 
subcellular fractionation is carried out in which the soluble protein fraction is separated from the 
chromatin-bound protein fraction.  
 
PCNA is mainly part of the soluble protein fraction, except during the S-phase of the cell cycle 
or during DNA repair. In confluent cultured cells the amount of chromatin-bound PCNA is 
very low, giving rise to the possibility to verify the efficiency of the subcellular fractionation 
method by comparing irradiated confluent cells with mock-irradiated confluent cells in their 
detectable chromatin-associated PCNA amounts. After establishing an appropriate method for 
subnuclear fractionation, immunodetection for p21 was carried out as well. For verification of 
an equal amount of total protein loaded actin was detected. Several methods were tested and 
modified until a reproducible result was achieved, as described below.  
 
 
 
2.3.1 Establishment of  a method to detect chromatin-bound PCNA 
 
 
Subcellular fractionation studies according to a protocol of Balajee and Geard [2001] (see Sect. 
4.7.3, page 105, for the exact protocol) led to high amounts of PCNA in the final pellet from 
both the mock-irradiated and the irradiated cells (data not shown). Using this method the pellet 
is discarded, as the supernatant is considered to contain the chromatin-bound protein fraction. 
In this approach, the protocol was modified according to Savio et al. [Savio et al., 1996] where 
the chromatin-bound proteins are released by an additional incubation of the final pellet with 
DNase I. To assess the fraction of proteins possibly still remaining within the final pellet, the 
pellet was further incubated under denaturing conditions in Laemmli buffer (Sect. 4.7.1). 
However, even with the DNase I digest, a huge amount of PCNA was still detected in these 
Laemmli lysates obtained from the remaining pellet of mock-irradiated and irradiated cells (data 
not shown).  
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To minimize the amount of S-phase cells and exclude this as possible reason for the PCNA 
signal in the former experiment, AG cells were cultured for 3 days under serum starvation, a 
common used method to induce cellular quiescence. Three serum concentrations were used 
instead of the normally 20% v/v serum concentration in the culture medium, to see if a 
difference could be achieved: 0.2%, 0.4% and 10% v/v serum. The analysis was done by 
microscopically detecting the S-phase cells after immunostaining for PCNA (Sect. 4.4.4, page 
100). This resulted in 2.7% (n = 113), 3.2% (n = 217) and 4.4% (n = 270) S-phase cells for 0.2%, 
0.4% and 10% serum, respectively (data not shown). Additional flow cytrometric analysis was 
done for cells kept under 0.4% serum starvation, measuring 5% of all analyzed cells in S-phase 
(data not shown). I conclude that the low fraction of cells in S-phase should not interfere with 
the nuclear fractionation experiments. For this reason, another method described by Xu and 
Stern [2002] was tested.  
 
According to Xu and Stern [2002] the subcellular fractions (e.g. cytosolic, nuclear and 
chromatin-bound protein fractions) are mainly separated by centrifugation after sequent lyses of 
the cell and nuclear membranes. The chromatin-bound protein fraction is then released by 
resuspension of the pellet, containing the chromatin-bound protein fraction in Laemmli buffer. 
With this method, hardly any chromatin-bound PCNA could be detected for the mock-
irradiated or for irradiated G1-phase cells at different times after irradiation (from 0.5 h up to 48 
h after irradiation; data not shown).  
 
A successful and reproducible subcellular fractionation procedure was finally achieved using the 
protocol from Stivala and Prosperi [2004]. Using this protocol, no PCNA signal for mock-
irradiated AG cells and clearly detectable PCNA signals for AG cells at 3 h after irradiation with 
8 Gy or 30 Gy X-rays were detected. A representative WB is shown in Fig. 36. The WB is 
probed for PCNA and β-actin. Detection of β-actin was used to asses the amount of total 
protein loaded (Fig. 36, upper bands). Lanes 2–3 and 12–14 display the soluble protein fractions. 
Here, a clear PCNA signal is observed for all samples: the mock-irradiated cells (lanes 2 and 12), 
the cells irradiated with 8 Gy (lanes 3 and 13) and the cells irradiated with 30 Gy X-rays (lanes 4 
and 14). The chromatin-bound protein fractions are loaded in lanes 5–7. The mock-irradiated 
cells do not show a detectable level of chromatin-bound PCNA (lane 5). After X-ray irradiation 
though, a clear signal for the chromatin-bound PCNA is obtained for the cells irradiated with 8 
Gy or 30 Gy X-rays (lanes 6 and 7, respectively). Interestingly, the detectable chromatin-bound 
PCNA fraction is higher for the cells irradiated with 30 Gy compared to the cells irradiated with 
8 Gy (Fig. 36 lane 7 versus 6). Lanes 15–17 show the supernatant from the first wash of the 
pellet containing the nuclei with the chromatin-bound protein fraction. Lanes 18–20 display the 
supernatant from the second wash of the nuclei, before the chromatin-bound proteins are 
released from the DNA. It is seen, that after the first wash, still PCNA and actin are detectable 
on the WB (Fig. 36 lanes 15–17). In the supernatant obtained after the second wash however, 
no detectable PCNA and only a very weak signal for β-actin were observed (lanes 18–20). Taken 
together, I conclude that all the soluble proteins are removed using the wash and extraction 
procedure described above, leaving only the chromatin-bound protein fraction in the pellet. 
Chromatin-bound proteins can then be released from the DNA by digestion with DNase I (Fig. 
36 lanes 5–7). 
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Lane       1       2       3        4       5        6       7       8       9      10     11    12     13     14     15     16      17     18      19     20  
    
  
 
β-actin 
 
 
PCNA 
Lane 
1  Molecular weight marker RPN 800 
2  mock-irradiated, soluble fraction 
3  8 Gy / 3 h post-irr., soluble fraction 
4  30 Gy / 3 h post-irr., soluble fraction 
5  mock-irradiated, chromatin-bound fraction 
6  8 Gy / 3 h post-irr. chr.-bound fraction 
7  30 Gy / 3 h post-irr., chr.-bound fraction 
8  mock-irradiated, remaining pellet 
9  8 Gy / 3 h post-irr., remaining pellet 
10  30 Gy / 3 h post-irr., remaining pellet 
 
Exposure time:  
β-actin: 8 min; PCNA: 20 sec 
 
Lane 
11  Molecular weight marker RPN 800 
12  mock-irradiated, soluble fraction 
13  8 Gy / 3 h post-irr., soluble fraction 
14  30 Gy / 3 h post-irr., soluble fraction 
15  mock-irradiated, wash 1 
16  8 Gy / 3 h post-irr., wash 1 
17  30 Gy / 3 h post-irr., wash 1 
18  mock-irradiated, wash 2 
19  8 Gy / 3 h post-irr., wash 2 
20  30 Gy / 3 h post-irr., wash 2 
 
Exposure time:  
β-actin: 8 min; PCNA: 20 sec 
 
Fig. 36 Mock-irradiated AG cells do not have a detectable amount of chromatin-bound 
PCNA. Total protein loaded: soluble: 15 μg; wash 1: 10 μg; wash 2: 1.4 μg; chromatin-bound 
(chromat.): 5 μg; pellet: 2.5 μg. WB: β-actin and PCNA. 
 
As with this method finally a clear irradiation-induced chromatin-bound fraction of PCNA was 
detected, the membrane was also probed for p21. Furthermore, as the sample irradiated with 30 
Gy X-rays showed an elevated amount of chromatin-associated PCNA compared to the sample 
irradiated with 8 Gy X-rays cells were irradiated with 30 Gy X-rays in the following experiments. 
 
 
 
 
2.3.2 The chromatin-bound p21 is degraded during subcellular 
fractionation 
 
 
Human fibroblasts were irradiated with 30 Gy X-rays and subcellular fractionation according to 
the established protocol (Sect. 4.7.3) was carried out at 1 h or 3 h after exposure. A 
representative WB obtained after detection of PCNA and p21 is displayed in Fig. 37. The 
soluble protein fractions show clear signals for PCNA and p21 (Fig. 37 lanes 2–4 and 12–14). 
Also the first washes of all three samples contain detectable PCNA and p21 protein signals (Fig. 
37 lanes 15–18). Wash 2 from the mock-irradiated and the irradiated sample at 1 h after 
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irradiation have hardly any visible protein-bands, the wash 2 from the cells incubated 3 h after 
irradiation gives a weak PCNA and a very weak p21 signal (Fig. 37 lane 20). The chromatin-
bound fractions however, do not have a detectable p21 band at the normally expected position 
at 21 kDa, but instead show bands of lower molecular weight (i.e. ~ 15 kDa; Fig. 37 lanes 5–7). 
As this signal is detected by the specific p21 antibody and a slight increase is seen with 
incubation time after irradiation, I assume that it is degraded p21 protein. The remaining pellets 
do not show any signal for PCNA or p21 after WB analysis (Fig. 37  lanes 8–10). 
 
 
Lane          1       2        3       4       5       6        7       8       9      10    11    12     13     14      15     16      17     18     19     20  
   
  
 
 
β-actin 
   
 
 
 
PCNA 
 
p21 
 
Lane 
1 Molecular weight marker RPN 800 
2 mock-irradiated, soluble fraction 
3 30 Gy X-ray 1 h post-irr., soluble fraction 
4 30 Gy X-ray 3 h post-irr., soluble fraction 
5 mock-irradiated, chromatin-bound fraction 
6 30 Gy X-ray 1 h post-irr. chr.-bound fraction 
7 30 Gy X-ray 3 h post-irr., chr.-bound fraction 
8 mock-irradiated, remaining pellet 
9 30 Gy X-ray 1 h post-irr., remaining pellet 
10 30 Gy X-ray 3 h post-irr., remaining pellet 
 
34 μg/lane AG1522C  
 
Lane 
11 Molecular weight marker RPN 800 
12 mock-irradiated, soluble fraction 
13 30 Gy X-ray 1 h post-irr., soluble fraction 
14 30 Gy X-ray 3 h post-irr., soluble fraction 
15 mock-irradiated, wash 1 
16 30 Gy X-ray 1 h post-irr., wash 1 
17 30 Gy X-ray 3 h post-irr., wash 1 
18 mock-irradiated, wash 2 
19 30 Gy X-ray 1 h post-irr., wash 2 
20 30 Gy X-ray 3 h post-irr., wash 2 
 
17 μg/lane AG1522C 
 
Fig. 37 The chromatin-bound fraction of p21 appears to be degraded after subcellular 
fractionation studies according to Prosperi et al. Exposure time: β-actin 20 sec; PCNA/p21 1 
min. WB: β-actin, PCNA and p21. 
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2.3.3 Full-length p21 in the chromatin-bound fraction 3 h after 30 Gy 
X-rays 
 
 
The degradation of the chromatin-bound p21 fraction obtained in the former experiment 
described above was assumed to be caused by the DNase I treatment, which was done at 37°C 
for 30 min. To release the chromatin-bound proteins however, a digestion of the DNA is 
required, as in previous experiments the chromatin-bound protein fraction to a big part 
remained in the pellet that is discarded. To solve this problem I digested the DNA by the use of 
Benzonase instead of DNase I, which does not need an incubation temperature of 37°C, but is 
active already at 4°C. With this modification, p21 was not degraded during the DNA digest. Fig. 
38 shows an exemplary WB analysis with detection of β-actin, PCNA and p21. AG cells were 
exposed to 30 Gy X-rays and subjected to subcellular protein fractionation at 1 h or 3 h after 
exposure. The soluble protein fraction of all samples has a detectable quantity of PCNA and p21 
(Fig. 38 lanes 2–4). PCNA is not detected in the chromatin-bound protein fraction of the mock-
irradiated sample (Fig. 38 lane 5). Cells lysed 1 h or 3 h after X-ray exposure have a clear 
detectable chromatin-bound PCNA fraction as seen in lanes 6 and 7, respectively (Fig. 38). The 
PCNA is almost completely cleared out of the resulting pellet, as hardly any PCNA is detected 
following lysis by Laemmli buffer (Fig. 38 lanes 8–10). A weak signal for full-length p21 is 
detected in the soluble protein fractions of all samples (Fig. 38 lanes 2–4), showing a slight 
increase for the cells incubated 3 h after exposure (Fig. 38 lane 4). The chromatin-bound protein 
fraction has a detectable p21 signal in the lysate gained from the cells lysed 3 h after irradiation 
compared to a not detectable p21 signal for mock-irradiated cells (Fig. 38 lane 7 versus lane 5). 
Irradiated cells, which were lysed 1 h after irradiation, show a very weak p21 band (Fig. 38 lane 
6). As seen in lanes 8–10 a little amount of p21 still remained in the resulting pellet, with an 
increase with the incubation time after exposure (Fig. 38 lane 10 compared to lane 9). 
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Lane                          1           2          3          4          5          6           7           8           9        10  
  
 
 
 
 
β-actin  
(Exposure time: 15 sec) 
 
PCNA 
(Exposure time: 4 min) 
 
 
p21  
(Exposure time:30 min)  
Lane 
1 Molecular weight marker RPN 800 and AG lysat 
2 mock-irradiated, soluble fraction 
3 30 Gy X-ray 1 h post-irradiation, soluble fraction 
4 30 Gy X-ray 3 h post-irradiation, soluble fraction 
5 mock-irradiated, chromatin-bound fraction 
6 30 Gy X-ray 1 h post-irradiation chromatin-bound fraction 
7 30 Gy X-ray 3 h post-irradiation, chromatin-bound fraction 
8 mock-irradiated, remaining pellet 
9 30 Gy X-ray 1 h post-irradiation, remaining pellet 
10 30 Gy X-ray 3 h post-irradiation, remaining pellet 
 
 
Fig. 38 p21 is part of the chromatin-bound protein fraction and can be detected 3 h after 
exposure to 30 Gy X-rays. Representative WB analysis for the presence of p21, PCNA and β-
actin after subcellular fractionation at 1 h and 3 h after exposure of human fibroblasts to 30 Gy 
X-rays. Note: Small amounts of PCNA remain within the pellet after Benzonase digest. The 
fraction of p21 that is not released by Benzonase treatment is approximately 50%. WB: β-actin, 
PCNA and p21. 
 
These results show that a method has been established with which a chromatin-bound protein 
fraction containing p21 and PCNA can be detected by Western Blot analysis. PCNA and p21 
are both shown to be detectable components of the DNA-associated protein fraction 3 h after 
DNA damage induction by exposure to 30 Gy X-rays. Interestingly, the PCNA level appears to 
be elevated at 1 h after irradiation compared to 3 h after irradiation, which was also seen in other 
experiments. The opposite is seen for p21, where the signal is elevated at 3 h after exposure. 
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2.4 p21 forms foci after low LET ionizing radiation 
 
 
In the previous section, p21 and PCNA both are shown to be part of the chromatin-bound 
fraction after X-ray irradiation by biochemical analysis. Also, the accumulation of these proteins 
after high LET has been studied here by immunocytochemistry (Sect. 2.2, page 31). However, it 
was not possible to discriminate high LET-induced foci for proteins involved in different DNA 
repair processes and a change in irradiation geometry did not help to further elucidate the repair 
pathways in which p21 is involved after charged particle irradiation. With X-ray irradiation 
though, a more homogeneous distribution of the various DNA damaged sites is induced. As a 
consequence, a more dispersed distribution of different DNA lesions and focal protein 
accumulations may answer the question as to what DNA repair pathway requires the 
relocalization of p21 after radiation damage. Here, I tried to visualise p21 accumulations after 
DNA damage induction by X-ray irradiation. And indeed, in normal human fibroblasts p21 
accumulates to small but discrete foci after irradiation with X-rays. Immunocytochemistry to 
detect p21 as well as other DNA repair proteins was carried out to investigate whether the focal 
accumulations of p21 after X-rays are associated with a specific DNA repair pathway.  
 
 
 
2.4.1 p21 foci are detectable after exposure to X-rays 
 
 
Human fibroblasts were first studied 3 h after exposure to X-rays as my previous experiments 
showed that at 3 h post 30 Gy X-rays a significant fraction of the p21 protein had associated 
with the chromatin. The samples were immunostained for p21 and γH2AX as described in Sect. 
4.4.4 (page 100). Without extraction of the soluble proteins, the p21 level throughout the 
nucleus is very heterogeneous and the p21 level of the soluble p21 fraction possibly too high to 
discriminate radiation-induced focal p21 accumulations from background staining (data not 
shown). This problem was abolished here by the use of the Hepes extraction buffer. 
 
Fig. 39 shows an example for p21 foci at 3 h after irradiation with 10 Gy X-ray irradiation. 
Soluble proteins were extracted with Hepes buffer (Sect. 4.4.2), followed by immunostaining of 
the fixed cells for p21 and γH2AX (Sect. 4.4.4). Focal accumulations of p21 (green) are visible in 
the irradiated AG cell nuclei (panel B). γH2AX foci (red) are also detected, but they are not as 
distinct as the p21 accumulations. Mock-irradiated cells do not show focal structures for p21 
(panel A). However, some nuclei show 1–3 γH2AX foci (not seen in the Figure shown below). 
Note, that the two proteins do not seem to colocalize in contrast to the results obtained from 
previous experiments using heavy ions (Sect. 2.1 and 2.2). 
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A B 
mock-irradiated 3 h post-irradiation 
Fig. 39 X-ray irradiation induces detectable p21 foci 3 h after irradiation. Human fibroblasts 
fixed and extracted with Hepes buffer 3 h after irradiation with 10 Gy X-rays. Immunostaining 
was carried out for p21 (green) and γH2AX (red). A: mock-irradiated cells; B: 3 h post-irradiation; 
DNA: blue (ToPro-3). Bar: 10 μm. 
 
 
 
 
2.4.2 Time-course for p21 foci formation after X-rays 
 
 
To elucidate at which time after X-ray irradiation p21 foci accumulate, human fibroblasts were 
irradiated with 10 Gy X-rays and fixed at 1, 3, 5, and 22 h after irradiation. Prior to 
immunostaining for p21 and γH2AX (Sect. 4.4.4) the soluble proteins were extracted with 
Hepes buffer as described in Sect. 4.4.2 (page 99). Mock-irradiated fibroblasts hardly show any 
p21 signal (green) after extraction (Fig. 40). As a positive control for the irradiation and to 
display induced DSBs γH2AX was stained, leading to clearly detectable foci in all irradiated 
samples (Fig. 40 panels B–E). As stated above, mock-irradiated fibroblasts also show a few 
γH2AX foci in some nuclei. Focal accumulations for p21 are visible in a minority of the nuclei at 
1 h after irradiation (Fig. 40 panel B) and 3 h post-irradiation most of the irradiated cells show 
p21 foci (Fig. 40 panel C). At 5 h post exposure to 10 Gy X-rays, the number of nuclei with p21 
foci appears to be reduced and 22 h after irradiation no focal accumulations for p21 are detected 
(Fig. 40 panels D and E, respectively). 
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A 
 
B 
 
 
mock-irradiated 1 h post-irradiation  
C 
 
D 
 
E 
 
3 h post-irradiation 5 h post-irradiation 22 h post-irradiation 
Fig. 40 Human fibroblast nuclei show p21 foci at 3 h after exposure to 10 Gy X-rays. Human 
fibroblasts were stained for p21 (green) and γH2AX (red) after extraction of the soluble proteins 
with Hepes buffer. A: mock-irradiated cells; B–E: irradiated cells fixed at the indicated times post-
irradiation; DNA: blue (ToPro-3). Bar: 10 μm. 
 
 
2.4.3 Dose dependency for p21 accumulations after X-irradiation 
 
 
As described above (Sect. 2.4.2) p21 foci were visible in almost all of the irradiated nuclei at 3 h 
after X-irradiation. To elucidate whether p21 colocalizes with other proteins at these X-ray 
induced DNA lesions, an irradiation dose at which the foci both are visible and can be 
discriminated from focal accumulations of other DNA repair proteins is favorable to carry out 
colocalisation analysis with Scion Image (Sect. 4.5.2). For this, human fibroblasts were irradiated 
with 2, 4, 6, 8 or 10 Gy X-rays followed by fixation and extraction of the soluble proteins by 
Hepes buffer 3 h post-irradiation. Immunostaining was carried out for p21 and γH2AX.  
 
Cells irradiated with 2 Gy X-rays show a slight irradiation-induced appearance of detectable p21 
(green) and γH2AX (red) signals, however these foci are too weak to be analyzed (Fig. 41 panel 
B). 4 Gy X-rays induce more foci for both proteins dispearsed throughout the nuclei, and after 6 
Gy the induced protein accumulations seem to be more easily distinguishable by eye (Fig. 41 
panels C and D, respectively). 8 Gy X-rays induce very distinct p21 foci throughout the nuclei 
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that are clearly seen, where the γH2AX foci are more indistinct than the p21 foci (Fig. 41 panel 
E). After 10 Gy X-irradiation, focal structures can still be discriminated, but the total number of 
p21 foci per nucleus is very high (Fig. 41 panel F). Note that the number of p21 foci is 
noticeably higher than the accumulations for γH2AX (Fig. 41 panels E and F visualise this 
observation). 
 
 
A 
 
B C 
 
mock-irradiated 2 Gy 4 Gy 
D 
 
E F 
 
6 Gy 8 Gy 10 Gy 
Fig. 41 Increasing number of detectable p21 foci with X-ray dose in human fibroblasts. 
Human fibroblasts irradiated with the indicated dose, fixed and extracted with Hepes buffer 3 h 
post-irradiation. Immunostained for p21 (green) and γH2AX (red). A: mock-irradiated cells; B–F: 
3 h post irradiation with the indicated X-ray dose. DNA: blue (ToPro-3). Bar: 10 μm. 
 
To confirm the lack of colocalisation I repeated the experiment with immunostaining carried 
out for p21 and 53BP1. As the amount of visible p21 foci after DNA damage induction by 10 
Gy X-rays are possibly too high for analysis of colocalization, this X-ray dose was not used 
again. Fig. 42 displays the nuclei from AG cells at 3 h after X-ray irradiation with the indicated 
doses, followed by fixation and extraction with Hepes buffer and immunostaining for p21 
(green) and 53BP1 (red). As in the former experiment, with an X-ray dose of 2 Gy already 
distinct p21 foci are detected (Fig. 42 B) and an increase in number of visible protein 
accumulations with the applied radiation dose is seen for both p21 and 53BP1 (Fig. 42 panels 
B–E). 53BP1 seems to show more foci than the γH2AX in the former experiment after 2 Gy X-
rays (Fig. 42 panel B). The clearest and still distinguishable p21 foci are detected after an X-ray 
exposure with 8 Gy. 
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mock-irradiated  2 Gy  
C 
 
D E 
 
4 Gy 6 Gy 8 Gy 
Fig. 42 Dose dependency for p21 and 53BP1 foci in human fibroblasts 3 h after X-rays. 
Human fibroblasts irradiated with the indicated dose, fixed and extracted with Hepes buffer 3 h 
post-irradiation. p21 (green) and 53BP1 (red). A: mock-irradiated cells; B–E: 3 h post-irradiation 
with the indicated X-ray dose. DNA: blue (ToPro-3). Bar: 10 μm. 
 
 
2.4.4 Colocalisation analysis for p21 foci with DSB related proteins 
 
 
In the previous section I have been able to show that p21 forms distinct focal accumulations 
after X-ray irradiation. Furthermore, p21 and the DSB markers γH2AX or 53BP1 do not seem 
to colocalise and differed in the number of detectable foci by visual observation. Here the 
colocalisation of p21 with DSB related proteins is elucidated by the use of Scion Image (Sect. 
4.5.2). 
 
Human fibroblasts were irradiated with 8 Gy X-rays and fixed with extraction of the soluble 
proteins (Hepes-extraction; Sect. 4.4.2) 3 h post-irradiation. Irradiated nuclei were stained for 
p21 in combination with γH2AX, 53BP1, TP53 or MDC1 (Sect. 4.4.4). 
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mock-irradiated 3 h post-irradiation 3 h post-irradiation  staining 
    
A B C 
p21/53BP1 
D E F 
p21/γH2AX 
G H I 
p21/TP53 
J K L 
p21/MDC1 
    
Fig. 43 Colocalisation studies for p21 with DSB related proteins after X-rays. Human 
fibroblasts irradiated with 8 Gy X-rays and fixed 3 h post-irradiation. Immunostaining was carried 
out after extraction by Hepes buffer for p21 (green) in combination with γH2AX, 53BP1, TP53 or 
MDC1 (red). A, D, G and J: mock-irradiated cells. B, C, E, F, H, I, K and L: 3 h post irradiation. 
DNA: blue (ToPro-3). Note: J, K and L no DNA staining. Bar: 10 μm. 
Results 
 
 62 
 
As seen in Fig. 43 clear p21 foci are detected in all irradiated nuclei (panels B, C, E, F, H, I, K 
and L) and weak 53PB1 (panels B and C), γH2AX (panels E and F) and TP53 (panels H and I) 
foci can be seen. MDC1 however, is not detected in clear focal accumulations after irradiation; 
instead it appears to be localized homogeneously throughout the nucleus (Fig. 43, panels K and 
L). As a result, MDC1 was not evaluated for colocalisation with p21. Noticeably more p21 foci 
per nucleus are observed than for the DSB related proteins (see Fig. 43 panels B, E and H).  
 
The colocalisation of p21 with 53PB1, γH2AX or TP53 was investigated by Scion Image with a 
program provided by B. Jakob (GSI) as described in Sect. 4.5.2 (page 103). 
 
 
Staining Chi20 n 
   
p21/53BP1 2.26 37 
p21/γH2AX 2.33 28 
p21/TP53 5.75 44 
Table 5 Colocalisation analysis of p21 with 53PB1, γH2AX or TP53. Def.: No 
colocalisation of the investigated proteins if Chi20 is below 8. Results are from two 
independent experiments. 
As depicted in Table 5, colocalisation of p21 foci with either 53BP1, γH2AX or TP53 does not 
occur after X-rays. These results suggest that the p21 protein, albeit accumulated in focal 
structures after irradiation with X-rays, is not associated with DNA DSBs. As many more p21 
foci per nucleus are seen than 53BP1, γH2AX or TP53 foci I speculate that the DNA lesions 
that p21 is associated with are more abundant than are DSBs and could represent SSBs as many 
more SSBs are induced after X-ray irradiation [Newman et al., 2000]. The ratio of DSBs to SSBs 
after exposure to 1 Gy X-rays is estimated to be 1:25 [Ward, 1988]. 
 
 
 
2.4.5 Colocalisation analysis of  p21 with the SSB protein XRCC1 
 
 
To elucidate whether p21 accumulates at X-ray-induced SSBs, immunostaining was carried out 
for p21 in combination with the SSB-related protein XRCC1. Human fibroblasts were irradiated 
with 8 Gy X-rays and fixed after Hepes extraction of the soluble proteins (Sect. 4.4.2) 3 h post-
irradiation. The cells were stained for p21 and XRCC1 (Sect. 4.4.4). 
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D 
3 h post-
irradiation 
Fig. 44 No colocalization of p21 and XRCC1 in human fibroblast after 8 Gy X-rays. Human 
fibroblasts exposed to 8 Gy X-rays. Soluble proteins extracted by Hepes buffer after fixation, 
followed by staining for p21 (green) and XRCC1 (red). A and B: mock irradiated cells. C and D: 
3 h post irradiation. DNA: blue (ToPro-3). Bar: 10 μm. 
 
Fig. 44 displays the microscopic analysis of human fibroblast 3 h after irradiation with 8 Gy X-
rays. Immunostaining for p21 (green) and XRCC1 (red), results in clear irradiation-induced p21 
accumulations (Fig. 44 C and D). XRCC1, however, gives a punctuate background signal and a 
strong signal within the nucleoli, but no clear irradiation-induced foci formation for XRCC1 is 
seen compared to the mock-irradiated cells (Fig. 44 C and D versus A and B, respectively). 
 
The absence of a clear X-ray induced XRCC1 signal precluded colocalisation studies for p21 and 
XRCC1 after DNA damage induction by X-ray exposure.  
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2.5 Camptothecin does not lead to distinct p21 foci 
 
 
As XRCC1 did not appear to localize into distinct detectable foci after X-rays (Sect. 2.4.5), I 
tried to visualize XRCC1 after the induction of DNA SSBs using the topoisomerase I (Top I) 
inhibitor camptothecin (CPT). Top I normally cleaves, unwinds and religates DNA, however, 
when CPT binds to Top I, Top I is able to cleave but not to religate DNA. Thereby CPT 
induces SSBs in the DNA [Covey et al., 1989]. In vicinity of the replication fork these SSBs can 
be converted to 1-ended DSBs in cycling cells [Furuta et al., 2003].  
 
Human fibroblasts (AG) were treated with 1 µM CPT for 1 h at 37°C as described in Sect. 4.3.1 
(page 98). The soluble proteins were either not extracted or extracted by Hepes buffer as 
indicated (Sect. 4.4.1 and 4.4.2, respectively). Fixed nuclei were stained for p21 and XRCC1 
(Sect. 4.4.4). In addition, immunostaining for 53BP1 was carried out to elucidate the levels of 
DSBs induced.  
 
Unfortunately, neither p21 (green) nor XRCC1 (red) show clear focal accumulations after 
exposure to CPT. Cells which were not extracted show detectable p21 and weak XRCC1 
staining, however, no difference in their appearance after incubation with CPT is seen (Fig. 45 A 
and B, respectively). The Hepes extraction reduced the p21 signal, the background signal for 
XRCC1 could still be detected (Fig. 45 C). After CPT treatment and following extraction of the 
soluble proteins, a slight increase in the overall signal for p21 (i.e. throughout the nucleus) is 
observed without any discernible focal accumulations (Fig. 45 D). This elevated signal shows 
that p21 is bound to some structure within the nucleus as it is not extracted. Furthermore, it is 
not due to an induction of p21 as an increase is not seen in the samples where the soluble 
proteins are not extracted (Fig. 45 panel A compared to panel B; panel E compared to panel F). 
XRCC1 does not show CPT-induced protein accumulations either, when compared to the non-
treated cells (Fig. 45 C and D, respectively). Interestingly, less of the treated cells show a high 
XRCC1 expression level in the nucleoli as seen in panel D and compared to the stronger 
nucleoli-bound signal for XRCC1 in non-treated cells (Fig. 45 C). The combined staining for 
p21 and 53BP1 shows that additional DSB are induced by the CPT treatment compared to non-
treated cells which also validates that the used CPT is active (Fig. 45 F and H compared to E 
and G, respectively). In these experiments, CPT does not induce visible p21 or XRCC1 
accumulations even if DNA damage induction is achieved. 
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Fig. 45 Camptothecin does not induce p21 accumulations in human fibroblast nuclei. Human 
fibroblasts treated with 1 μM camptothecin for 1 h at 37°C (panels B, D, F and H); fixed without 
extraction (panels A, B, E and F) or with Hepes buffer extraction (panels C, D, G and H). 
Immunostaining was carried out for p21 (green) and XRCC1 (red; panels A–D) or 53BP1 (red; 
panels E–H). A, C, E and G: non-treated cells. DNA: blue (ToPro-3). Bar: 10 μm. 
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2.6 H2O2 leads to punctuate signal for p21 
 
 
As camptothecin, which was used to induce mainly SSBs did not give any clear structural change 
of the detectable p21 or XRCC1 signals after immunostaining, DNA lesions were induced by 
hydrogen peroxide (H2O2). Treatment of cells with H2O2 produces specific DNA lesions 
including oxidized bases, SSBs and to a minor extends DSBs. The aim of these experiments is to 
elucidate whether p21 colocalises with BER/SSB-related proteins such as XRCC1 which has 
been shown to recruit to H2O2 induced DNA lesions [El-Khamisy et al., 2003].  
 
Human neonatal fibroblasts (NHDF) were incubated with different H2O2 concentrations in PBS 
for 20 min at RT as described in Sect. 4.3.2 (page 99) to acquire a concentration at which distinct 
protein accumulations are detected that can be differentiated. Following H2O2 exposure, the 
cells were briefly rinsed with PBS and incubated at 37°C for 15 min and fixed after extraction 
with Hepes buffer (Sect. 4.4.2) and immunostaining was carried out (Sect. 4.4.4). 
 
With a H2O2 concentration of 10 mM or 5 mM the proteins p21 and XRCC1 were detected 
throughout the nuclei and did not show singularized foci (data not shown). After treatment with 
0.5 mM H2O2 the detected p21 and XRCC1 signal became more dispersed, but could still not be 
discriminated (data not shown). With a concentration of 0.2 mM H2O2 granular structures for 
p21 and XRCC1 were detected, making me use this H2O2 concentration for the further 
experiments. 
 
Immunostaining for XRCC1 and γH2AX was carried out to see whether a different distribution 
of the SSB related protein XRCC1 and the DSB related protein γH2AX after H2O2 treatment 
could be achieved. Fig. 46 displays representative images of NHDF cells treated with 0.2 mM 
H2O2 followed by immunostaining for XRCC1 and γH2AX. Many of the cells that are not 
treated with H2O2 show XRCC1 localized mainly in the nucleoli as seen in Fig. 46 panel B. For 
γH2AX 0–4 foci are seen in non-treated cells (Fig. 46 A). H2O2 treated cells show a higher level 
and granular structure throughout the nucleus for XRCC1 compared to the non-treated cells 
(Fig. 46 A–C compared to G and I, respectively). XRCC1 appears to change its position, as the 
high XRCC1 signal in the nucleoli as seen in many of the non-treated cells is reduced in cells 
exposed to H2O2. After treatment with H2O2, an elevated amount of γH2AX foci are detected 
within the nucleus (Fig. 46 D, E, H and I). It is clearly seen however, that the H2O2-induced 
XRCC1 and γH2AX foci are localized at different areas throughout the nucleus. Furthermore, 
many distinct punctuate signals are detected for XRCC1 whereas only a few γH2AX foci per 
nucleus are visible (Fig. 46 G and H, respectively). With this H2O2 treatment, a method is found 
to induce dispersed XRCC1 foci, with some additional DSBs that can be visualized and 
distinguished by the detection γH2AX. 
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Fig. 46 H2O2 induced SSBs and DSBs can be discriminated and visualized by 
immunostaining for XRCC1 and γH2AX. NHDF cells 15 min after treatment with 0.2 mM 
H2O2 for 20 min, fixed and extracted with Hepes buffer; immunostained for XRCC1 (green) and 
γH2AX (red). A, B and C: non-treated cells. D–I: treated for 20 min with 0.2 mM H2O2. Blue: 
DNA (ToPro-3). Bar: 10 μm. 
 
As a difference is visualized between the SSB-related protein XRCC1 and the DSB-related 
protein γH2AX after H2O2 treatment, p21 is detected in combination with XRCC1. NHDF 
cells, treated as above, were immunostained for p21 and XRCC1 and are displayed in Fig. 47 
below. 
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Fig. 47 p21 and XRCC1 both form granular structures after H2O2 treatment of NHDF cells. 
NHDF cells after oxidative DNA lesion induction by 0.2 mM H2O2 for 20 min at RT. 
Immunostained for p21 (green) and XRCC1 (red) after extraction by Hepes buffer and fixation 15 
min after H2O2 treatment. A. non-treated. B–F: treated with 0.2 mM H2O2. The nuclei visualised 
by ToPro-3 DNA staining (blue). Bar: 10 μm. 
Cells which are not exposed to H2O2 generally show XRCC1 in the nucleoli, p21 is not 
detectable (Fig. 47 panel A). The cells which are treated with 0.2 mM H2O2 show a granular 
structure for both p21 and XRCC1 (Fig. 47 panels B–E). These granular signals for p21 and 
XRCC1 were checked in individual nuclei for colocalisation as described in Sect. 4.5.2 (page 
103). 22 nuclei were analysed giving a Chi20 of 2.4, suggesting, that p21 does not colocalize with 
the SSB-related protein XRCC1 after DNA damage induction by H2O2 in NHDF cells.  
 
To exclude the possibility of some structural change caused by the H2O2 treatment leading to 
this result, additional experiments were done where cells were pre-treated with 0.2 mM H2O2 
and irradiated with Ni ions. Here, weak XRCC1 foci and p21 foci were detected in some nuclei 
which colocalized (data not shown). This verified that H2O2 does not disturb the possibility of 
p21 and XRCC1 recruitment to the same site. These results indicate that p21 is not gathered at 
the here induced oxidative lesions that are recognized by XRCC1. 
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2.7 Ectopical expression of  a GFP-p21 fusion protein 
 
 
The possibility of making GFP fusion proteins gives the opportunity to detect proteins 
independently of staining methods. Furthermore, GFP fusion proteins can be observed in living 
cell systems, which has been shown to be very helpful to monitor the very early responses to 
induced DNA damage. To study the early kinetics of the p21 accumulations to heavy ion-
induced DNA lesions, a GFP-p21 fusion protein was constructed. 
 
The full-length p21 open reading frame (ORF) was obtained from the wtp21 plasmid kindly 
provided by Prof. Dr. S. Dimmeler (University of Frankfurt). The p21 ORF was amplified by 
PCR using the primers and the pEGFP-C2 plasmid as described in Sect. 4.10. With this vector 
the GFP is expressed at the N-terminal site of the expressed protein. The former experiments 
from showed that p21 needs the intact interaction with PCNA to accumulate at the DNA 
lesions (Sect. 2.2 page 31). The interaction with PCNA occurs at the C-terminal domain of p21 
which is not altered by the use of the pEGFP-C2 plasmid. HCT116p21-/- cells and HeLa cells 
were transfected with the GFP-p21 plasmid (Sect. 4.10.6). 24 h after transfection, Laemmli 
lysates (Sect. 4.7.1) were prepared and the successful transfection and expression of the GFP-
p21 fusion protein was verified by Western Blot analysis (Sect. 4.9) as shown in Fig. 48. 
 
Lane       1       2        3        4       5       6  
 
GFP detection 
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Exposure time: 1 min 
 
p21 detection 
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p21  
Exposure time 25 min 
Lane 
1 AG cell lysate 
2 HCT116p21-/- non-transfected 
3 HCT116p21-/- transfected with GFP-p21 
4 HeLa non-transfected 
5 HeLa transfected with GFP-p21 
6 Molecular weight marker RPN 800 
 
 
Fig. 48 HCT116p21-/- and HeLa cells express GFP-p21 24 h after transfection with the 
GFP-p21 expression plasmid. Western Blot analyses of the ectopically expressed GFP-p21 
fusion protein shows clear bands for GFP-p21 in the transfected HCT116p21-/- and HeLa cells 
after GFP (upper WB) and p21 (lower WB) detection (lanes 3 and 5, respectively). Non-
transfected cells show a weak non-specific signal after GFP detection and no signal after p21 
detection (lanes 2 and 3). 
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Clear bands are seen after GFP detection for both cell lines transfected with the GFP-p21 
plasmid; lane 3 displays the HCT116p21-/- cells, lane 5 the HeLa cells (Fig. 48 upper panel). The 
additional bands are possibly caused due to degradation of the extremely high expressed fusion 
protein. A weak non-specific signal is observed when anti-GFP antibody is used. Non-
transfected HCT116p21-/- or HeLa cells and the AG cells do not show a specific GFP signal 
(Fig. 48 lanes 2, 4 and 1, respectively). The WB was stripped for the antibodies and the detection 
reagent (Sect. 4.9.5) after the GFP detection and probed to anti-p21 antibody (Fig. 48 lower 
panel). Endogenously expressed p21 is detected in AG cells (Fig. 48 lane 1), but not in non-
transfected HCT116p21-/- cells, that do not express endogenous p21 , or in HeLa cells, that 
express only very small amounts of endogenous p21 (Fig. 48 lanes 2 and 4, respectively). 
 
 
 
2.7.1 The GFP-p21 fusion protein localizes to the sites of  particle 
traversals 
 
 
After verification of the GFP-p21 expression in the used cell systems, GFP-p21 transfected cells 
were irradiated with particles to test whether the expressed fusion protein is able to accumulate 
at damaged DNA sites. HCT116p21-/- cells and HeLa cells were transfected with GFP-p21 as 
described in Sect. 4.10.6.2 (page 123) and irradiated with samarium (Sm; 3×106 p/cm2; 11.4 
MeV/u; 10290 V/μm) ions 24 h after transfection. The cells were fixed without extraction of 
the soluble proteins 30 min post-irradiation and immunostained for γH2AX (Sect. 4.4.4). To 
verify the irradiation induced signal of endogenously expressed p21, non-transfected 
HCT116p21+/+ cells and non-transfected HeLa cells were irradiated additionally and 
immunostained for p21 and γH2AX.  
 
Fig. 49 displays HCT116p21-/- cells transfected with GFP-p21. Mock-irradiated cells show 
heterogeneous GFP-p21 levels without any focal accumulations (green fluorescence signal), 
verifying the successful transfection and expression of the GFP-p21 plasmid (Fig. 49 A). 
Irradiated cells show distinct focal accumulations of GFP-p21 (green; Fig. 49 panel B) and 
γH2AX (red; Fig. 49 panel C) at 30 min after Sm irradiation. The same result was obtained for 
HeLa cells transfected with the GFP-p21 construct and irradiated with Sm ions (supplement 6.3 
Fig. 74) 
 
These results suggest that the ectopically expressed GFP-p21 protein is, at least in part, 
functional as it, similarly to the wild-type p21 protein, accumulates to foci that co-localize with 
γH2AX foci at heavy ion-induced DNA lesions. With this, a fluorescent signal of the GFP-p21 
fusion protein and its response to heavy charged particle irradiation can be monitored in living 
human cells. 
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mock-irradiated   
B 
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GFP-p21 γH2AX merge 
Fig. 49 GFP-p21 fusion protein accumulates to foci in HCT116p21-/- cells after Sm 
irradiation. HCT116p21-/- cells transfected with GFP-p21 plasmid and irradiated with Sm ions 
(3×106 p/cm2; 11.4 MeV/u; 10290 V/μm) 24 h after transfection (B–D). Fixed without extraction 
and stained for γH2AX (red) 30 min post-irradiation. A: mock-irradiated. GFP-p21: green. DNA: 
blue (ToPro-3). Note: only approx. 20% of the transfected cells express the fusion protein to a 
level where it can be detected as foci. Bar: 10 μm. 
 
 
 
2.7.2 Online observation of  the formation of  GFP-p21 foci 
 
 
The very early accumulation of ectopically GFP-p21 was studied by live-cell imaging as the 
former experiment confirmed the functionality of the GFP-p21 in response to heavy ions. To 
do so, living cells expressing fluorescent proteins (here: p21) are observed on-line during the 
irradiation and for a desired time after irradiation. Here, live-cell imaging was kindly carried out 
by B. Jakob (GSI) using the GFP-p21 as described in Sect. 4.6 (page 103). 
 
HeLa cells grown on polycarbonate dishes (Ø 18 mm) were transfected by Lipofectamine with 
the GFP-p21 construct 24 h before irradiation as described in Sect. 4.10.6. The polycarbonate 
dish with the transfected cell populations was mounted in a closed chamber and placed in the 
developed on-line microscopic system positioned directly at the beamline. After finding a 
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representative cell (i.e. a cell expressing GFP-p21), live-cell imaging was started remotely and the 
cells was then irradiated with krypton ions (4.8 MeV/u, LET 5265 keV/µm). An exemplary 
image series is shown in Fig. 50 below. 
 
 
 
Fig. 50 Live-cell imaging to show the recruitment of GFP-p21  in response to krypton ions. 
Live-cell images were taken at the times indicated that are relative to the start of irradiation at 
0 min. The very early accumulation of GFP-p21 is detectable at 0.5 min post-irradiation. Before 
irradiation and at 0 min, no distinct protein accumulations are detected. The darker spots in the 
nucleus represent the nucleoli. 
The live-cell imaging shows a very fast appearance of the GFP-p21 foci at the ion-induced 
DNA lesions. The GFP-p21 foci are seen as early as 0.5 min after irradiation, and show greatest 
brightness at about 7.5 min post-irradiation. Foci did not show any further changes during the 
time-course of observation. Note: at later times (i.e. > 8.5 min) the foci appear weaker due to 
photo-bleaching, caused by the close frame-rate of 15 sec (every 30 sec is pictured in Fig. 50). 
0 min–0.5 min–1 min –1.5 min 0.5 min 
1 min 2 min1.5 min 2.5 min 3 min 
3.5 min 4 min 4.5 min 5 min 5.5 min 
6 min 6.5 min 7 min 7.5 min 8 min 
8.5 min 9 min 10.5 min 11 min 11.5 min 
12 min 12.5 min 13 min 13.5 min 14 min 
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2.8 Focal accumulation of  p21 at the DNA lesions is independent of  
PARP-1 
 
 
Poly(ADP-ribose) polymerase-1 (PARP-1) is the founding family member of the PARP super 
family. PARP-1 plays a role in the detection and signalling of DNA strand interruptions. It has 
been described to be involved in early DNA damage recognition [Fernet et al., 2000], base 
excision repair [Dantzer et al., 1998; Masson et al., 1998] and genome surveillance [for review see 
Shall and DeMurcia, 2000]. Due to its early involvement in the DNA damage response, I 
studied whether the focal accumulation of p21 was dependent of the interaction with PARP-1 as 
it has been shown that PARP-1 binds to p21 [Frouin et al., 2003]. For this experiment Dr. G. 
DeMurcia (University of Strasbourg) kindly provided mouse embryonic fibroblasts (MEFs) 
derived from both wild-type (PARP-1+/+) and PARP-1 deficient mice (PARP-1-/-). The available 
antibodies against human p21 did not detect the endogenously expressed mouse p21 in these 
cells (data not shown). Therefore, the MEFs were transiently transfected with the formerly 
constructed GFP-p21 plasmid (Sect. 2.7) to be able to observe ectopically expressed human p21 
protein in this cell system.  
 
The transfection and expression of GFP-p21 in PARP-1-/- cells was verified by Western Blot 
analysis using anti-GFP antibody. The WB in Fig. 51 displays a clear GFP-p21 signal for PARP-
1-/- cells transfected with GFP-p21 (lane 2). Non-transfected PARP-1-/- cells do not show any 
signal after GFP detection (Fig. 51 lane 3).  
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2 PARP-1-/- transfected with GFP-p21 
3 PARP-1-/- non-transfected 
 
 
Fig. 51 Western Blot to show the expression of GFP-p21 in PARP-1-/- cells.  Note: the bands 
of the used MWM runs higher with the here used NuPage SDS-PAGE than it should; with self-
cast SDS-PAGE the GFP-p21 is detected at approx. 30 kDa MWM. WB: p21 
Following verification of successful transfection and expression of the GFP-p21 plasmid as 
described above, transfected cells were irradiated with uranium ions 24 h after transfection. The 
cells were fixed 30 min post-irradiation without extraction of the soluble proteins (Sect. 4.4.1) 
and immunostained for γH2AX (Sect. 4.4.4). Mock-irradiated transfected PARP-1-/- cells show 
heterogeneous GFP-p21 levels as seen in Fig. 52 panel 1. After irradiation, clear green 
fluorescent foci are detectable, showing that GFP-p21 is able to form irradiation-induced foci in 
absence of PARP-1 (Fig. 52 panels B and C). Non-transfected PARP-1-/- cells do not show any 
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green fluorescence signal as expected (Fig. 52 D: mock-irradiated cells, E and F irradiated cells). 
The change in the γH2AX signals verifies the irradiation procedure. Unfortunately, γH2AX foci 
are only detectable in few nuclei (Fig. 52 F). 
 
 
A 
 
B 
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E 
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F 
+ GFP-p21 
Fig. 52 Ectopically expressed GFP-p21 forms foci in PARP-1-deficient MEFs after 
irradiation with uranium ions. A, B and C non-transfected PARP-1-/- MEFs; D, E and F 
transiently transfected PARP-1-/- MEFs express GFP-p21 (green); A and D mock-irradiated; B–F 
30 min post-irradiation with uranium ions (2×106 p/cm2; 11.4 MeV/u; 14925 keV/μm). Stained 
for DNA (blue, ToPro-3) and γH2AX (red; unfortunately weak in this experiment). Non-
transfected cells do not show any detectable green fluorescence, neither the mock-irradiated (A), 
nor the irradiated cells (B and C). Mock-irradiated cells transfected with GFP-p21 show a GFP-
p21 expression (green) but no focal structures (D). Bar: 10 μm. 
The mock-irradiated PARP-1-/- MEFs, transiently transfected to express GFP-p21, show 
ectopical expression of GFP-p21 in many nuclei, without any detectable focal accumulations 
(Fig. 52 D). Thirty min post-irradiation, clear focal accumulations of the GFP-p21 were detected 
in the PARP-1-/- MEFs cells transfected with the GFP-p21 plasmid (Fig. 52 E, F). 
Unfortunately, the γH2AX signal was very weak and distinct foci were only seen in few nuclei. 
Non-transfected PARP-1-/- MEFs cells did not have any green fluorescent signal 30 min post-
irradiation (Fig. 52 D, E). These results demonstrate that the ectopically expressed GFP-p21 is 
able to form foci independently of PARP-1 in MEFs and in response to HI-induced DNA 
damage. 
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From these results I conclude that p21 foci formation at heavy ion-induced DNA lesions, at 
least at the time-points investigated and in this cell system, is not greatly dependent on the 
presence of PARP-1 expression. 
 
 
 
 
 
2.9 p21 accumulates at DNA lesions in absence of  XRCC1 
 
 
The former experiment showed that p21 is able to recruit to foci independently of PARP-1. 
PARP-1 has been reported to detect and signal SSB and with this is involved in a very upstream 
step of the repair pathway. PARP-1 then recruits XRCC1 to the DNA lesion, which plays an 
important role in SSB repair and BER. El-Khamisy et al. showed that PARP-1 is required for the 
recruitment of XRCC1 at H2O2 induced DNA lesions [El-Khamisy et al., 2003]. Here I elucidate 
whether XRCC1, which does not colocalise with p21 after H2O2 treatment as seen in Sect. 2.6 
(page 66), is needed for the accumulation of p21 at HI-induced DNA lesions. For this, XRCC1 
deficient hamster cells (EM9) and XRCC1 deficient hamster cells stably transfected with 
XRCC1-GFP were used. The cells were transiently transfected with the human wtp21 plasmid 
(Sect. 4.10.6), as the available p21 antibodies did not visualize the hamster p21 (data not shown). 
24 h after transfection the cells were irradiated and fixed 30 min after exposure without 
extraction of the soluble proteins (Sect. 4.4.1). To confirm the successful transfection and 
expression of the human wtp21, non-transfected EM9 cells were investigated additionally. 
 
Fig. 53 displays EM9 cells either transfected with wtp21 (Fig. 53 A and B) or non-transfected 
cells (Fig. 53 C and D). Mock-irradiated EM9 cells transfected with wtp21 clearly show 
expression of the human wtp21 protein (Fig. 53 A, red signal). Irradiated wtp21 transfected 
EM9 cells have irradiation induced accumulations of wtp21 (Fig. 53 B, red signal). Non-
transfected EM9 cells do not have any detectable red fluorescence signal as expected, neither the 
mock-irradiated nor the irradiated samples (Fig. 53 C and D, respectively). 
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Fig. 53 Human wtp21 is recruited to the induced DNA lesions in absence of XRCC1. 
XRCC1 deficient hamster cells transiently transfected with human wtp21 show detectable wtp21 
foci (red) after irradiation with Sm (3×106 p/cm2; 11.4 MeV/u; 10290 V/μm) ions. A and B: EM9 
cells transfected with wtp21. C and D: non-transfected EM9 cells. A and C: mock-irradiated. B 
and D: 30 min after exposure to Sm ions. DNA: blue (ToPro-3). Bar: 10 μm. 
 
EM9 cells stably transfected with XRCC1GFP (EM9-XRCC1GFP) were treated as the EM9 
cells above to confirm the obtained signal in the EM9 cells. Panel A (Fig. 54) shows mock-
irradiated EM9-XRCC1GFP cells expressing the human wtp21 (red signal) without any wtp21 
protein accumulations. 30 min after irradiation with Sm (3×106 p/cm2; 11.4 MeV/u; 10290 
V/μm) ions, XRCC1GFP (green) and wtp21 (red) foci are detected (Fig. 54 B and C, 
respectively). 
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Fig. 54 XRCC1GFP and wtp21 form heavy ion-induced foci in EM9-XRCC1GFP cells. 
EM9 cells stably transfected with XRCC1GFP and transiently transfected with wtp21 show 
detectable Sm (3×106 p/cm2; 11.4 MeV/u; 10290 V/μm) ions-induced foci for both proteins 
(XRCC1: green, B and D; wtp21: red, C and D). A: mock-irradiated cells. B–C: 30 min after 
irradiation with Sm ions. DNA: blue (ToPro-3). Bar: 10 μm.  
 
These results indicate that the ectopically expressed human wtp21 is able to accumulate at the 
heavy ions-induced DNA damaged sites in this cell system in absence of XRCC1. 
 
 
 
 
 
2.10 Peptide mapping 
 
 
As shown in Sect. 2.2 (page 31), p21 requires the intact interaction with PCNA to form 
irradiation-induced foci. This means that p21 is bound to PCNA at the DNA lesions as seen in 
Sect. 2.3 where both proteins were shown to be part of the chromatin associated protein 
fraction. For the p21-PCNA interaction p21 has to be dephosphorylated at threonine 145. Here, 
I aimed to show this irradiation-induced dephosphorylation of p21 by peptide mapping. With 
peptide mapping proteins are analyzed by separating and detecting the mixture of the peptides 
after enzymatic digestion of the protein of interest. With this method, a change in the 
phosphorylation status of a protein can be monitored. As the amount of protein assayed is very 
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small, the proteins are labelled with radioactive phosphor (32P orthophosphate). Confluent 
NHDF cells and HeLa cells transfected with wtp21 to have a high p21 level were used for this 
experiment. 
 
The cells were incubated overnight with phosphate-free culture medium at 37°C. The cells were 
exposed to 10 Gy γ-irradiation and labelled immediately with 2.5 mCi 32P orthophosphate per 
plate as described in Sect. 4.11 (page 123) and incubated for 2.5 h at 37°C. The cells were lysed 
and p21 immunoprecipitation was carried out as described in Sect. 4.11. The 
immunoprecipitated complexes were separated by 12% SDS-PAGE which was dried and 
exposed to a hyperfilm (Amersham) film overnight. In Fig. 55 the autoradiograph is displayed, 
showing the 4 lanes of the prepared samples.  
 
 
Lane        1            2           3            4  Exposure time: over night 
   
 
Lane 
1 NHDF mock-irradiated 
2 NHDF 10 Gy γ-irradiation 
3 HeLa transfected with wtp21 mock-irradiated 
4 HeLa transfected with wtp21 10 Gy γ-irradiation 
 
 
 
 
 
 
 
 
 
 
p21his6-cmyc 
 
 
p21 
Fig. 55 Autoradiograph visualizing the labelled p21his6-cmyc and p21. SDS-PAGE of the 
immunoprecipitated complexes from the 32P orthophosphate labelled samples. The rectangles 
show the areas of the gel which were excised from each lane, obtaining the 32P orthophosphate 
labelled p21, and prepared for the 2-dimansional phosphopeptide mapping. 
 
The areas of the gel where p21 or p21his6-cmyc were detected were excised and prepared for 
the 2-dimensional phosphopeptide mapping on thin-layer cellulose (TLC) plates as written in 
Sect. 4.11. This includes the digestion of the purified p21 with trypsin that specifically cuts after 
arginine (R) and lysine (K) leaving many small fragments (25 fragments with a length of 1–16 
aa.). These peptides are then separated by 2-D electrophoresis on TCL plates. After the 2-
dimensional electrophoresis, the TLC plates were exposed to a hyperfilm (Amersham) for 4 
weeks and developed. Results are shown in Fig. 56 below.  
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NHDF mock-irradiated  NHFD γ-irradiated 10 Gy 
 
 
 
   
HeLa mock-irradiated  HeLa γ-irradiated 10 Gy 
 
 
 
 
Fig. 56 Autoradiographs of TLCs to demonstrate that p21 is dephosphorylated after 10 Gy γ-
irradiation. Mock-irradiated NHDF cells show hardly detectable spots on the film (upper left) 
which are not visible for the irradiated NHDF cells (upper right). The mock-irradiated HeLa cells 
transfected to express wtp21 show clear spots (lower left panel) whereas irradiated and transfected 
HeLa cells show no signal at all (lower right panel). 
 
The mock-irradiated NHDF cells show a few faint spots as indicated by the arrow pointing to 
the left. However, at that exact same position no signal is obtained for irradiated NHDF cells 
(Fig. 56 upper two panels), indicating that dephosphorylation of p21 may have occurred in 
response to 10 Gy γ-rays. Nonetheless, the endogenously expressed p21 appears to be at very 
low levels in NHDFs precluding the definite detection of a clear dephosphorylation event. On 
the other hand, the higher amount of the ectopically expressed wtp21 in the HeLa cells clearly 
suggests that p21 is dephosphorylated in these cells in response to 10 Gy γ-rays (Fig. 56 lower 
two panels).  
 
These results implicate the dephosphorylation of p21 after DNA damage-induction by γ-
irradiation. This dephosphorylation is likely to enable the interaction between p21 and PCNA 
which has been shown to be a crucial factor for the ability to form p21 foci at HI-induced DNA 
lesions (Sect. 4.2). 
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3 DISCUSSION 
 
 
Ionizing radiation induces DNA lesions that lead to the activation of complex damage response 
pathways in mammalian cells. In one of these pathways the p21 protein, which is one of the 
main cell cycle-depended kinase inhibitors, is induced via stabilisation of TP53 after DNA 
damage. TP53 regulates p21 on the transcriptional level, which in turn inhibits CDK and results 
in hyperphosphorylation of the Rb protein, leading to G1 arrest [El-Deiry et al., 1993; Deng et 
al., 1995; Brugarolas et al., 1995]. However, recent studies suggest additional functions for p21 in 
diverse cellular processes such as DNA repair and apoptosis [review: Gartel et al., 2002; Livneh, 
2006; Janicke et al., 2007].   
 
In this thesis I aimed to elucidate a function for p21 at radiation-induced DNA lesions. PCNA, 
a well known interaction partner of p21, played an essential role in my investigations as it is 
known to be active in both DNA repair and replication [Tsurimoto, 1999; Warbrick, 2000; Maga 
and Hübscher, 2003]. Furthermore, I anticipated to correlate the formation of p21 foci after 
DNA damage to the occurrence of specific DNA lesions by investigating the co-localisation of 
DSB- and SSB-related proteins with p21. 
 
 
 
 
3.1 Protein accumulations at charged particle-induced DNA lesions 
 
 
Charged particle irradiation has been shown to be a powerful tool to investigate the response of 
certain proteins to the DNA lesions induced. In the past, our lab has shown that p21 forms 
distinct HI-induced foci [Jakob et al., 2000] which colocalize with the sites of particle traversal 
[Scholz et al., 2001] together with other DNA repair-related proteins such as hMre11, Rad50 or 
PCNA [Jakob et al., 2002] and γH2AX [Jakob et al., 2003]. Interestingly, the persistence of the 
HI-induced p21 foci increased with the LET of the ion [Jakob et al., 2002]. These data suggested 
an involvement of p21 in DNA repair or damage recognition. In my Diploma Thesis [Heede, 
2002], I was able to show that the presence of p21 status does not affect cell survival or DSB 
rejoining in HCT116 cells after exposure to X-rays. The p21 focus was shown to be a dynamic 
entity with p21 turnover at the HI-induced DNA lesion. Furthermore, the HI-induced p21 foci 
were independent of de novo protein synthesis. 
 
 
 
 
3.1.1 p21 and PCNA show similar kinetics for heavy ion-induced foci 
formation 
 
Both p21 and PCNA were detected as early as 2 min after exposure to uranium ions. 
Interestingly, the number of nuclei displaying PCNA foci appeared to be higher than the 
number of nuclei with p21 foci (51 versus 41 out of 69 analysed nuclei, respectively). However, 
both proteins formed foci in many nuclei (31 out of 69 analysed nuclei). Nonetheless, my 
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observation that PCNA foci are present in more nuclei than p21 foci needs to be interpreted 
with caution, as these proteins are likely to be extracted to different degrees which could result 
in a visualization problem as the number of protein molecules is a limiting factor for foci 
detectability (for example, it has been shown by Scheer et al. [1984] that 70–190 RPI molecules 
of an actively transcribing rRNA gene are needed to visualize individual transcription units by 
indirect immunofluorescence). This is also supported by my data showing that more nuclei show 
p21 foci after irradiation with uranium ions compared to irradiation with chromium ions. As 
early as 2 min after uranium irradiation, 95% of the nuclei showed detectable p21 foci and 100% 
PCNA foci (n = 76), compared to 54% of p21- and 81% of PCNA-positive nuclei after 
irradiation with chromium ions (n = 81). Uranium ions of 11.4 MeV/u have a much higher LET 
(14925 keV/μm versus 2810 keV/μm), resulting in a massive number of ionisation events along 
the trajectory, leaving far more DNA lesions of high complexity by passing the nucleus 
compared to the used chromium ions with lower LET (11.4 MeV/u; 2810 keV/μm). Due to the 
higher amount of total DNA lesions induced along the trajectory, more repair related proteins 
are accumulated, leading to a better detectability. That not all nuclei display clear p21 
accumulations after HI-exposure could be caused by the heterogeneous expression level of this 
protein, as detected after p21 immunostaining [Fournier et al., 2007]. Even if G1-phase 
fibroblasts were used, which express a high level of p21 [Cai and Dynlacht, 1998], a 
heterogeneous nuclear expression level of p21 was observed if the soluble protein fraction was 
not extracted. 
 
When live-cell imaging was used employing a GFP-p21 construct to examine very early times 
after HI irradiation, alterations in protein detection limits due to the indirect 
immunofluorescence method were avoided. As observed for endogenous p21, GFP-p21 
accumulated at the HI-induced DNA lesions. The live-cell imaging experiments demonstrated 
that GFP-p21 accumulates at the HI-induced DNA lesions within 30 s after exposure to 
krypton ions (Sect. 2.7.2; page 71). Interestingly, using live-cell imaging Perucca et al. [2006] have 
recently shown that both p21 and PCNA are recruited very fast to laser-induced (405 nm) DNA 
lesions. Their results display that p21-GFP could be detected at 12 s after the laser irradiation, 
whereas RFP-PCNA already was visible as early as 4 s after exposure, suggesting that p21 
recruitment follows the recruitment of PCNA at these laser-induced DNA lesions.  
 
 
 
 
3.1.2 Heavy ion-induced DNA lesions are complex and individual 
SSBs and DSBs can not be identified by immunofluorescence 
 
To obtain a more dispersed distribution of the DNA lesions and with this to be able to 
discriminate DNA lesions of different nature along the particle trajectory, the irradiation 
geometry was changed (Sect. 2.1; page 22) as described in Jakob et al. [2003]. With this method 
cells were irradiated with an angle of the beam towards the cell monolayer of less than 5°. To 
discriminate between the induced DSBs and SSBs, the DSB-related proteins γH2AX or 53BP1 
and SSB-related protein XRCC1 were stained.  
 
As described in Sect. 2.1 (page 22), streaks of p21 were found to co-localize with streaks of both 
53BP1 and XRCC1 as early as 2 min after HI irradiation. These results are in line with former 
results obtained in our lab, where it was shown that p21 and γH2AX localize at the same sites 
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along the particle trajectory [Jakob et al., 2003]. After immunodetection of γH2AX in 
combination with XRCC1, a very similar localization along the trajectory was detected. The 
XRCC1 signal however, was detected in smaller areas ('microfoci') within the larger streaks of 
γH2AX (Sect. 2.1.4; Fig. 19). That the area of detectable γH2AX signal is larger than the XRCC1 
signal could be explained by the fact that the phosphorylation of H2AX in the vicinity of a DSB 
spreads over a region of ca. 50 kb surrounding the lesion [Shroff et al., 2004]. Interestingly, 
Shroff et al. [2004] found that within 1–2 kb of the break only very little γH2AX could be 
detected, where other repair proteins were localized. Furthermore, Bekker-Jensen et al. (2006) 
have shown that single stranded DNA (ssDNA) can be visualized as microfoci within laser 
induced γH2AX streaks, displaying a similar picture to the here detected XRCC1 microfoci. This 
may suggest that the XRCC1 microfoci present ssDNA within the HI-induced protein streaks, 
in line with the described function for XRCC1 in SSB repair. Nonetheless, as the XRCC1 
microfoci are localized within the γH2AX signal, I conclude that with the experimental setup 
used here, DNA lesions of different nature cannot clearly be distinguished after HI irradiation 
using immunofluorescence. Due to the fact that heavy ions produce a large spectrum of highly 
clustered DNA lesions, proteins from many different repair pathways (e.g. DSB repair, SSB 
repair, BER repair, NER repair) accumulate along the sites of particle traversal, such that the 
individual components of specific repair pathways cannot be distinguished from each other. The 
HI-induced protein streaks however, appeared to change with time as they became more 
dispersed with increasing time after exposure (p21/53BP1 and γH2AX/XRCC1 at 5 h after 
irradiation with Fe ions; Sect. 2.1.2 and 2.1.4, respectively), as if the protein tracks slowly 
dissolve, suggesting that DNA repair has taken place or chromatin domain movement during 
lesion procession as described by Aten et al. [2004]. The repair of the induced DNA lesion over 
time would be in line with the observation that the number of nuclei scored with p21, 53BP1 or 
γH2AX streaks was clearly reduced at 16 h after irradiation. The DNA repair after high-LET 
irradiation however is shown to be delayed and more difficult than low-LET irradiation, 
reflecting an unfaithful repair due to the high clustered DNA damages induced [Löbrich et al., 
1996; Equchi-Kasai et al., 1996; Okayasu et al., 2006]. 
 
The time after which the protein streaks were visible varied between the experiments (as seen 
for p21 in Sect. 2.1.1 versus Sect. 2.1.2  where p21 streaks were detected up to 16 h post Fe ions 
irradiation or not, respectively). These variations could be due to the experimental procedure 
that includes many steps before the final microscopic analysis limiting the conclusions that can 
be made regarding the kinetics and quantitative analysis. 
 
Interestingly, the protein tracks (p21, γH2AX, 53BP1, aprataxin and XRCC1) did not display 
continuous tracks throughout the nucleus, but showed areas apparently free of protein. This 
discontinuous accumulation along the particle trajectory was detected for p21, γH2AX, 53BP1, 
aprataxin and XRCC1 and has been described also for PCNA and MRE11B in a previous study 
from our lab [Jakob et al., 2003]. The nucleoli, visualized by the reduced DNA staining, were 
spared out of the detected protein tracks in all samples, leaving no detectable streaks. Particle 
trajectories displayed by protein staining could be detected at the nucleoli boundaries, but never 
throughout the nucleoli. Differences in the content, compaction and accessibility of the DNA 
have also been suggested to account for this observation [Bakkenist and Kastan, 2003; Jakob et 
al., 2003; Kruhlak et al., 2006]. Costes et al. [2007] recently showed that DNA damage-induced 
foci are detected more frequently in regions with low DNA density and especially at the 
boundaries between high and low DNA density. Furthermore, Kim et al. [2007] have shown that 
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H2AX is not efficiently modified in heterochromatin after DNA damage induction in yeast and 
mice embryonic fibroblast cells. 
 
It must be noted, that 53BP1 and γH2AX showed focal accumulations in many of the mock-
irradiated nuclei, likely to be localizing to spontaneously generated DSBs or at replication forks 
in S-phase cells as mentioned in literature before [Ward et al., 2001; Sengupta et al., 2004; Halicka 
et al., 2005]. Costes et al. [2007] for example scored 1–5 DSB foci in 11% of nonirradiated 
human fibroblasts. Tumour cells seem to display overall more foci in more of the nonirradiated 
cells as Banath et al. [2004] described that 20–66% nuclei showed 1–54 foci, depending on the 
cell type.  
 
 
 
 
3.1.3 Ectopically expressed GFP-p21 is recruited to the HI-induced 
DNA lesions independently of  PARP-1 and XRCC1 
 
PARP-1- (poly(ADP-ribose) polymerase-1) or XRCC1- (X-ray cross complementing factor 1) 
deficient cell lines were used to elucidate whether these two proteins are essential for the 
recruitment of p21 to the HI-induced DNA lesions and to investigate a possible role for p21 in 
BER or SSB repair. PARP-1 has been shown to play a key role in BER/SSB repair by its early 
binding to SSBs and subsequent activation modifying itself and other target proteins [for review 
see Amé et al., 2004]. It has also been shown by El-Khamisy et al. [2003] that PARP-1 is required 
for the recruitment of XRCC1 at oxidative DNA damaged sites which are repaired by BER. My 
results from Sect. 2.8 (page 73) show that the accumulation of ectopically expressed GFP-p21 to 
the heavy ion-induced DNA lesions occurs independently of the presence of PARP-1. This 
means that after heavy ions, p21's recruitment is not dependent on the early PARP-1 signalling. 
XRCC1 has been shown to interact with PARP-1 [Masson et al., 1998; Dantzer et al., 2000; 
Schreiber et al., 2002] and also plays an important role in both BER and SSB repair [for review 
see Caldecott, 2001]. It has been described to coordinate the assembly of repair complexes at the 
DNA damaged sites [Okano et al., 2003; review: Caldecott, 2003] and XRCC1-deficient cells 
show a reduced rate of SSB repair [Thompson et al., 1982]. In Sect. 2.9 (page 75) I show that the 
GFP-p21 foci formation occurs in absence of XRCC1 (EM9 cells), although the GFP-p21 
accumulations are not as distinct as observed for the XRCC1 wild type cells. This may be caused 
due to the findings of Fan et al. [2004] where they propose that XRCC1 colocalizes and 
physically interacts with PCNA at replication foci in S-phase HeLa cells to facilitate the single-
strand break repair. Also, Lan et al. [2004] have shown that PCNA recruits to DSBs but not to 
SSBs induced by laser irradiation in absence of XRCC1. Taken these findings together with my 
observation that p21 accumulates at the HI-induced damaged DNA sites independently of 
XRCC1 and PARP-1 and, that p21 is shown to be dependent of PCNA for its foci formation, as 
discussed below, suggests that PCNA is recruited to these lesions independently of these 
proteins as well. This leads to the assumption that the seen GFP-p21 foci display the induced 
DSBs after HI-irradiation where PCNA also is recruited independently of XRCC1. The 
difference in foci structure should be investigated further with better microscopic analysis. 
Nonetheless, the fact that the GFP-p21 fusion protein accumulates in an irradiation dependent 
manner in absence of PARP-1 or XRCC1 suggests that p21 has no major role downstream the 
PARP-1- and XRCC1-dependent DNA repair pathways. 
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3.2 p21 and PCNA interact at irradiation-induced DNA lesions 
 
 
Very similar kinetics for PCNA and p21 accumulations at HI-induced DNA damaged sites was 
shown in Sect. 2.2.1 (page 31), leading me to elucidate whether the direct interaction of p21 with 
PCNA is required for p21 foci formation at these lesions. As the used immunofluorescence 
studies can not determine whether two proteins physically interact, immunoprecipitations were 
carried out to test the interaction of PCNA with mutant forms of p21 disrupting its interaction 
with PCNA. DNA lesions were provoked by HI to elucidate the necessity of an intact p21-
PCNA interaction. I addition, the chromatin-association of p21 and PCNA was investigated 
after X-ray induced DNA lesions. 
 
 
 
 
3.2.1 PCNA is required for the accumulation of  p21 at heavy ion 
induced DNA lesions 
 
Three forms of p21 were expressed in human cells to asses the necessity of an intact PCNA 
binding site for p21 foci formation: wtp21 plasmid containing the full-length p21 ORF, 
p21T145A and p21T145D [Rossig et al., 2001]. As observed by Rossig et al. for human umbilical 
cord cells, the interaction of ectopically expressed wtp21 or p21T145A with PCNA was 
observed for HeLa and HCT116 cells in my study (Sect. 2.2.3, page 38). Furthermore, both 
proteins accumulated at HI-induced DNA damaged sites (Sect. 2.2.5, page 42). The phospho-
mimetic p21 construct p21T145D was shown not to interact with PCNA (Sect. 2.2.4, page 40) 
similarly as described by Rossig et al. [2001]. Interestingly, it was not recruited to the HI-induced 
DNA lesions (Sect. 2.2.6, page 47). My results show that the accumulation of p21 at HI-induced 
DNA lesions requires the physical interaction between p21 and PCNA. 
 
Former immunocytochemical results from our lab however, indicated that PCNA binding to 
particle-induced DNA lesions is not required for p21 to remain localized to foci [Jakob et al., 
2002]. One could argue that if PCNA acts as a loading dock for proteins, as suggested by Balajee 
and Geard [2001], p21 is able to stay at the lesion after it once is recruited. In my Diploma 
Thesis [Heede, 2002] though, I concluded that the p21 foci are a dynamic entity with p21 
turnover, meaning that a quantity of PCNA is needed at the DNA lesion for p21 recruitment. 
That my results disagree with former findings from our lab is most probably due to the used 
method. As described above, the detection by indirect immunostaining has some difficulties and 
limits the outcome of kinetic studies. Possibly, a minor amount of PCNA which was not 
detectable with the immunohistochemical staining method used may be enough to recruit a 
detectable quantity of p21. The dependency of PCNA for the p21 recruitment at HI-induced 
DNA lesions shown in this thesis is sin accordance with the behaviour during NER repair 
revealed by the live-cell imaging recently done by Perucca et al. [2006] where the RFP-PCNA 
fusion protein appeared to be slightly faster visible at laser-induced DNA lesions than the p21-
GFP fusion protein. 
 
Interestingly, a delayed response of both p21 and PCNA to DNA damage induction by UVC 
light in XPA defecient cells (XPA cells) which are not able to carry out NER, compared to AG 
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cells that are proficient for NER was shown by D. Fink et al. [2006]. This indicates that also after 
UVC irradiation p21 and PCNA are both accumulated at an early timepoint at DNA lesions 
which are mainly repaired by NER, confirming a role for p21 in NER [Perucca et al., 2006]. That 
p21 may play a role in NER through binding to PCNA supports findings of McDonald et al. 
[1996] who showed that cells with an intact p21-PCNA interaction were able to carry out NER, 
cells expressing a mutant p21 form, not able to interact with PCNA, however, were NER 
deficient. The delay of the accumulation in XPA deficient cells could implicate that as the NER 
pathway is inhibited other repairpathways, leading to p21 and PCNA recruitment, are activated. 
Paralell experiments with DNA lesion induction by HI revealed no difference in the appearance 
of p21 or PCNA foci in XPA and AG cells, which is in line with the fact that many different 
DNA lesions are induced due to the clustered nature of HI-induced DNA lesions and with this 
several repair pathways are activated.  
 
The fact that p21 needs an intact PCNA binding site was also supported by the phosphorylation 
status studies performed in this thesis using p21 peptide-mapping. However, peptide-mapping 
was performed after exposure to high doses of γ-rays as the necessity to obtain large amounts of 
p21 existed. Following exposure to HI, presumable overall smaller amounts of p21 are recruited 
to the DNA damaged sites. Here, I was able to show that p21 indeed is dephosphorylated 
following DNA damage induction by γ-rays. This suggests that a part of p21 is 
dephosphorylated by which it becomes capable to interact with PCNA and possibly gather at 
the induced DNA lesions.  
 
 
 
 
3.2.2 p21 and PCNA are both part of  the chromatin-bound protein 
fraction after X-ray exposure 
 
The similar kinetics of p21 and PCNA recruitment to the HI-induced DNA lesions and the 
PCNA dependency for p21 accumulation at these damaged DNA sites made me investigate a 
possible association of p21 and PCNA with the damaged DNA. The lesions induced by HI 
irradiation however, recruit only a small amount of the total protein to the charged particle-
induced DNA lesion trajectories. To investigate a chromatin-associated protein fraction, a large 
amount of protein is needed. For this reason, homogenously distributed DNA lesions were 
induced by exposure of the cells to X-rays to provoke a large quantity of DNA lesions and with 
this recruitment of large amounts of p21 and PCNA to the DNA damaged sites.  
 
The establishment of a successful and reproducible method to analyse an irradiation induced 
chromatin-bound protein fraction of human fibroblasts after DNA damage induction appeared 
to be a major problem. After several modifications I finally succeeded in separating the soluble 
protein fraction from the chromatin-associated protein fraction (Sect. 2.3.3, page 54). In this 
chromatin-associated protein fraction, both p21 and PCNA were detected after X-rays using 
Western Blot analysis, and no chromatin-associated p21 or PCNA was detected in mock-
irradiated AG cells. At 3 h after exposure an increased fraction of PCNA was chromatin-
associated compared to earlier times after X-irradiation. Similarly, when compared to lower X-
ray doses (8 Gy) higher X-ray doses (30 Gy) lead to an increasee in the fraction of chromatin-
associated PCNA. The amount of chromatin-associated p21 after 30 Gy X-rays appeared to be 
clearly lower than detected for PCNA, although likely variations in antibody affinities need to be 
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taken into account. Interestingly, a higher p21 level was detected at 3 h after exposure than at 1 
h post irradiation and the contrary was seen for PCNA. The elevated p21 signal 3 h post 
exposure may be due to the fact that more p21 protein is available at later times post irradiation 
due to the irradiation-induced induction of p21 by TP53. The observed reduction of PCNA at 
later times post irradiation appears to be in line with suggestions by others who have postulated, 
that p21 releases PCNA from the DNA after UV irradiation [Savio et al., 1996; Stivala et al., 
2001]. In the same line, former results from our lab showed that p21 is still detectable in foci at 
4 h after exposure to carbon ions whereas PCNA is not [Jakob et al., 2002]. 
 
The binding of p21 to PCNA has been shown to block the DNA synthesis [Waga et al., 1994]. 
This has been supported by Cazzalini et al. [2003] who proposed that p21 does not interfere with 
the loading of PCNA at DNA replication sites, but inhibits the subsequent binding of DNA pol 
δ at the G1/S phase transition, suggesting that p21 can act as a switch between DNA repair and 
replication for the function of PCNA. By inhibiting DNA synthesis but not repair its cell cycle 
inhibitor function is supported as to gain time for the repair process without retarding the DNA 
repair efficiency. Furthermore, Frouin et al. [2003] have suggested that the association of 
chromatin-bound p21 with PARP-1 may avoid an interaction of p21 with PCNA, enabling 
PCNA to be recruited to DNA lesions. This finding is not supported by my results, as I have 
shown that p21 recruitment is dependent on PCNA (Sect. 2.2, page 31) and that the 
accumulation of p21 at the damaged DNA sites is independent of PARP-1 as described in Sect. 
2.8 (page 73). 
 
 
 
 
3.3 p21 accumulations can not clearly be correlated to either DSBs or 
SSBs 
 
 
The accumulation of p21 at the HI-induced DNA damaged sites could not be related to a 
specific DNA lesion due to the highly clustered nature of the DNA damage induced as 
discussed in Sect. 3.1.2 (page 81). This made me try to visualise p21 after DNA damage 
induction by X-rays, CPT and H2O2 as they mainly provoke homogenously distributed SSBs 
with some additional DSBs. 
 
 
 
 
3.3.1 X-rays induce distinct p21 foci that do not colocalize with DSB 
repair proteins. 
 
The DNA damage induction by X-rays lead to distinct p21 foci in AG cells (Sect. 2.4, page 56). 
The X-ray-induced p21 accumulations appeared to be time dependent with good detectability at 
3 h after exposure, mirroring the increase in the chromatin-associated p21 fraction at this time 
point as discussed in Sect. 3.2.2 above. Also, an increase in the number of p21 foci with an 
increase in X-ray dose (2 Gy to 10 Gy) was observed, underlining that p21 recruitment is 
induced in a dose (i.e. DNA damage) dependent manner. 
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Parallel immunostaining of p21 with the DSB-related proteins γH2AX, 53BP1 or TP53 clearly 
showed a higher fraction of p21 foci than γH2AX, 53BP1 or TP53 foci induced after exposure 
to 8 Gy X-rays (Sect. 2.4.4, page 60). Furthermore, colocalisation analyses by Scion Image 
resulted in no detectable colocalisation of p21 with any of the tested DSB repair proteins. My 
preferred view of these observations is that p21 does not accumulate at X-ray-induced DSBs but 
rather is gathered to X-ray-induced SSBs. However, I did not detect the SSB repair-related 
protein XRCC1 in foci after X-rays. Potentially, XRCC1 already have vanished at 3 h post 
exposure or the level of accumulated XRCC1 protein may have been too low for its detection by 
immunostaining. It has been described by Thompson et al. [1990] that XRCC1 deficient cells are 
1.8-fold more sensitive to γ-irradiation, demonstrating a role for XRCC1 in the repair of 
radiation damage. Also, it has been reported that XRCC1 is recruited DNA SSBs by its BRCT1 
domain shortly after DNA damage induction [Okano et al., 2003; El-Khamisy et al., 2003; Ame et 
al., 2004]. Further studies should be performed to clarify a possible colocalization of p21 and 
XRCC1 at X-ray induced DNA lesions. 
 
Interestingly, the X-ray irradiation-induced p21 foci were not detected in neonatal human 
fibroblasts (data not shown). I presume that these cells have a lower p21 level, preventing 
detectable p21 protein accumulations. Experiments to elucidate whether the low p21 expression 
level is the reason could be done by incubation of the cells with a proteasome inhibitor, such as 
lactacystine, by which the p21 levels are artificially elevated. 
 
 
 
 
3.3.2 Hydrogen peroxide induces punctuate accumulations of  p21 that 
do not colocalize with the SSB repair protein XRCC1. 
 
Since, after X-rays, focal accumulations for XRCC1 could not be detected, camptothecin (CPT) 
and hydrogen peroxide (H2O2) were employed. However, treatment of AG cells with CPT did 
not result in visible p21 accumulations (Sect. 2.5, page 64). The overall nuclear p21 level was 
slightly elevated after treatment and following extraction, suggesting that p21 is bound to some 
intra-nuclear structure partially preventing its extraction from treated nuclei (note: this 
phenomenon was not observed for nuclei from non-treated cells). For XRCC1, no CPT-
induced foci were detected, but it was observed, that the XRCC1 level within the nucleoli 
changed after CPT treatment. The XRCC1 level in the nucleoli was reduced after CPT 
treatment, suggestive for a translocation of XRCC1 from the nucleoli to the CPT-induced 
damaged DNA sites. That the protein accumulations at the CPT-induced DNA lesions could 
not be detected may be due to the amount of protein localised at the single lesions or be caused 
by a difference in accessibility of the DNA lesions due to the binding of Top I. Others have 
shown that cells lacking XRCC1 are about 3-fold more sensitive to CPT treatment than wild 
type cells [Caldecott et al., 1991; Barrows et al., 1998], proposing that XRCC1 is involved in the 
repair of CPT lesions.  
 
The incubation with H2O2 resulted in homogenously distributed punctuate accumulations of 
both p21 and XRCC1 (Sect. 2.6, page 66). A role for XRCC1 in the repair of oxidative DNA 
damage was described earlier with XRCC1-deficient cells being about 2-fold more sensitive to 
hydrogen peroxide [Cantoni et al., 1987] and H2O2 induced recruitment of XRCC1 in XRCC1 
wild type cells [El-Khamisy et al., 2003]. In my experiments, the H2O2-induced p21 and XRCC1 
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accumulations did not colocalise. Here it must be noted, that the concentration of H2O2 (0.2 
mM) at which the punctuate protein pattern was observed lead to a considerable amount of 
DNA damages, inducing a high number of protein accumulations throughout the nucleus. This 
complicates colocalisation evaluation as foci may partially colocalize randomly. Further 
investigations should address this issue more carefully. It has recently been described by Levy et 
al. [2006] that XRCC1 may also be part of the DSB response after X-ray irradiation. They 
speculate that after replication fork stalling XRCC1 may direct the repair to the NHEJ repair 
pathway which is in line with others who have suggested an additional role for XRCC1 in DSB 
repair [Audebert et al., 2004]. Taken together, one could speculate that the seen accumulations of 
XRCC1 after H2O2 treatment do not only display SSBs which was aimed. However, the H2O2-
induced XRCC1 accumulations observed in my experiments do not colocalize with the 
visualized DSBs. Audebert et al. [2004] described a role for XRCC1 in an alternative route for 
DSB repair, meaning that if the normal DSB repair pathways are intact, XRCC1 may not be 
recruited at the induced DSB. This makes me assume that the H2O2-induced XRCC1 
accumulations shown in this thesis do visualize SSBs, implicating that p21 is not part of the 
XRCC1-related SSB repair pathway.  
 
Interestingly, Hwang et al. [2007] have shown that H2O2 at higher concentrations induces 
nucleocytoplasmatic translocation of p21 via two nucleolar export signals (NES) and 
degradation of the cytoplamatically localized p21. It is suggested, that depending on the 
oxidative stress cells are exposed to, proteins may be translocated and change function. 
 
Immunostaining of γH2AX showed that DSBs were also induced by treatment with 0.2 mM 
H2O2 (Sect. 2.6, page 66). This observation is contradictive to former results described in 
literature, where no DSBs were formed with H2O2 concentrations of below 0.3 mM [Ismail et al. 
2005]. These authors describe that ATM is not activated by H2O2 treatment below 3 mM and, 
using the FAR assay they conclude that no DSBs are induced after treatment with 0.3 mM 
H2O2. However, this assay is not very sensitive and can only detect DSBs down to 10 Gy, a dose 
expected to generate 200-500 DSBs per cell [Ismail et al. 2005]. With the immunohistochemical 
staining used in this thesis DSBs can be detected after an X-ray dose of 50 mGy, leading to 
approximately 3 DSB per cell as done in our lab by Y. Schweinfurth [PhD. Thesis, 2007]. Also, 
Rothkamm and Lobrich [2003] quantified DSBs by immunostaining after an X-ray dose down 
to 1 mGy. Ismail et al. [2005] estimated that < 0.1% of the total DNA strand breaks induced by 
3 mM H2O2 are DSBs and describe that approximately 30000 SSBs per cell are induced at 
0.2 mM H2O2. Taken their results together and assuming a linear dose-response relationship, 
less than 30 DSBs per cell would be induced by 0.2 mM H2O2, which explain my observations 
for γH2AX foci formation. 
 
 
 
Discussion 
 
 89 
 
3.4 Conclusions 
 
 
The results obtained during this thesis show that p21 accumulates at damaged DNA sites after 
HI-, X-ray- and H2O2-induced DNA lesions. The p21 recruitment at HI-induced lesions is 
dependent on an intact interaction of p21 with PCNA. Furthermore, p21 and PCNA are 
chromatin-associated after X-ray irradiation. Unfortunately, I was not able to directly connect 
p21 to either DSBs or SSBs, but the results suggest that p21 is not directly involved in the repair 
of DSBs induced by HI or X-ray irradiation. This supports the findings during my Diploma 
Thesis, where p21 was shown not to play a major role in DSB repair based on DSB rejoining 
and cell survival experiments [Heede, 2002]. 
 
My hypothesis is that p21 acts more as a switch on repair processes by occupying the binding 
site on PCNA than as a protein being itself directly active in the DNA repair. The results 
obtained by McDonald et al. [1996] indicated that the binding of p21 to PCNA modulates the 
ability for NER repair, as only cells capable of the p21-PCNA interaction were able to carry out 
NER. This could be caused by the fact that when the p21 binding site of PCNA was not 
occupied, other proteins had the chance to interact with PCNA and by this possibly inhibiting 
NER. Thus, due to its PCNA interaction, p21 can be recruited to damaged DNA sites, yet is not 
directly active in the DNA repair itself. This could also be the case here for lesions not related to 
NER. The p21 protein seems to have a function as regulator protein, guiding other proteins to 
specific pathways. A model supporting a regulatory function has previously been described by 
Livneh [2006] and Avkin et al. [2006] for a role of p21 in translesion DNA synthesis (TLS; see 
Prakash and Prakash, [2002]), where the authors postulate that the p21 binding to PCNA causes 
the release of pol δ from PCNA and the DNA, leading to synthesis arrest. 
 
Perucca et al. [2006] stated that the p21 response seems to be independent of the type of DNA 
lesion, but related to PCNA dependent repair pathways. The independency of the type of DNA 
lesions is not supported by the results in this thesis, as it is clearly shown not to be DSB related 
after DNA damage induction by exposure to X-rays or H2O2 as seen in Sect. 2.2.4 and Sect. 2.6, 
respectively. The relation to PCNA however is in line with the shown chromatin association of 
both p21 and PCNA after X-ray exposure (Sect. 2.3.3) and the findings of D. Fink et al. [2006] in 
XPA cells where both p21 and PCNA are recruited with a similar delay after UVC irradiation in 
contrast to the immediate recruitment following exposure to heavy ions. 
 
On the basis of the kinetic studies on p21 and PCNA accumulation to UV-laser-induced DNA 
lesions carried out by Perucca et al. [2006] further studies should be preformed aimed at 
investigating the early kinetics of p21 and PCNA at ionizing radiation-induced DNA lesions as 
produced by heavy ions. The use of differentially tagged constructs of these two proteins, 
allowing the live-cell imaging of both proteins in the same cell, will shed light on the hierarchy of 
PCNA and p21 associated to repair processes other than NER. 
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4 METHODS 
 
 
 
4.1 Cell cultivation 
 
 
All cell types were cultivated at 37°C with 5% CO2 and 95% humidity. Depending on the 
experimental outline, the cells were grown either on Ø 30 mm cover slips (Menzel-Gläser, 
Braunschweig, Germany), in Ø 32 mm or Ø 150 mm petri dishes (Nunc, Roskilde, Denmark) or 
in 25 cm2 or 75 cm2 culture flasks (Falcon, BD Biosciences, CA, USA). The following cell types 
were used: 
 
 
 
4.1.1 Finite lifespan normal human fibroblasts  
 
 
Two different human fibroblast strains were used: normal human foreskin fibroblasts 
(AG1522C) and neonatal human dermal fibroblasts (NHDF).  
 
AG1522C cells (in further context described as AG cells) were obtained from the Coriell Cell 
Repositories (Camden, NJ, USA) and were derived from a 3 day-old healthy infant. The AG 
cells that were utilized in the experiments described below were at 20–30 cumulated population 
doublings (CPD) and at passages 8–15. 
 
The neonatal human dermal fibroblasts, referred to as NHDF in the following, were obtained 
from CellSystems Biotechnologie (St. Katharinen, Germany). As NHDF reach confluence faster 
than AG cells they were preferred in some of the experiments and were used at 11–20 CPD and 
passage number 6–12. 
 
The CPD gives the total number of the population doublings (PD) of a cell population and is 
calculated as follows: 
 
 
2ln
ln
0
⎥⎦
⎤⎢⎣
⎡
×= PEN
N
PD  
 
 
∑= PDCPD  
 
 
PD: population doublings      N: no. of cells harvested      N0: no. of cells seeded        PE: plating efficiency           
CPD: cumulative population doublings       Σ PD: total no. of population doublings 
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Both cell strains were cultivated in EMEM medium (BioWhitaker/Cambrex), added 15% (v/v) 
foetal calf serum (Biochrom, Berlin, Germany), 2 mM L-glutamine (Biochrom), 100 U/ml 
penicillin and 100 μg/ml streptomycin (Biochrom). Unless stated otherwise, cells were grown 
10–14 days with medium exchanges performed twice a week until they reached a monolayer, 
where the used fibroblasts reach confluence. Confluent fibroblasts are growth arrested due to 
contact inhibition and accumulate in G0/G1-phase. Cell cycle analysis was performed by flow 
cytometry to ensure that approximately 85–95% of growth arrested cells were in G0/G1. 
 
Cell cultures were split by incubating the cell monolayer with a trypsine-EDTA solution 
(0.05 g/l trypsine, 1 g/l EDTA-solution in PBS without Mg2+ and Ca2+ obtained from PAN, 
Aidenbach, Germany) at 37°C for 5 min to detach the cells from the culture vessel. To obtain a 
single cell suspension the cells were mixed by pipetting up and down for several times. The 
trypsine solution was inactivated by addition of 3 × the volume of serum containing culture 
medium and an aliquot of this cell suspension was taken to assess the cell concentration using a 
cell counter (Z2 Coulter Counter, Beckman Coulter, Krefeld, Germany). The cells were 
reseeded at the appropriate density. 
 
 
 
4.1.2 Human cancer cells  
 
 
Due to accumulated genetic alterations within genes that control cell proliferation and/or cell 
death cancer cells divide in culture indefinitely. Thus, it is relatively easy to maintain large 
populations of cancer cells and it is much more difficult to maintain large populations of finite 
lifespan normal cells. In addition, human cancer cells are tolerant to genetic manipulations and it 
is much harder to genetically manipulate normal human fibroblasts. Therefore, in this thesis 
many of the transfection and transgene expression experiments were performed in human 
cancer cells. 
 
 
 
4.1.2.1 Human colon cancer cells (HCT116) 
 
To study the influence of p21, human colon cancer cells (HCT116) were used. HCT116 cells are 
TP53 wild-type (wt) and have a p21-deficient sister cell line (HCT116 p21-/-) in which both 
genes for p21 were deleted by homologous recombination [Waldman et al., 1995]. The HCT116 
p21wt and the HCT116p21-/- cell lines were kindly provided by Bert Vogelstein (The Johns 
Hopkins Oncology Center, Baltimore, USA). 
 
The HCT116 cells were cultivated in McCoy’s 5A Medium (Sigma) with addition of 10% (v/v) 
foetal calf serum (Biochrom) and 2.8 mM L-glutamine (Biochrom). For routine passages, cells 
were split 1/8 twice a week as described under Sect. 4.1.1 (page 90) like human fibroblasts. The 
p21-defecient cells have a geniticin resistance and were kept under geniticin selection (0.4 
mg/ml geniticin G418; Gibco BRL). The p21-defeciency was confirmed by Western Blot 
analysis (Sect. 4.9 page 112). 
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4.1.2.2 HeLa cells 
 
HeLa cells are human cervical cancer cells that have been studied in culture extensively since 
1951. HeLa cells were derived from a 31 year-old woman named Henrietta Lack and express the 
E6 protein due to transduction with the human papillomavirus The E6 protein promotes the 
degradation of endogenous TP53 via the ubiquitin pathway. This unstable TP53 protein in 
HeLa cells leads to the expression of very low levels of endogenous p21 that cannot be detected 
by Western Blot analysis. In some experiments derivates of HeLa cells were used which were 
stably transfected with APTX-GFP [Gueven et al., 2004] 
 
HeLa cells were kindly provided by Nuri Gueven (Queensland Institute of Medical Research, 
Brisbane, Australia) and were used in this study for experiments in which ectopically expressed 
mutant forms of p21 were investigated. HeLa cells were cultivated in RPMI medium with 
10% (v/v) foetal calf serum (Biochrom) and 2.8 mM L-glutamine (Biochrom). The cells were 
split 1/8 twice a week as outlined in Sect. 4.1.1 for human fibroblasts. 
 
 
 
4.1.3 Mouse embryonic fibroblasts 
 
 
Mouse embryonic fibroblasts (MEFs) were used for experiments in which I investigated 
whether or not the formation of p21 foci was dependent on the presence of poly(ADP-ribose) 
polymerase-1 (PARP-1). Both PARP-1 wt and PARP-1 knockout MEFs were kindly provided 
by Dr. G. de Murcia (University of Strasbourg, France). These cells are immortalized MEFs 
derived from 13.5 days PARP-1+/+ or PARP-1-/- embryos as described in DeMurcia et al. [1997]. 
The cells were cultivated in DMEM medium with 10% (v/v) foetal calf serum (Biochrom).  
 
 
 
4.1.4 Chinese hamster ovary cells 
 
 
Chinese hamster ovary cells (CHO) were used to test whether p21 foci formation is dependent 
on the presence of X-ray repair cross-complementing gene 1 (XRCC1). Parental CHO cells 
(AA.8) that express wild-type XRCC1 were used for comparison purposes and an AA.8 derivate 
(EM9 cells) expressing a truncated polypeptide lacking two-thirds of the normal hamster 
XRCC1 sequence was used as XRCC1-knockout. In some experiments derivates of EM9 cells 
were utilized that stably express recombinant APTX-GFP (EM-APTX-GFP cells) [Gueven et 
al., 2004] or recombinant XRCC1-GFP (EM9-XRCC1-GFP cells). The XRCC1-GFP was 
generously donated by Dr. G. de Murcia (University of Strasbourg, France) and the EM9-
XRCC1-GFP cells were generated as outlined for the EM-APTX-GFP cells in Gueven et al. 
(2004). The AA.8, EM-APTX-GFP and EM9-XRCC1-GFP cells were kindly provided by Dr. 
N. Gueven (Queensland Institute of Medical Research, Brisbane, Australia). The EM9 cells used 
were obtained from Dr. L.H. Thomson (LLNL, USA). 
 
All CHO lines were cultivated in RPMI medium containing 10% (v/v) foetal calf serum 
(Biochrom) and 2.8 mM L-glutamine (Biochrom).  
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4.1.5 Cell stocking 
 
 
For each cell line used, a frozen cell stock in multiple aliquots was prepared. For finite lifespan 
normal human fibroblasts this is particularly important as these cells differentiate and become 
senescent in culture. The p21 protein is involved in both processes and its expression level is 
affected and altered throughout the differentiation process. Therefore, it was necessary during 
the course of the work presented here to perform all experiments employing normal human 
fibroblasts with cells of similar differentiation status, e.g. similar CPD and passage number, 
which were frozen from expanded cell populations once.  
 
For cell stocking, cells were trypsinized, counted with a cell counter (Z2 Coulter Counter, 
Beckman Coulter, Krefeld, Germany), centrifuged and resuspend at 1 × 106 cells/ml in the cell-
specific freezing medium. To assure controlled and slow freezing, freezing vials with 2 ml cell 
suspension each were kept in an isopropanol container (Nalgene Cryo 1°C Freezing Container) 
at – 80°C, allowing for a temperature controlled freezing process (1°C/min). After 15–20 h at – 
80°C, the freezing vials were transferred to a liquid nitrogen tank and kept there until further 
usage.  
 
Human fibroblast (AG and NHDF) were frozen in EMEM medium (BioWhittaker) containing 
15% (v/v) foetal calf serum (Biochrom), 2 mM L-glutamine (Biochrom), 100 U/ml penicillin 
and 100 μg/ml streptomycin (Biochrom) and 10% (v/v) glycerol. All other cell lines used were 
frozen in McCoy’s 5A Medium (Sigma) with 10% (v/v) foetal calf serum (Biochrom) and 
2.8 mM L-glutamine (Biochrom) and 10% (v/v) DMSO. 
 
To taw the cells the vial was incubated briefly at 37°C. The cells were resuspended in 15 ml pre-
warmed cell culture medium and this cell suspension was transferred to a 75 cm2 culture flask. 
On the next day the culture medium was removed and replaced by fresh culture medium. For 
the human fibroblasts (AG and NHDF), the cell number in the removed medium was 
determined to assess the number of attached cells, giving the actually number of seeded cells 
(N0) to determine the CPD (see Sect. 4.1.1). 
 
 
 
4.1.6 Test for contamination of  cell cultures with mycoplasma 
 
 
Mycoplasma are the smallest free-living and self-replicating organisms (0.2−2 μm in diameter). 
They are very restricted in metabolic potential and closely associated to eukaryotic cells. 
Mycoplasma in cell cultures live as extracellular parasites, usually attached to the external surface 
of the cell membrane. Contamination of cell cultures with mycoplasma can alter DNA, RNA 
and protein synthesis and also initiate chromosomal aberrations. All cells used were checked 
regularly for contamination with mycoplasma using the ‚Mycoplasma Detection Kit’ (Boehringer 
Mannheim) according to the manufacturer's protocol. When an infection with mycoplasma was 
detected, the cells were successfully treated with plasmocin from Amaxa according to the user's 
manual.  
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4.2 Irradiation of  cells 
 
 
For irradiation, cells were cultivated depending on the experimental outline either on glass cover 
slips (∅ 30 mm; Menzel-Gläser, Braunschweig, Germany), on petri dishes (∅ 32 mm or 150 
mm; Nunc, Roskilde, Denmark) or in culture flasks (25 cm² or 75 cm²; Falcon). The cells were 
irradiated with X-rays, γ-rays or heavy ions as described below. 
 
 
 
4.2.1 X-ray irradiation 
 
 
Artificially produced X-rays have a wide spectrum of energies resulting from the deceleration of 
electrons as they traverse high-atomic-number materials. Additional filtration selectively removes 
the less energetic photon component (i.e. the “soft” X-rays) and by this, hardens the X-rays. 
Here, the exposure to X-rays was performed using a industrial X-ray generator Isovolt DS1, 
type IV320-13, manufactured by Seifert (Germany). This X-ray tube is equipped with a 7 mm 
beryllium filter and one aluminium and one copper filter of 1 mm thickness each (Fig. 57). 
These additional filters are positioned below the tube and serve to eliminate the soft X-rays. The 
samples were irradiated with a voltage of 250 kV and a current of 16 mA. All samples were 
irradiated with a dose rate of 2–3.5 Gy/min. The dosimetry was done with a SN4 dosimeter 
(PTW Freiburg), calibrated according to Fricke [Fricke and Hart, 1966].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X-ray focus
Filters 
Sample holder 
Dosimeter 
Fig. 57 Experimental setup for the exposure of cell cultures to X-rays. 
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4.2.2 γ-Irradiation 
 
 
For experiments involving peptide mapping the cells were irradiated with γ-rays at the 
Forschungscentrum Karlsruhe. The γ-irradiation was performed at room temperature using a 
Gammacell 220 (A.E.C.L. Atomic energy of Canada limited, Ottawa, Canada) with a 60Cobalt 
source. The cells were grown and irradiated in ∅ 150 mm petri dishes (Nunc, Roskilde, 
Denmark). The samples were irradiated with a dose of 10 Gy at a dose rate of 2 Gy/min. 
 
 
 
4.2.3 Heavy ion irradiation 
 
 
Two different facilities were used to expose cell cultures to heavy ions: the SIS 
('Schwerionensynchrotron': Heavy Ion Synchrotron) and the BIBA ('Biologische Bestrahlungs 
Apparatur': biological irradiation device) of the UNILAC (Universal Ion Linear Accelerator) 
facility [Kraft et al., 1980; Haberer et al., 1993] at the GSI (Fig. 58).  
 
 
South injector
North injector
High-charge
injector
Transfer channel
Experimental hall
Therapy
Target hall
UNILAC
Fig. 58 Schematic plan of the accelerator and experimentation facilities at the GSI. 
Ions are injected by the North and South injectors and pass through the Wideröe structure 
or originate in the high-charge injector before being fired into the Alvarez structure. Part 
of the beam is diverted to the experimental hall for experiments, while the remainder is 
transferred to the SIS for further acceleration (GSI). 
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4.2.3.1 The UNILAC facility 
 
The UNILAC is a 120 m long linear accelerator that accelerates ions to 20% of the speed of 
light. The ions, coming from a high current injector (HCI), are accelerated by a radiofrequency 
quadrupole (RFQ; up to 120 keV/u) plus interdigital H-structure up to 1.4 MEV/u. The 
collision of the ions with a N2-jet stripper results in a partially stripping the ions of their 
electrons, giving the further acceleration higher efficiency. The UNILAC can accelerate ions to 
energies of 2−18 MeV/u. 
 
For the detection of protein accumulations in form of foci after heavy ion irradiation, cells were 
cultivated and irradiated in petri dishes (∅ 32 mm; Nunc, Roskilde, Denmark). The petri dishes 
were placed vertically in a specially designed magazine, which can accommodate up to 20 petri 
dishes. The magazine was filled with the appropriate cell culture medium to avoid drying out of 
the cell monolayers during the irradiation procedure. The magazine then was placed into the 
BIBA device of the UNILAC facility. A computer controlled robot arm pulled out one petri 
dish after the other to expose the cell monolayers to the particle beam until the desired dose was 
applied. The irradiation procedure, including the transport to and from the BIBA device to the 
laboratory, took approximately 20 min. For experimental setup see Fig. 59. 
 
A possible influence of the temperature during the irradiation was checked by cooling the used 
magazins (filled with medium) to a temperature of 4°C or by incubation of the magazins with 
medium at 37°C prior irradiation. 
 
 
 
Fig. 59 Schematic diagram of the sample holder for irradiation experiments at the 
UNILAC facility. 
For the experiments in which protein accumulations along the heavy ion tracks and horizontal 
to the culture surface were detected, cells were grown and irradiated on glass cover slips 
(∅ 30 mm; Menzel-Gläser, Braunschweig, Germany). Because of the short penetration depth of 
the ions accelerated with the UNILAC facility, the cells could not be irradiated on cover slips 
positioned horizontally to the particle beam. For exposures, the cover slips were fixed in the 
beam line at an angle of approximately 4° (see Fig. 60 for experimental setup) and the cells could 
not be covered with medium. To make sure that the cells did not suffer drying out, cells were 
kept without medium for less than 2 min during the irradiation procedure. With this setup, one 
cover slip at time could be irradiated.  
Beam
BIBA arm
Magazine with 12 petri dishes
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Fig. 60 Sample holder for experiments where cells were irradiated at a low angle 
towards the beam-line. 
 
 
 
4.2.3.2 The SIS facility 
 
The SIS is a heavy ion synchrotron with a diameter of 219 m that can accelerate the ion beam 
up to 90% of the speed of the light. After the acceleration at the UNILAC, ions can be led to 
the SIS. In the section between the UNILAC and the SIS facility, the ions pass a thin carbon 
foil, which ionizes the ions further. In the vacuum ring of the SIS, the ions are kept in a circular 
path by strong magnetic fields. Here, energies up to 2 GeV/u can be reached. 
 
For the detection of protein tracks horizontal to the culture surface after irradiation at the SIS 
facility, cells were cultivated in petri dishes (∅ 32 mm; Nunc, Roskilde, Denmark) and irradiated 
horizontal to the particle beam. With the SIS facility, very high particle energies can be reached, 
which results in a high penetration depth, enough to penetrate the petri dish with medium. The 
petri dishes were placed in a plastic box filled with medium. For irradiation, a maximum of 4 
petri dishes per box, in total 3 boxes, were irradiated. For experimental setup see Fig. 61. 
 
 
 
Fig. 61 Sample holder for the petri dishes and experimental setup for the horizontal 
irradiation at the SIS facility at the GSI. 
The dosimetry of the heavy ion irradiation was done with an ionisation chamber, developed at 
the GSI and calibrated using the nuclear detector CR39. CR39 is a plastic that shows the ion 
tracks after it has been etched with 11 M NaOH [Scholz et al., 2001]. 
Sample holder with 12 petri dishes 
Beam
Sample holder
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The given dose was determined from the fluence as follows: 
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The charged particles used for experiments mentioned in this thesis involving heavy ions are 
summarized in Table 6 below. 
 
 
Ion 
Fluence 
[P/cm²] 
Energy 
[MeV/u] 
Energy  
on target [MeV/u]
LET 
[keV/μm] 
Au 2×106; 3×106 11.4 4.0 13030 
Cr 2×106 11.4 5.6 2810 
Fe 6×106 200 175 337 
Kr 3×106 11.4 4.8 5265 
Ni 2×106; 3×106 11.4 4.5 3790 
Sm 3×106 11.4 4.2 10290 
U 2×106; 3×106; 1×107 11.4 4.2 14925 
Zn 3×106 11.4 4.8 4120 
Table 6 Heavy ions used for the experiments described in this thesis. 
 
 
 
 
4.3 DNA damage induction by chemicals 
 
 
4.3.1 CPT treatment 
 
 
CPT was added to the medium of confluent NHDF cells on petri dishes to a final concentration 
of 1μM CPT. The cells were incubated at 37°C for 1 h. The medium was removed and the 
monolayer rinsed with PBS. The soluble proteins were either not extracted or extracted by 
Hepes buffer as indicated and described in Sect. 4.4 (page 99). Immunostaining for p21 and 
XRCC1 or 53BP1 was carried out (Sect. 4.4.4, page 100) and the cells analysed by confocal laser 
scanning microscopy (Sect. 4.5, page 101). 
 
 
Comment [j1]:  
Methods 
 
 99 
 
4.3.2 H2O2 treatment 
 
 
The medium of NHDF cells was removed, the cell monolayer rinsed with PBS and incubated 
with 0.2 mM H2O2 in PBS for 20 min at RT. The H2O2 containing PBS was replaced by 
conditioned medium and the cells were incubated at 37°C for 15 min. The cells were washed 
with PBS and immunostained after fixation and extraction with Hepes buffer as described in 
Sect. 4.4 below. 
 
 
 
 
4.4 Immunostaining 
 
 
Protein accumulations within the nucleus were detected by indirect immunostaining. Specific 
primary antibodies were used to detect the proteins of interest. A secondary fluorochrome-
labelled antibody was utilized to detect the primary antibody. Depending on the protein of 
interest, different cell extraction methods were used. For the detection of most proteins 
investigated in this thesis, either the no extraction prior to immunostaining or extraction of 
soluble proteins by Hepes-buffer was used. The detection of the PCNA protein required a 
special extraction method, as the PCNA could not be detected by the other methods used. 
Immunostaining to detect PCNA was done after extraction of the soluble proteins according to 
the modified Streck extraction protocol. The used protocols are described below. 
 
 
 
4.4.1 Fixation and permeabilization of  the cells without extraction of  
the soluble proteins 
 
 
Following irradiation and a given incubation time, the culture medium was removed from the 
cells and the cells were washed with PBS. The cells were fixed with 2% paraformaldehyde 
(2% w/v) in PBS) for 20 min at RT prior to the permeabilization with 0.5% Triton X-100 
(0.5% (v/v) in PBS) for 10 min. Cells were washed twice with PBS for 5 min and the non-
specific antibody binding sites were blocked by incubation with a 0.5% BSA solution 
(0.5% (w/v) in PBS), either for 30 min at RT or over night at 4°C. Immunostaining for proteins 
of interest was carried out as described in Sect 4.4.4 (page 100). 
 
 
 
4.4.2 Extraction of  the soluble proteins by Hepes-extraction buffer 
 
 
If the extraction of the soluble proteins was required, the method described by Pagano et al. 
[1994] with slight modifications was used. The medium was removed from the cells and the cells 
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were rinsed with PBS. Soluble proteins were extracted by a 10 min incubation on ice with 
Hepes-extraction buffer (10 mM Hepes-KOH, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 
0.1% (v/v) Triton X-100; pH 7.9), a hypotonic buffer containing the non-ionic detergent Triton 
X-100. Cells were fixed with 2% paraformaldehyde (2% (w/v) in PBS) for 20 min at RT, washed 
twice in PBS for 5 min each and the non-specific antibody binding sites were blocked with a 
0.5% BSA solution (0.5% (w/v) in PBS), either for 30 min at RT or over night at 4°C. The 
specific proteins were immunostained as outlined in Sect. 4.4.4 (page 100). 
 
 
 
 
4.4.3 Extraction of  the soluble proteins by the GSI modified Streck 
method 
 
 
Due to the nuclear abundance of the PCNA protein a specific signal for the irradiation-induced 
accumulated chromatin-associated fraction of the PCNA could not be obtained easily. For this 
reason, a special protein extraction and fixation method became necessary for the detection of 
the chromatin-associated PCNA fraction. Here, I have utilized the modified Streck method 
[Mirzoeva and Petrini, 2001] with slight modifications by B. Jakob (GSI) to visualize the 
chromatin-bound PCNA by indirect immunostaining. This method is referred to as the ‘GSI 
modified Streck’ method in the following. 
 
The medium was removed from the cells, the cells were washed with PBS and the soluble 
proteins were extracted with cytoskeleton extraction buffer (10 mM pipes, 100 mM NaCl, 
300 mM sucrose, 3 mM MgCl2, 1 mM EGTA, 0.5% (v/v) Triton X-100, 4 mM Vanadyl-ribosyl 
complex, 1 mM AEBSF; pH 6.8) for 10 min on ice. Cells were then washed with PBS and fixed 
by incubation with 1% paraformaldehyde (1% (w/v) in PBS) for 5 min at RT, followed by 
incubation with the Streck fixative (150 mM 2-bromo-L-nitro-1.3-propandiol, 108 mM 
diazolidinyl urea, 10 mM sodium citrate, 50 mM EDTA, pH 5.7) for 30 min at RT. The cells 
were permeabilized with 0.5% Triton X-100 (0.5% (v/v) in PBS) for 10 min at RT, washed 
twice in PBS for 5 min each and the non-specific antibody binding sites blocked by incubation 
in 0.5% BSA solution (0.5% (w/v) in PBS) for 30 min at RT or over night at 4°C. 
Immunostaining for specific proteins was carried out as described below. 
 
 
 
 
4.4.4 Indirect immunostaining  
 
 
Following the incubation of cells in BSA blocking solution (0.5% (w/v) BSA in PBS), the 
proteins of interest were detected by the indirect immunohistochemical staining method. For 
this, specific primary antibodies are used to target the protein of interest and, in a second step, 
the primary antibody is targeted by a secondary antibody which is linked to a fluorochrome (Fig. 
62). 
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Fig. 62 Schematic diagram of the indirect immunostaining. 
 
BSA blocked cell monolayers were incubated for 1 h at RT with the primary antibody (see Table 
7), followed by three washes with PBS for 5 min each. Then cells were incubated with the 
fluorochrome-labelled secondary antibody (see Table 7) for 30 min at RT. All antibodies were 
diluted in 0.5% (w/v) BSA in PBS and used in concentrations as shown in Table 7 (page 116). 
To reduce the amount of antibody necessary for each antibody reaction and to prevent drying 
out of the samples, the cell monolayers were covered with Mylar foil during the incubation 
periods. To visualize the nucleus the DNA was stained for 20 min at RT with a 1 μM ToPro-3 
in PBS (Molecular Probes, Leiden, Netherlands) with addition of 100 μg/ml RNase A from 
Boehringer Mannheim), followed by three washes for 5 min in PBS. The samples were air-dried 
and, to prevent a fading of the fluorescence signal, 'Vectashield Mounting Medium' (Vector 
Laboratories, Burlingame, CA, USA) was used to mount the cover slip (∅ 30 mm; Menzel-
Gläser, Braunschweig). Until microscopic analysis the samples were kept protected from light at 
4°C. 
 
 
 
 
 
4.5 Confocal laser scanning microscopy (CLSM) 
 
 
Microscopic analysis was carried out according to our standard procedures and as described in 
Jakob et al. [2000]. I used a Leica TCS confocal laser scanning system. This system is equipped 
with a DM IRBE inverted microscope (lens: PlanApo 63 × / 1.32 oil) and an argon/krypton 
laser (light amplification by stimulated emission of radiation). The microscope was connected to 
a Märzhäuser computerised stage control SCAN 100 × 100. The used argon/krypton mixed gas 
laser gives three spectral lines for excitation at 488 nm (green), 568 nm (red) and 647 nm (dark 
red; displayed as blue on the monitor). The observed field was approximately 0.05 cm² large 
which in average showed 2000 cells.  
 
 
Fluorochrome linked 
secondary antibody 
Protein of interest 
Primary antibody 
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4.5.1 Characteristics of  CLSM 
 
 
The CLSM uses a tiny laser spot, focused in a defined image plane, to excite fluorescence. This 
spot is scanned in lines across the field, resembling image formation by an electron beam on a 
monitor. The detection of fluorescence can be regulated by a photomultiplier with high 
sensitivity. The principal function and ray pathway of a CLSM is shown in Fig. 63 The laser, 
beam splitter and excitation filter wavelength are exemplified for FITC (488 nm; green) 
detection. 
 
 
 
 
Fig. 63 Schematic diagram of the CLSM laser (Leica). 
 
The laser produces high-intensity, coherent light of a defined wavelength. The principle of a 
laser is based on the fact that excited atoms or molecules radiate photons of a wavelength, which 
are perfectly coherent. Between laser and beam splitter, where the light is mirrored into the 
objective, the pinhole (an excitation aperture) produces a thin laser beam. The objective projects 
the laser beam into the focal plane within the sample. By fluorescence excitement, one image 
point (pixel) is formed out of a raster of 512 by 512 pixels. After straight transmission of the 
beam splitter, only this pixel is detected by the photomultiplier (PMT), as the emission pinhole is 
in a confocal position to the excitation pinhole. The different intensities recorded by the PMT 
are converted back into x/y information and depicted on the CLSM monitor. The intensity can 
be controlled by changing the voltage as well as the offset of the PMT.  
 
Note that in some Fig. the protein tracks appear as if going through the nucleoli. This is 
obtained because the images shown represent the mean projection of the microscopically 
obtained 4–12 single planes. By displaying a single plane of the microscopically acquired stack, it 
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is inferred that the protein tracks are either above or below the nucleolus (single planes of the 
stacks are not shown in this thesis). 
 
 
 
4.5.2 Evaluation of  protein colocalisation 
 
 
To verify whether the immunostained proteins colocalize after irradiation Scion Image 
(http://www.scioncorp.com) was used with a program provided by Dr. B. Jakob (GSI). Here, 
the median of the projections which were obtained with the CLSM were inverted in gray scala. 
The intensity of each channel was displayed separately and the colocalisation of the detected 
areas of each channel was calculated (see Fig. 64). If the resulting chi20 factor is above 8 the two 
channels are considered to show good colocalisation meaning two proteins colocalize. A 
random colocalisation is assumed with a chi20 factor of 1. 
 
 
 
   
Green: p21 
Red: 53BP1 P21 53BP1 Colocalisation  
Fig. 64 Example for the evaluation of colocalisation for p21 and 53BP1 following 
exposure to 6 Gy X-rays. 
 
 
 
 
4.6 Live-cell imaging by beam-line microscopy 
 
 
This method was developed by Dr. B. Jakob at the GSI [Jakob et al., 2005] who also kindly 
performed the live-cell imaging for the very early kinetics of the heavy ion-induced foci 
formation of the recombinant GFP-p21 for this thesis. 
 
HeLa cells were seeded on approximately 2.4 × 2.4 cm ethanol-sterilized polycarbonate squares 
(40 µm thick) placed in petri dishes (∅ 32 mm; Nunc, Roskilde, Denmark) 3 days prior to the 
irradiation. To do so, 20000 cells were suspended in 1 ml of medium and centre-plated on the 
polycarbonate square. After adhesion of the cells, 2 ml of medium were added. One day prior to 
irradiation the cells were transfected with the GFP-p21 plasmid as described in Sect. 4.10.1. Just 
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before irradiation a silicon spacer with a thickness of 500 µm was placed on the polycarbonate 
square and covered with a cover slip. The spacer allowed for a medium layer on top of the cells 
to avoid drying out of the cells during imaging. The polycarbonate square with the spacer and 
cover slip was placed on an aluminium carrier and fixed on the microscopic setup as shown in 
Fig. 65 
 
The irradiation was done with krypton ions (4.8 MeV/u; LET: 5265 keV/µm). 
 
 
 
 
 
 
Fig. 65 A: Schematic diagram of the radiation setup including polycarbonate square 
with spacer and coverslip on aluminium tray, microscope lens and ion beam. For 
microscopy, a water immersion lens NPL Fluotar 50×/NA 1.0 was used. The fluorescence 
signal was detected through culture medium and a cover slip. B: Top view (photo) of the 
cell container with silicon spacer. 
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4.7 Preparation of  cell lysates 
 
 
Crude cell lysates were prepared under denaturing or native conditions. In addition, fractionated 
cell extracts were prepared according to several methods (see below). 
 
 
 
4.7.1 Preparation of  cell lysates under denaturing conditions 
 
 
Whole cell lysates for Western Blot analysis were prepared according to Laemmli [Laemmli, 
1970]. The medium was removed and the cell monolayer was rinsed with PBS. The cells were 
lysed by adding 2 × Laemmli buffer (100 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 20% (v/v) 
glycerol) and removed from the culture vessel surface with a cell scraper. The lysates were 
heated for 10 min at 100°C and centrifuged at 13000 × g for 10 min at 15°C. The supernatant 
containing the proteins was transferred to a new tube and stored at – 20°C until further usage. 
The pellet containing the cell debris was discarded. 
 
 
 
4.7.2 Preparation of  native cell lysates 
 
 
After some modifications, satisfying results were reached with the following method for the 
preparation of native cell lysates. The medium was removed and the cells were rinsed with PBS. 
The cells were incubated with the cell specific trypsine-EDTA solution (see Sect. 4.1 Cell 
cultivation, page 90) for 5 min on ice, detached from the culture surface with a cell scraper and 
singularized by pipetting several times up and down. The enzymatic activity of the trypsine was 
stopped by adding the 3-fold of culture medium. The cells were counted and centrifuged for 
10 min (107 × g at 4°C), washed with PBS and centrifuged again (107 × g at 4°C, 10 min). The 
supernatant was discarded and the cells were resuspend at 3 × 107 cells per ml in RIPA buffer 
(1% (v/v) NP40, 50 mM Tris/HCl, 150 mM NaCl, 1 mM EDTA, 0.5% (v/v) sodium 
deoxycholate) with protease inhibitors (Complete, Roche). The cell suspension was 
homogenized by taking it 40 × through a 25 G cannula followed by a 30 min incubation on ice. 
The cell debris was separated by centrifugation (8000 × g for 30 min at 4°C) and the supernatant 
containing the proteins was kept at – 80°C.  
 
 
 
4.7.3 Subnuclear fractionation studies 
 
 
To analyze chromatin-associated proteins, subcellular fractionation is carried out in which the 
soluble protein fraction is separated from the chromatin-bound protein fraction. After this 
separation, the chromatin-bound proteins can be released from the DNA by several methods 
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and analyzed by the Western Blot analysis. For the subcellular fractionation of proteins many 
different protocols exist. However, depending on the protein of interest, only some of the 
protocols may give satisfying results. I tested several different protocols to investigate the 
presence of p21 and/or PCNA in subnuclear protein fractions to find the best suitable method. 
The different approaches are written below. 
 
 
 
4.7.3.1 Subcellular protein fractionation by the use of Douncer pestles 
 
Cells were harvested by trypsination as outlined in Sect. 4.1 (page 90), rinsed with PBS and 
pelleted by centrifugation (107 × g, 10 min, 4°C). The cells were resuspended in PBS and the 
exact cell number determined (Beckman Coulter Counter). The cells were spun down (230 × g, 
10 min, 4°C), resuspended in Dignam buffer A (1.5 mM MgCl2, 10 mM Hepes buffer pH 7.9, 
10 mM KCl, 0.5 mM AEBSF, 0.5 mM DTT, protease inhibitors Complete from Roche; 5 × 107 
cells/ml) and lysed by 40 strokes of a loose-pestle Dounce homogenizer (Wheaton, Millville, NJ, 
USA) on ice. The homogenate was centrifuged (8000 × g, 5 min, 4°C) to pellet the nuclei from 
the cytosolic proteins. The supernatant was transferred to a new tube and stored at – 20°C until 
further usage. The pelleted nuclei were resuspend in Dignam buffer C (1.5 mM MgCl2, 20 mM 
Hepes buffer pH 7.9, 0.42 M NaCl, 0.2 mM EDTA, 25% (v/v) glycerol, 0.5 mM AEBSF, 
0.5 mM DTT, protease inhibitors Complete from Roche; 5 × 107 cells/ml) by 40 strokes of 
tight-pestle Dounce homogenizer (on ice). After high speed centrifugation (19000 × g, 30 min, 
4°C), the supernatant containing the nuclear protein fraction was transferred to a new tube and 
stored at – 80°C until further usage; the pellet discarded. 
 
 
 
4.7.3.2 Cell fractionation according to Balajee and Geard [2001] and with modifications according to 
Savio et al. [1996] 
 
Cell fractionation studies according to the protocol of Balajee and Geard [2001] led to high 
amounts of protein in the final pellet, which then is discarded using this method. The 
supernatant is considered to contain the chromatin-bound proteins. However, it became 
obvious that not all of the chromatin-bound proteins were released using a buffer with 0.5 M 
NaCl as requested according to Balajee and Geard. For this reason, the protocol was modified 
according to Savio et al. [1996] by releasing the chromatin-bound proteins by incubation with 
DNase I buffer as followed. 
 
The medium was removed from the cells, the cells were washed with PBS and incubated with a 
trypsin-EDTA solution (0.05 g/l trypsine, 1 g/l EDTA-solution in PBS without Mg2+ and Ca2+ 
obtained from PAN) on ice for 2 min. The cells were scraped off, singularised and the trypsin 
was stopped by the addition of 3-fold culture medium. The cell concentration was determined 
with a cell counter (Beckman Coulter Counter) and cells were spun down (107 × g, 4°C, 
10 min). The cell pellet was washed with PBS, centrifuged (107 × g, 4°C, 10 min) and the cells 
were resuspended at 107 cells/ml in Buffer I (10 mM Tris-HCl pH 7.4, 2.5 mM MgCl2, 
0.5% v/v) NP40, 1 mM AEBSF) with protease inhibitors (Complete) and incubated for 10 min 
on ice. The suspension was centrifuged with 735 × g at 4°C for 5 min, the supernatant 
containing the soluble cytosolic and nuclear proteins was transferred into a new tube and frozen 
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at − 80°C (lysate 1). The pellet was resuspended in Buffer I, incubated on ice for 10 min and 
spun down again. This was repeated to be sure that all soluble proteins were removed from the 
chromatin-bound protein fraction (lysate 2 and 3). Finally, the pellet was resuspended in DNase 
I buffer solution (200 u/107 cells DNase I in Buffer III: 10 mM Tris-HCl pH 7.4, 10 mM NaCl, 
5 mM MgCl2, 0.1 mM AEBSF) with protease inhibitors (Complete, Roche) at 107 cells/ml and 
incubated for 30 min at 37°C. The DNase I activity was stopped by adding EDTA (10 mM) and 
incubation on ice. After centrifugation (14000 × g, 4°C, 5 min), the supernatant containing most 
of the chromatin-bound proteins was transferred to a clean microfuge tube (lysate 4). The pellet 
was resuspended in a high salt concentration buffer (3 × 107 cells/ml Buffer II; 25 mM sodium 
phosphate buffer pH 7.4, 0.5 M NaCl, 1 mM EDTA, 0.5% (v/v) Triton X-100, 10% (v/v) 
glycerol, 5 mM MgCl2) with protease inhibitor (Complete, Roche) to release the maintaining 
chromatin-bound proteins for 20 min on ice and centrifuged (14000 × g, 4°C, 5 min). This 
supernatant was combined with the previous supernatant obtained after DNase I digest (lysate 
4). To assess the fraction of proteins remaining within the final pellet this pellet was lysed under 
denaturing conditions in 2 × Laemmli buffer (100 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 20% 
(v/v) glycerol) as described previously (Sect. 4.7.1 page 105). 
 
 
 
4.7.3.3 Cell fractionation as described by Xu and Stern [2002] 
 
The medium was removed from the cells and cells were rinsed with PBS, trypsinized (0.05 g/l 
trypsine, 1 g/l EDTA-solution in PBS without Mg2+ and Ca2+ obtained from PAN) and scraped 
of the culture dish and singularised. The trypsin solution was inactivated by addition of culture 
medium and the cell concentration was determined using a cell counter followed by 
centrifugation (107 × g, 4°C, 10 min) and washing in PBS. The cell pellet was resuspended at 
1.5 × 107 cells/ml buffer A (10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 
10% (v/v) glycerol, 1 mM DTT, 0.1% (v/v) Triton X-100) with protease inhibitors (Complete, 
Roche) and lysed on ice for 5 min. The nuclei were separated from the cytosolic proteins by 
centrifugation (1500 × g, 4°C, 5 min). The supernatant was transferred into a new tube and 
centrifuged (13000 × g, 4°C, 10 min) to clear the cytosolic proteins from the cell debris. This 
supernatant containing the cytosolic proteins was kept at − 80°C until further usage (lysate S2). 
Nuclei were washed in buffer A and repelleted (1500 × g, 4°C, 4 min).  The supernatant was 
discarded. Then the nuclei were lysed on ice for 10 min in buffer B (1.5 × 107 cells/ml; 3 mM 
EDTA, 0.2 mM EGTA, 1 mM DTT) with protease inhibitors (Complete, Roche). Following 
centrifugation (2000 × g, 4°C, 4 min), the supernatant with the soluble nuclear proteins was 
transferred to a new tube and frozen at − 80°C (lysate S3). The pellet, containing the chromatin-
bound nuclear proteins, was washed in buffer B and centrifuged (13000 × g, 4°C, 10 min) and 
the supernatant stored at − 80°C until further usage (lysate S4). The pellet with the remaining 
chromatin-bound proteins was resuspended in 2 × Laemmli buffer (100 mM Tris-HCl pH 6.8, 
2% (w/v) SDS, 20% (v/v) glycerol), heated for 10 min at 100°C and centrifuged (13000 × g, 
4°C, 10 min). The supernatant with the remaining chromatin-bound proteins was frozen at 
− 80°C (lysate P3). 
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4.7.3.4 Cell fractionation according to Stivala and Prosperi et al. [2004]  
 
After medium removal, the cell monolayer was rinsed with PBS and the cells detached from the 
petri dish and singularized by a trypsin-EDTA solution (0.05 g/l trypsine, 1 g/l EDTA-solution 
in PBS without Mg2+ and Ca2+ obtained from PAN) incubation. The cell number was 
determined with a coulter counter and the cells pelleted by centrifugation (107 × g, 4°C, 
10 min). Cells were resuspended with 107 cells/ml in a hypotonic lysis buffer (10 mM Tris-HCl 
pH 7.4, 2.5 mM MgCl2, 0.5% (v/v) NP40, 1 mM DTT, 1 mM AEBSF, protease inhibitor 
cocktail Complete from Roche) and lysed for 10 min on ice. Centrifugation at 300 × g for 1 min 
(4°C) separated the soluble proteins (supernatant) from the chromatin-bound protein fraction 
(pellet). To be sure that all soluble proteins were separated from the chromatin-bound protein 
fraction, the pellet containing the chromatin-bound proteins and cell debris was washed twice by 
resuspending the pellet in washing buffer (107 cells/ml; 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 
1 mM AEBSF, protease inhibitor cocktail Complete from Roche) and centrifuge at 300 × g for 
1 min (4°C). The pellet was resuspended in DNase I solution (108 cells/ml; 20 mM NaCl, 
0.1 mM AEBSF, 200 DNase I units/107 cells) and 2 × digestion buffer was added (108 cells/ml; 
20 mM Tris-HCl pH 7.4, 20 mM NaCl, 10 mM MgCl2, protease inhibitor cocktail Complete 
from Roche) and incubated rotating for 30 min at 37°C. After centrifugation at 14000 × g for 
1 min (4°C) the supernatant contained the chromatin-bound protein fraction - released by the 
DNase I digestion - and the pellet the cell debris. The remaining pellet was resuspended in 70 μl 
2 × Laemmli buffer (100 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 20% (v/v) glycerol) to assess 
potential remaining proteins.  
 
As with this method the chromatin-associated p21 appeared to be degraded, the DNA digestion 
was done by 45 min incubation with Benzonase (200 units/107 cells) at 4°C instead of DNase I. 
 
 
 
 
 
4.8 Immunoprecipitation of  specific protein complexes 
 
 
To detect whether proteins interact with each other in native cell extracts, protein complexes 
can be co-immunoprecipitated by specific antibodies. The precipitated protein complex can be 
separated under denaturing conditions and can be analysed by the Western Blot technique.  
 
After establishing a successful method for p21 immunoprecipitation (see Sect. 4.8.1 below) the 
IPs were carried out as described in the following, if not stated otherwise: 
An aliquot of the cell lysate corresponding to 1 mg of total protein was diluted in 1 ml Ripa 
buffer without SDS (2% (v/v) Igepal, 100 mM Tris/HCl, 300 mM NaCl, 2 mM EDTA 
0.5% (v/v) sodium deoxycholate, protease inhibitors Complete from Roche). This lysate was 
precleared by addition of normal IgG (Amersham) for 2 h at 4°C (rotating). Ultralink 
Immobilized Protein A/G beads (10 μl; Pierce) were added and another 2 h of incubation at 
4°C (rotating) was given. The lysate was cleared of the beads with the bound IgG and non-
specific IgG binding proteins by centrifugation for 5 min with a speed of 1000 × g at 4°C. The 
supernatant was transferred to a new tube, the pellet containing the unspecific IgG binding 
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proteins discarded. The specific antibody was added (1 μg) and incubated over night at 4°C 
(rotating). Ultralink Protein A/G beads (10 μl) was added and incubated rotating for additional 2 
h at 4°C. The samples were centrifuged (8000 rpm, 5 min, 4°C), the supernatant discarded and 
the beads with the bound protein complexes washed 4 times by resuspend with each 1 ml Babco 
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% (v/v) NP40, 1 mM EDTA pH 8.0, 0.25% 
(v/v) gelatine) and centrifuge (4000 × g, 5 min, 4°C). The final pellets containing beads with the 
IP proteins were resuspended each in 30 μl 2 × Laemmli SDS-sample buffer (100 mM Tris-HCl 
(pH 6.8), 2% (w/v) SDS, 20% (v/v) glycerol, 0.02 mg/ml bromphenolblue, 2% (v/v) β-
Mercaptoethanol) and denaturated for 10 min at 100°C. After centrifugation (13000 × g, 10 
min, 10°C) the supernatant was transferred to a new tube and stored at – 80°C until Western 
Blot analysis was carried out; the pellet discarded. 
 
 
 
4.8.1 Establishment of  a method to immunoprecipitate a p21 complex 
 
 
To establish a method for IP of a p21 complex, I used HCT116 cells, for which the isogenic p21 
knockout cell line is available that can be used as a negative control. HCT116p21+/+ and 
HCT116p21-/- cells were irradiated with 15 Gy X-rays as described in Sect. 4.2.1 (page 94) to 
induce DNA lesions and with this increase the amount of potentially available p21/PCNA 
complexes. Subnuclear protein fractionation was done with the Douncer pestles 16 h post 
irradiation as outlined in Sect. 4.7.3.1 (page 106). The immunoprecipitation was done with an 
anti-p21 polyclonal rabbit antibody (Ab5, Oncogene, Cambridge, USA) in Dignam A buffer 
(1.5  mM MgCl2, 10 mM Hepes buffer pH 7.9, 10 mM KCl 0.5 mM PMFS, 0.5 mM DTT with 
protease inhibitors Complete from Roche) as described in Sect. 4.8 (page 108). 
Immunoprecipitated p21 complexes were analyzed by Western Blot analysis for the presence of 
p21 and PCNA. 
 
The Western Blot analysis of the p21 IP's in Fig. 66 shows that the p21 pulldown from the 
chromatin-associated protein fraction from mock-irradiated HCT116p21+/+ and HCT116p21-/- 
cells does not co-immunoprecipitate PCNA, as expected (Fig. 66 lanes 2 and 4, respectively). 
However, both irradiated samples show a weak PCNA signal (Fig. 66 lanes 3 and 5). Peculiarly, 
the HCT116p21-/- cells show even more co-immunoprecipitated PCNA than the wild-type p21 
cells (Fig. 66 lane 5 versus lane 3). The p21 detection displays a clear induction of the 
immunoprecipitated p21 from the wild-type p21 cells (Fig. 66 lanes 2 and 3). Curiously, the 
HCT116p21-/- cells also show a detectable amount of p21 and a slight increase with irradiation 
(Fig. 66 lane 4 versus 5). Because of their p21 status however, they should not have a detectable 
p21 signal and with this, not be able to precipitate PCNA by specific p21 immunoprecipitation.  
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   Lane             1      2      3              4       5             6 Exposure time 15 min 
  
  heavy IgG chain 
 
PCNA  
  
 
 
 
p21 
 
Lane 
1 Molecular weight marker RPN 800 
2 p21 pulldown HCT116 mock-irradiated 
3 p21 pulldown HCT116 15 Gy / 16 h 
4 p21 pulldown HCT116p21-/- mock-irradiated 
5 p21 pulldown HCT116p21-/- 15 Gy / 16 h 
6 HCT116 mock-irradiated lysat 0.3 µg  
 
 
Fig. 66  Western Blot detection of PCNA and p21 after p21 pulldown from HCT116 cell 
lysates. Specific p21 pulldown from p21-deficient HCT116 cells result in a irradiation induced 
co-immunoprecipitated PCNA signal (lane 5).  
 
The protocol for the IP was modified several times with the aim first to have no PCNA signal 
for the p21 IP from HCT116p21-/- cells. The first approach was to try another antibody that 
differed in the epitope for the p21 pulldown. I compared the p21 polyclonal rabbit antibody 
(Ab5, Oncogene, Cambridge, USA) with a potentially more specific p21 monoclonal mouse 
antibody (Ab3, Oncogene, Cambridge, USA). For these experiments, cells were not irradiated 
and whole cell lysate was used for the IP, as first I aimed a Western Blot analysis of the p21 
pulldown of HCT116p21-/- cells with a non-detectable PCNA signal. A slight difference 
between the used antibody was seen, as the detectable PCNA band is elevated with the use of 
the p21 polyclonal rabbit antibody compared to the IP's done with the p21 monoclonal mouse 
antibody (supplement 6.4 Fig. 75 lanes 3 and 5 versus lanes 2 and 4). As the Ab5 p21 antibody 
gave the clearest detectable PCNA signal, this antibody was used for the further IP's.  
 
My next approach was to check the non-specific binding of PCNA to the used IgG's. The 
pulldown with IgG mouse or IgG rabbit antibody in Dignam A buffer (1.5 mM MgCl2, 10 mM 
Hepes buffer pH 7.9, 10 mM KCl 0.5 mM PMFS, 0.5 mM DTT with protease inhibitors 
Complete from Roche) both resulted in detectable PCNA signals for both HCT116 cell lines 
(supplement 6.4 Fig. 76, lanes 2 and 3 and lanes 5 and 6, respectively). This shows that with the 
used IgG's a non-specific binding of a PCNA complex is indeed reached. Before the specific 
p21 precipitation however, the lysates are precleared with the appropriate IgG antibody to make 
sure that this unspecific binding of PCNA does not interfere with the specific p21 pulldown 
results. Therefore, I assume that this is not the problem leading to the PCNA signal in the 
HCT116p21-/- cells. If the PCNA signal is caused by binding of a p21-like protein, possibly the 
binding affinity differ from the specific binding of p21. This made me try various protocols 
using different harsh buffers. It must be mentioned however, that the immunofluorescence 
analysis nor the WB analysis of HCT116p21-/- whole cell lysate did not give any positive p21 
signal with the here used p21 antibodies.  
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Immunoprecipitations were carried out in RIPA buffer without SDS (2% (w/v) Igepal, 100 mM 
Tris/HCl, 300 mM NaCl, 2 mM EDTA 0.5% (v/v) sodium deoxycholate, protease inhibitors 
Complete from Roche) or Dignam A buffer (1.5 mM MgCl2, 10 mM Hepes buffer pH 7.9, 
10 mM KCl 0.5 mM PMFS, 0.5 mM DTT with protease inhibitors Complete from Roche) and 
the Babco waschbuffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% (v/v) NP40, 1 mM 
EDTA pH 8.0, 0.25% (v/v) gelatine) was changed from 0.1% SDS Babco buffer to 0.5% SDS 
Babco buffer. The change of the buffer in which the IP was carried out from Dignam A to Ripa 
buffer made a severe difference in the unspecific IgG pulldown from the HCT116p21-/- cells. 
The IP in Dignam A buffer with the IgG rabbit from the HCT116p21-/- cell lysate resulted in a 
clear PCNA band after WB analysis (supplement Fig. 77 lane 3). However, if the RIPA buffer 
was used during this IP, a hardly detectable PCNA signal was observed (supplement 6.4 Fig. 77 
lane 4). Also, the p21 pulldown with the p21 Ab5 antibody in HCT116p21+/+ cells showed a 
difference in the PCNA signal, depending on the used buffer. The detectable PCNA is clearly 
reduced by the usage of the RIPA buffer in stead of Dignam A buffer throughout the IP 
(supplement 6.4 Fig. 77 lane 5 versus 6).  
 
In spite of the done modifications, still a clear PCNA band was detected in the p21 pulldown 
lysate from the HCT116p21-/- cells. This finally made me test another cell system for these 
experiments. The HeLa cells seemed to be a useful cell line, as their instable TP53 status leaves 
them a non-detectable p21 level (see Sect. 2.2.2, page 35 for WB analysis and Sect. 2.2.5, page 42 
for immunofluorescence staining).  
 
RIPA cell lysates were prepared from mock-irradiated and with 30 Gy X-ray irradiated HeLa 
cells (Sect. 4.2.1, page 94) harvested 3 h after irradiation. IgG and specific p21 
immunoprecipitation was carried out as described in described above (Sect. 4.8). The Western 
Blot analysis with immunodetection for PCNA is shown in Fig. 67. No PCNA signal is 
observed for the IgG or the p21 IP from the HeLa cell lysates after PCNA immunodetection of 
the WB, when exposed the normal exposure time to the X-ray film (2 min; data not shown). 
However, to see whether after a prolonged exposure still no PCNA signal is detected, the WB 
was exposed 30 min to the X-ray film (Fig. 67). Here, a slight PCNA signal is seen for the HeLa 
cells (Fig. 67 lanes 2–4). This signal however, is not elevated after irradiation and present in all 
HeLa samples, making me assume that it is a non-specific signal (Fig. 67 lanes 2 and 3 versus 4, 
respectively). The detected upper bands of the WB in Fig. 67 display the heavy chain of the IgG 
used for the immunoprecipitation (Fig. 67lanes 2–6). In addition, p21 IP was done with NHDF 
cells to verify the established protocol for cells expressing endogenous p21. The specific p21 IP 
in these cells resulted in a clear PCNA signal, verifying the established method (Fig. 67 lane 6). 
The additionally loaded AG lysate gives the position of endogenously expressed PCNA from 
AG whole cell lysate (Fig. 67 lane 7).  
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 Lane                 1       2             3       4     5      6      7  
  
 
 
 
 
heavy IgG chain 
 
PCNA 
 
Lane 
1 Molecular weight marker RPN 800 
2 HeLa Ripa-lysate; IgG rabbit pulldown 
3 HeLa mock-irradiated Ripa-lysate; p21 Ab5 pulldown 
4 HeLa 30 Gy / 3 h Ripa-lysate; p21 Ab5 pulldown 
5 Molecular weight marker RPN 800 
6 NHDF mock-irradiated Ripa-lysate; p21 Ab5 pulldown 
7 AG mock-irradiated Ripa lysate 
 
 
Fig. 67 p21 pulldown in HeLa cells results in a non-detectable specific PCNA signal after 
WB analysis. 
 
This shows that finally a method was found to co-immunoprecipitate PCNA with a p21 
antibody from p21 expressing cells with no PCNA signal after specific p21 pulldown in HeLa 
cells.  
 
 
 
 
 
4.9 Western Blot analysis 
 
 
Denatured proteins can be qualitatively and quantitatively assessed by the Western Blot 
technique. First, proteins are separated on denaturing sodium dodecyl sulphate (SDS) 
polyacrylamide gels (SDS-PAGE). Here, the anionic detergent SDS binds quantitatively to the 
proteins subjected to separation, giving them linearity and uniform negative charge. By this, the 
proteins are separated by the electrophoresis solely on the basis of their size. The separated 
proteins are then transferred (blotted) to a nylon membrane. The membrane is then exposed 
sequentially to the primary antibody directed against the protein of interest and the enzyme 
coupled secondary antibody that binds to the primary antibody. The enzyme, here horseradish 
peroxides (HRP), reacts with a particular substrate that is converted to an unstable intermediary 
product emitting chemiluminescence. By exposing the membrane to an X-ray film, the protein 
of interest can be detected. 
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4.9.1 Protein quantitation 
 
 
Protein quantitation were performed according to Lowry [Lowry et al., 1951] using the modified 
Lowry assay (DC Protein Assay Bio-Rad) or according to Bradford [Bradford, 1976] using the 
Rotiquant system from Roth (Karlsruhe, Germany). 
 
 
 
4.9.1.1 Lowry assay 
 
The Lowry protein quantitation is based on the reduction of Cu2+ to Cu+ in an alkaline solution 
by forming a complex with the proteins of the lysate. Cu+ then reduces the Folin-Ciocalteau 
reagent, forming a blue complex. The light absorption of this solution gives the protein 
concentration of the samples as it is compared with a calibration curve of known protein 
concentration. The absorption was measured by an Elisa-Reader (ELX 800, Bio-Tek Instruments) 
at 630 nm. 
 
To produce a standard calibration curve a BSA stock solution of known protein concentration 
was used and serial dilutions of this stock solution were generated (0, 0.2, 0.4, 0.8 and 1 mg/ml). 
 
 
 
4.9.1.2 Bradford assay 
 
This assay is based on the light absorbance shift of coomassie brilliant blue from 465 nm to 
595 nm when it binds to proteins in an acidic solution. The light absorption of the solution 
measured by an Elisa-Reader (ELX 800, Bio-Tek Instruments) is compared to a calibration curve 
of known BSA concentration (0, 5, 10, 20 and 40 μg/ml).  
 
 
 
 
4.9.2 SDS-PAGE 
 
 
The proteins are separated solely according to their molecular weight by the SDS-PAGE. SDS is 
an anionic detergent, which denatures proteins by covering the polypeptide backbone of the 
proteins. SDS binds to proteins relative specifically in a mass ration of 1:4 (1.4 g SDS/g protein 
in a 1% (w/v) SDS-solution). By this, SDS confers a negative charge to the polypeptide in 
proportion to its length. The disulphide bridges in the proteins are reduced by the addition of β-
Mercaptoethanol to the lysates. Polyacrylamide is used as support matrix as it inhibits a 
convective mixing of the samples and acts as a sieve for the means of separating molecules by 
size. In this thesis, proteins were separated by the discontinuous system according to Laemmli 
[Laemmli, 1970]. This means that a non-restrictive large pore stacking gel (Tris-glycine buffer, 
pH 6.8; 3−7% acrylamide/bis-acrylamide ratio 29:1) is layered on top of a separating gel, the 
resolving gel (Tris-glycine buffer, pH 8.8; and 5−8% acrylamide/bis-acrylamide ratio 29:1). 
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Protein separation was done either with the BioRad system as described below or with the 
NUPAGE system. 
 
 
 
4.9.2.1 BioRad system 
 
Protein separation with the BioRad system was done with the ‚Mini-Protean II’ according to the 
user's manual. A 12% acrylamide/bis-acrylamide (ratio 29:1) separating gel with a size of 7 cm × 
8 cm × 1 mm was used for the separation for proteins with a molecular weight of 10 to 100 
kDa. The used stacking gel was a 3.2% acrylamide/bis-acrylamide (ratio 29:1) gel. The casted 
separating gel was topped off with H2O to ensure a flat polymerisation surface and to exclude 
the contact with air, and was left to polymerize at RT for 1 h. After polymerisation, the H2O was 
removed carefully and the stacking gel was casted on top of the separating gel. A comb with 15 
or 10 wells holding 20 μl or 35 μl respectively was used. The separating gel was left at RT for 
30 min to polymerize.  
 
To the required amount of the samples an equal amount of 2 × SDS-sample buffer (100 mM 
Tris-HCl (pH 6.8), 2% (w/v) SDS, 20% (v/v) glycerol, 0.02 mg/ml bromphenolblue, 2% (v/v) 
β-Mercaptoethanol) was added and heated for 10 min at 80°C. The samples were centrifuged 
briefly (minifuge) and loaded into the wells. To verify the molecular weight of the separated 
proteins, a premixed protein molecular weight marker (RPN 800 ‚Full range rainbow protein 
molecular weight marker’ 10 to 250 kDa; Amersham) was loaded once on each gel. 
Gelelectrophoresis in SDS-PAGE running buffer (50 mM Tris-base, 0.38 M glycine, 0.1% (w/v) 
SDS) was carried out for 2 or 3.5 h, for 1 or 2 gels respectively, at a constant currant of 16 mA 
and a voltage between 29 V and 85 V. 
 
 
 
4.9.2.2 NuPAGE 
 
For some Western Blot analysis the NuPAGE system was used, including precast 12% Bis/Tris 
SDS-PAGEs. The NuPAGEs were prepared and loaded according to the user's manual and run 
for 50 min with 200 V (110–70 mA; MOPs buffer).  
 
 
 
4.9.3 Protein blotting from the SDS-gel to a polyvinyliden fluoride 
membrane 
 
 
After protein separation by SDS-PAGE proteins were transferred to a polyvinylidene fluoride 
(PVDF) membrane. The proteins are transferred to the membrane by an electric field. In this 
field, the smaller SDS molecules are faster and so separated from the proteins during the 
transfer. The used transfer buffer contains methanol, which reduces the interaction of SDS with 
the proteins and facilitates the binding of the proteins to the membrane. 
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The transfer of the proteins from the gel to the membrane was done using the vertical tank-
blotting system ‚Mini Trans-Blot’ from Bio-Rad or the NuPAGE system as indicated. To do so, 
the membrane (Immobilon-P; MILLIPORE), filter paper and pads were pre-soaked in the 
transfer buffer (Bio-Rad: 20% (v/v) methanol, 0.02 M Tris-HCl (pH 8.3), 0.15 M glycine, 
0.1% (w/v) SDS; NuPAGE: 20% (v/v) methanol, 0.025 M Bis-Tris-HCl (pH 8.3), 0.25 M 
Bicine, 1 mM EDTA; pH 7.2). The hydrophobic membrane was soaked in methanol and 
washed in water before it was soaked in the transfer buffer. The gel was positioned on the pre-
soaked membrane with a pre-soaked filter paper and pad on either side. This sandwich was 
placed in the tank-blotting apparatus filled with transfer buffer. The transfer was done at 
constant voltage of 20 V and a current between 60 mA and 80 mA for 14 hours with the Bio-
Rad system and 30 V (170–110 mA) for 1 h with the NuPAGE system. After the protein 
transfer, the membrane was subjected to the immunodetection (Sect. 4.9.4). 
 
 
 
 
4.9.4 Immunodetection  
 
 
Proteins that have been transferred to the nylon membrane can be identified and quantified by 
immunodetection using a protein specific primary and an enzyme-conjugated primary specific 
secondary antibody. The protein detection is based on the catalytic activity of the HRP linked to 
the secondary antibody. HRP – in the presence of H2O – catalyses the oxidation of luminol 
generating an excited product that emits high intensity chemiluminescence which is detected on 
an X-ray film. 
 
For the immunostaining, the membrane was briefly washed in 1 × TBST (10 mM Tris-HCl, 
150 mM NaCl, 0.05% (v/v) Tween 20) directly after the protein transfer to remove remaining 
transfer buffer and SDS-gel fragments. First, the membrane was blocked by incubation in 5% 
blocking solution (5% (w/v) non-fat Nestlé milk powder in 1 × TBST) for 2 hours at RT with 
slight agitation. Then the membrane was incubated for 2 h at RT with the primary antibody, 
diluted in 5% blocking solution. Following this incubation the membrane was washed 3 × for 
10 min wash in 1 × TBST to remove remaining primary antibody. Then the membrane was 
incubated with the HRP-linked secondary antibody, also diluted in 5% blocking solution, at RT 
for 1 h. The membrane was washed 6 × for 10 min each in 1 × TBST to remove remaining 
secondary antibody and incubated for 5 min at RT with the 'ECL PlusTM Western Blotting 
detection system' (Amersham) according to the user’s manual. After incubation with the ECL 
PlusTM, the membrane was exposed to an X-ray film (Hyperfilm ECL; Amersham) to detect the 
chemiluminescence signal. The exposure time depended on the antibodies used and took from 5 
seconds to overnight. For the antibodies used and their working concentrations see Table 7. 
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Primary antibodies 
stock solutions 
Produced in Epitope (if known) Dilution for WB Dilution for IF 
Cip1/WAF1 
Transduction Laboratories 
250 µg/ml 
Mouse full length 1:4000 1:80 
WAF1 (Ab-5) 
Oncogene 100 µg/ml Rabbit 15–61 1:1000 1:20 
WAF1 (Ab-3) 
Oncogene 100 µg/ml Mouse 58–77 1:100 - 
p53 FL393 
Santa Cruz 200 µg/ml Goat full length 1:1000 1:100 
p53 (Ab-6) 
Oncogene 100 µg/ml Mouse 21–25 1:2000 1:50 
Myc 
Invitrogen 1.2 mg/ml Mouse - 1:4000 1:200 
PCNA MAB424 
PC10 
Chemicon 1 mg/ml 
Mouse 111–125 1:4000 1:50 
PCNA (FL-261): sc-7907 
Santa Cruz 200 µg/ml Rabbit 1–261 1:2000 1:20 
CDK2 
PharMingen Rabbit C-terminal domain 1:1000 - 
α-tubulin  
Sigma  Mouse C-terminal domain 1:4000 - 
β-actin 
Sigma  Rabbit N-terminal domain 1:500 - 
GFP 
Abcam Rabbit full length 1:2500 1:100 
53BP1 
Oncogene 2 mg/ml Rabbit full length - 1:500 
γH2AX (ser139) 
Upstate 1 mg/ml Rabbit 134–142 - 1:200 
γH2AX (ser139) 
clone JBW361 
Upstate 1 mg/ml 
Mouse 134–142 1:1000 1:500 
Mouse-IgG  
Amersham Pharmacia Sheep - 1:10000 - 
Rabbit-IgG 
Amersham Pharmacia Sheep - 1:10000 - 
Alexa Fluor 488 labbeled 
goat-anti-mouse-
F(ab')2-IgG-fragments 
Molecular probes 2 mg/ml 
Goat  1:400 - 
Alexa Fluor 568 labbeled 
goat-anti-mouse-
F(ab')2-IgG-fragments 
Molecular probes 2 mg/ml 
Goat  1:400 - 
Alexa Fluor 488 labbeled 
goat-anti-rabbit-F(ab')2-
IgG-fragments 
Molecular probes 2 mg/ml 
Goat  1:400 - 
Alexa Fluor 568 labbeled 
goat-anti-rabbit-F(ab')2-
IgG-fragments 
Molecular probes 2 mg/ml 
Goat  1:400 - 
Table 7 Antibodies used for Western Blot detection and Immunofluorescence staining. 
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4.9.5 Stripping and reprobing of  membranes 
 
To be able to reprobe membranes after the first detection, the primary and secondary antibodies 
from the first detection reaction have to be removed. The membrane can be stripped of bound 
antibodies and reprobed several times if needed. For this, the membrane is rinsed with 1×TBST 
for 10 min and incubated for 30 min in stripping buffer (62.5 mM Tris-HCl pH 6.7, 2% (w/v) 
SDS, 100 mM β-Mercaptoethanol) at 50°C with slight movement. After washing the membrane 
4 × 15 min in 1 × TBST the immunodetection can be carried out as described above (Sect. 
4.9.5). 
 
 
 
 
 
4.10 Expression of  recombinant p21 protein in mammalian cells 
 
 
To understand the function of proteins, the expression of recombinant proteins in mammalian 
cells can be helpful. With this it is possible to construct plasmids expressing a high level of the 
protein of interest. In this thesis I have used plasmids to express different p21 constructs and a 
GFP-p21 fusion protein. To gain the plasmid, the plasmid is transfected into E. coli from which 
it then is isolated. The mammalian cells are then transiently transfected with the plasmid, 
resulting in an expression of the encoded protein. The protocols and used vectors are described 
in brief below. 
 
 
 
4.10.1 Cultivation and transformation of  E. coli 
 
 
All plasmids described in this thesis were replicated by the use of the Escherichia coli bacterium 
DH5α (Life Technologies, Gaithersburg, USA) or the dam- GM2163 (Fermentas, St. Leon-Rot, 
Germany). Competent bacteria were transformed with the specific plasmid as described in the 
user’s manual. 50 μl E. coli were transformed with 1-10 μg plasmid. The transformed cells were 
cultivated in LB medium (Lennox; Roth, Karlruhe, Germany) and plated on agar plates (Luria-
Bertani Agar; Lennox; Roth, Karlruhe, Germany) with a specific selection antibiotic, either 
ampicillin (100 μg/ml; Applichem, Darmstadt, Germany) or kanamycin (50 μg/ml; Applichem, 
Darmstadt, Germany) depending on the used plasmid and incubated at 37°C over night until 
single colonies could be picked and used for the DNA purification as described for the used 
Qiagen kit.  
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4.10.2 Plasmids for the expression of  recombinant p21 in mammalian 
cells 
 
 
4.10.2.1 pcDNA3 
 
The wtp21, p21T145A and p21T145D constructs used in this thesis were generously donated by 
Prof. S. Dimmeler (University of Frankfurt). These plasmids were constructed as described in 
Rossig et al. (2001) using a pcDNA3.1-Myc-His vector from Invitrogen (Fig. 68).  
 
 
Fig. 68 Vector used for the wtp21, p21T145A and p21T145D constructs 
(Invitrogen). 
 
 
 
4.10.2.2 pEGFP-C2 
 
The vector used to make the GFP-p21 construct was the pEGFP-C2 vector from BD 
Biosciences Clontech (Fig. 69) which was kindly donated by Dr. C. Blattner (Institute of 
Toxicology and Genetics, Forschungszentrum Karlsruhe). With this vector, the EGFP is fused 
at the N-terminal site of the expressed protein. This vector was chosen, as the PCNA binding 
site, which has been proved to be of importance for the p21 foci formation at the damaged 
DNA sites, is on the C-terminal domain of p21 (see Fig. 12; page 17).  
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Fig. 69 Vector used for the GFP-p21 construct (BD Biosciences Clontech). 
 
 
 
4.10.3 PCR 
 
 
For the construction of the GFP-p21 fusion protein, the p21 cDNA was isolated from the 
wtp21 plasmid provided by Prof. S. Dimmeler (University of Frankfurt) by a PCR reaction using 
following primers (ordered at MWG-Biotech AG): 
 
 
p21 primer forward: 
 
                                                HIND III 
5‘ – ACT CAG ATC TCG AGC TCA AGC TTC ATG TCA GAA. CCG GCT GGG GAT GTC – 3’ 
                          multiple cloning site                                                  p21 
 
 
 
p21 primer reverse: 
 
                                          Xba I 
5‘ – TGA TCA GTT ATC TAG ATT TAG GGC TTC CTC TTG GAG AA.G ATC – 3’ 
                multiple cloning site                                       p21 
 
 
The primers were resuspended in TE (10 mM Tris-Cl pH 7.4, 1 mM EDTA pH 8.0) to a 
concentration of 10 mg/ml and diluted with H2O (as EDTA inhibits the polymerase) to a final 
concentration of 50 µg/ml. The p21 template was diluted with H2O to a final concentration of 
100 µg/ml. 
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5 µl p21 forward primer (0.25 µg) 
5 µl p21 reverse primer (0.25 µg) 
5 µl 10 × Pfu buffer (Promega) 
5 µl template DNA wtp21 (0.5 µg) 
1 µl dNTP mix (Promega) 
1 µl Pfu polymerase (Promega) 
1 µl 50 mM MgCl2 
27 µl H2O 
 
Time 5 min 30 sec 30 sec 1 min 5 min ∞ 
Temperature 94°C 94°C 55°C 72°C 72°C 4°C 
Cycles  35 cycles  
Table 8 PCR reaction. 
 
The PCR product was digested as described in Sect. 4.10.5.1 (page 121) and verified by gel 
electrophoresis as outlined in Sect. 4.10.5.2 (page 121).  
 
 
 
 
4.10.4 Purification of  plasmid DNA from E. coli 
 
 
The plasmid preparation was done with the Qiagen kit (Qiagen, Hilden, Germany) according to 
the user's manual. Depending on the amount of cultures from which the plasmids were purified, 
either the miniprep or the maxiprep was carried out.  
 
 
 
 
4.10.5 Plasmid analysis 
 
 
To verify the plasmids enriched by E. coli, the plasmids were restricted with endonucleases to 
excise the insert and verified by gelelectrophoretical analysis. 
 
For the GFP-p21 construct the restriction of the plasmid was not only for the verification of the 
plasmid. Here, the cDNA of p21 had to be isolated from the PCR product to be able to ligate 
the insert in the GFP vector. To be able to ligate the excised p21 insert with the GFP vector, the 
PCR product and GFP vector were digested with the same endonucleases. After digestion, the 
products were verified by gel electrophoresis. 
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4.10.5.1 Digestion of DNA with restriction endonucleases 
 
The pEGFP-C2 vector and the wtp21 PCR product from Sect. 4.10.3 (page 119) were restricted 
with HIND III and Xba I from Promega (Mannheim, Germany). The restriction sites for these 
enzymes were encoded in the used primers for the p21 PCR. The use of two different enzymes 
ensured that the possibility of self ligation of the vector or the insert was minimized.  
 
 
45 μl p21wt PCR product 
1 μl HIND III 
1 μl Xba I 
5 μl 10 × buffer B 
 
3 μl pEGFP-C2 (5 μg) 
1 μl HIND III 
1 μl Xba I 
3 μl 10 × buffer B 
22 μl H2O 
Table 9 Restriction mix 
 
The PCR product and vector were digested for 2 h at 37°C. The obtained DNA fragments were 
verified by agarose gel electrophoresis as described below.  
 
 
 
4.10.5.2 Agarose gel electrophoresis 
 
By gel electrophoresis the DNA fragments obtained after digestion are separated and allow 
purifying the p21 DNA and the linearized vector DNA. The gelelectrophoretic analysis was 
done with 1% agarose gels (1% (w/v) agarose in 1 × TAE buffer) with the gel electrophorese 
system from Renner (Dannstadt, Germany) with a constant voltage of 70 V and a current in the 
range of 65–85 mA for 1 h.  
 
 
 
4.10.5.3 GFP-p21 
 
After gel electrophoretic separation of the digested p21 PCR product and the pEGFP-C2 
vector, the p21 DNA band (65 mg) and vector band (91 mg) were excised from the gel and 
purified using the DNA purification kit Easy pure (Biozym Diagnostik, Oldendorf, Germany) 
according to the user's manual. The purified p21 insert and linearized pEGFP-C2 were ligated 
for 1 h at room temperature giving the GFP-p21 plasmid used in the experiments.  
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2 μl 10 × ligase buffer T4 (Promega) 
2 μl pEGFP-C2 (linearized and purified) 
6 μl p21 insert  
1 μl DNA ligase T4 (Promega) 
9 μl H2O 
Table 10 Ligation mix 
 
 
 
4.10.5.4 Sequence analysis 
 
In Sect. 2.2 (page 31) different p21 plasmids, which were kindly donated by Prof. S Dimmeler 
(University of Frankfurt), were used: wtp21, p21T145A and p21T145D. The p21T145A and 
p21T145D have an aa. change at Thr145 that influences the PCNA binding possibility. To be 
sure that the results obtained in Sect. 2.2 was due to the single aa. change in p21T145D, making 
the protein expressed from this construct unable to interact with PCNA, this plasmid was 
sequenced by GATC Biotech (Konstanz, Germany). The single aa. change at Thr145 of p21 was 
confirmed. 
 
 
p21                       MSEPAGDVRQNPCGSKACRRLFGPVDSEQLSRDCDALMAGCIQEARERWNFDFVTETPLE 
p21T145D            MSEPAGDVRQNPCGSKACRRLFGPVDSEQLSRDCDALMAGCIQEARERWNFDFVTETPLE 
 
p21                       GDFAWERVRGLGLPKLYLPTGPRRGRDELGGGRRPGTSPALLQGTAEEDHVDLSLSCTLV 
p21T145D            GDFAWERVRGLGLPKLYLPTGPRRGRDELGGGRRPGTSPALLQGTAEEDHVDLSLSCTLV 
 
p21                       PRSGEQAEGSPGGPGDSQGRKRRQTSMTDFYHSKRRLIFSKRKPZ--------------- 
p21T145D            PRSGEQAEGSPGGPGDSQGRKRRQDSMTDFYHSKRRLIFSKRKPDIQHSGGRSSLEGPRF 
 
p21                   --------------------------------------------------------- 
p21T145D        EQKLISEEDLNMHTGHHHHHHZVZTRZSASTVPSSCQPSVVCPSPVPSLTLEGATPT 
                             c-myc tag                      (his)6-tag 
 
 
 
 
4.10.6 Transfection of  mammalian cells 
 
 
The main problem of expressing ectopically proteins in mammalian cells is the transfection of 
these cells with the desired plasmid. Several methods are described; the efficiency however, 
depends on the used cell system and plasmid. In this thesis I have use two different systems to 
transfect mammalian cells. Electroporation was used for cell lines which were not or only with 
were little efficiency transfected by the otherwise used liposome mediated transfection. This was 
the case for AG and NHDF cells, probably due to their extracellular matrix. The two systems 
are briefly described below. 
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4.10.6.1 Electroporation 
 
With the electroporation technique, the cell membrane is disrupted by a strong external electric 
field which leads to a diffusive permeability. By this, a DNA solution surrounding the cells can 
pass the membrane. For cells electrophorated in this thesis, the Nucleofector from Amaxa 
(Köln, Germany) was used. The cells and solutions were prepared according to the user's 
manual. 
 
 
 
4.10.6.2 Liposome mediated transfection 
 
The liposome mediated transfection was done either with Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA, USA) or FuGENE 6 (Roche, Basel, Switzerland) according to the user's manual. 
HCT116 cells were transfected with FuGENE 6 and HeLa cells with Lipofectamine 2000 as 
experiments showed that the transfection efficiency for each cell line differed; making me chose 
the transfection reagent with the highest efficiency (data not shown). 
 
 
 
 
4.11 Peptide mapping 
 
 
Peptide mapping gives the possibility to detect the phosphorylation status of a protein by 
radiolabelling. In this thesis the phosphorylation status of p21 in NHDF and with wtp21 
transfected HeLa cells was investigated after γ-irradiation and 32P labelling. For this, the cells 
were grown on 15 cm Ø culture dishes. HeLa cells were transfected by Lipofectamine 
(Invitrogen, Karlsruhe, Germany) with wtp21 24 h prior to irradiation.  
 
The cells were incubated overnight with phosphate-free culture medium containing 10% (v/v) 
dialyzed FCS (Biochrom, Berlin, Germany) at 37°C. After 10 Gy γ-irradiation (Sect. 4.2.2, page 
95) the cells were labelled immediately with [32P]orthophosphate by adding 2.5 mCi 
[32P]orthophosphate per plate and incubate for 2.5 h at 37°C. The cells were lysed on ice for 1 h 
with NP40 lysis buffer (10 mM NaH2PO4 pH 7, 1% (v/v) NP40, 50 mM Tris pH 8, 5 mM 
EDTA, 150 mM NaCl, 1 mM AEBSF). The lysates were centrifuged for 10 min at 13000 × g at 
4°C and the supernatants were collected. Immunoprecipitation for p21 from the supernatants 
was carried out as followed. 
 
The p21 antibody (AB) was pre-linked to the beads (1 μg AB with 20 µl beads) by incubation 
for 1.5 h at 4°C (rotating). The lysates were added to this antibody complex and incubated for 
2 h at 4°C (rotating). After incubation, the antibody complexes were subsequently washed 
4 times with the NP40 lysis buffer. The supernatants were discarded and the pellets were added 
20 μl 2 × SDS sample buffer (4% (w/v) SDS, 0.16 M Tris pH 6.8, 20% (v/v) glycerol, 
10% (v/v) β-Mercaptoethanol, 0.002% (w/v) bromophenol blue). The immunoprecipitated 
complexes were denaturated by heating for 10 min at 100°C and protein separation was carried 
out on a 12% SDS-PAGE (see Sect. 4.9.2, page 113). 
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The 12% SDS-PAGE was dried and exposed to a hyperfilm (Amersham, Buckinghamshire, 
UK) overnight. The fragments of the gel containing the radiolabeled p21 from the NHDF cells 
or p21his6-cmyc from the HeLa cells were excised, rehydrated and fractionated with a douncer 
pestle in 500 μl ammonium bicarbonate solution (4 mg/ml). 500 μl ammonium bicarbonate 
solution (4 mg/ml), 0.2% (w/v) SDS and 2% (v/v) β-Mercaptoethanol were added and the 
samples heated for 5 min at 95°C followed by incubation at room temperature over night 
(rotating). After 2 times centrifugation for 10 min, the supernatants were added 20 μg RNase 
and 250 μl of ice cold 100% trichloroacetic acid to precipitate the proteins during 1 h incubation 
on ice. After centrifugation the pellets were washed with 1 ml 100% EtOH and centrifuged 
twice; the supernatant discarded. The pellets obtained after both centrifugation steps were 
resuspended in 50 μl performic acid (10% (v/v) H2O2 in formic acid) each to oxidize the 
proteins (performic acid converts Met to Met sulfone and Cys to cysteic acid) and unified. 300 μl 
H2O was added and the samples were lyophilised.  
 
The protein was digested over night at 37°C using trypsin (25 μg per sample) that specifically 
cuts after arginine (R) and lysine (K) residues leaving many small fragments (25 fragments with a 
length of 1–16 aa.). After adding another 25 μg trypsin and further incubation for 2 h at 37°C, 
300 μl H2O was added and the samples lyophilised. The samples were rehydrated 3 times with 
300 μl H2O and lyophilised. The final pellets were resuspended in 5 μl pH 1.9 buffer 
(7.8% (v/v) acetic acid, 2.5% (v/v) formic acid) and incubated over night at RT. The samples 
were centrifuged, the pellet discarded and the supernatants lyophilised. The lyophilised samples 
were resuspended in 50 μl pH 1.9 buffer and given drop wise on a thin-layer cellulose (TLC) 
plate each. The TLC plate was connected with the electrophoresis buffer (pH 1.9 buffer) by 
Whatman papers as displayed in Fig. 70 A. The 1st dimension was run at 500 V (8–10 mA) for 
1.5 h. 
 
The TLC plates were dried before the 2nd dimension was run, placed in phosphopeptide 
chromatography buffer (37.5% (v/v) n-butanol, 25% (v/v) pyridine, 0.75% (v/v) acetic acid) as 
displayed below in Fig. 70 B. After 6 h the TCL plates were dried and exposed to a Hyperfilm 
(Amersham) for 4 weeks.  
 
sample
buffer
TLC
sample
marker whatman
buffer
_ +
TLC
A B
 
Fig. 70 Schematic diagram of the 1st and 2nd Dimension of the phosphopeptide mapping. 
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5 MATERIALS 
 
5.1 Cell culture 
 
AG medium 
EMEM (BioWhittaker, Walkersville, UK) with addition of 20% (v/v) foetal calfserum 
(Biochrom, Berlin, Germany), 2 mM L-glutamin (Biochrom), 100 U/ml penicillin 
(Biochrom) and 100 μg/ml streptomycin (Biochrom) 
 
AG freezing medium 
AG medium with addition of 10% (v/v) glycerol 
 
HCT medium  
McCoy’s 5A Medium (Sigma) with addition of 10% (v/v) foetal calfserum (Biochrom, 
Berlin, Germany) and 2.8 mM L-glutamin (Biochrom)  
HCT116 p21-/- additional  0.4 mg/ml geniticin G418 (Gibco BRL) 
 
HCT freezing medium 
HCT medium with addition of 10% (v/v) DMSO 
 
 
 
5.2 Solutions and buffers 
 
Agarose gel loading buffer 
5% glycerol, 0.025% bromphenolblue in 0.5 × TBE 
 
Blocking solution 5% (w/v) 
5% non-fat Nestlé-milkpowder in 1 × TBST 
 
BSA solution 
0.5% (w/v) in PBS 
 
Dialyzed FCS (Biochrom, Berlin, Germany) 
 
Ethidiumbromid staining solution  
2 μg/ml EtBr in H2O 
 
Hepes extraction buffer 
10 mM Hepes-KOH (hydroxyethylpiperazinethansulfosäure), 10 mM KCl, 1.5 mM 
MgCl2, 0.5 mM dithiothreitol, 0.1% (v/v) triton X-100; pH 7.9, equilibrated with 1 M 
KOH 
 
2 × Laemmli sample buffer  
10 mM Tris-HCl pH 6.8, 2% (v/v)w, 20% (v/v) Glycerol 
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Paraformaldehyde solution 
2% (w/v) paraformaldehyde in PBS 
 
PBS  
Sigma w/o Ca2+ and Mg2+ (Dulbecco) 
 
ToPro-3 solution with RNase A 
1 μM ToPro-3 in PBS (Sigma) with addition of 100 μg/ml RNase A (Boehringer 
Mannheim) 
 
SDS-PAGE laemmli running buffer 
50 mM Tris-Base, 0.38 M Glycin, 0.1% (w/v) SDS 
 
SDS-PAGE laemmli loading buffer 
100 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 20% (v/v) Glycerol, 0.02 mg/ml 
bromphenolblue, 2% (v/v) 2-mercaptoethanol 
 
SDS-PAGE stacking gel (pH 6.8) 
3.2% (v/v) acrylamid/bis-aAcrylamid (29:1), 0.125 M tris-HCl, 0.1% (w/v) SDS, 0.03% 
(w/v) ammoniumpersulfate, 0.05% (v/v) N,N,N’,N’-tetramethylethylendiamin 
 
SDS-PAGE seperating gel (pH 8.8) 
12% (v/v) acrylamid/bis-acrylamid (29:1), 0.35 M tris-HCl, 0.1% (w/v) SDS, 
0.03% (w/v) ammoniumpersulfate, 0.05% (v/v) N,N,N’,N’-tetramethylethylendiamin 
 
1 × TBST (pH 8.0) 
10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20 
 
10 × TE (pH 8.0) 
0.1 M tris-base, 0.01 M EDTA 
 
SDS-PAGE transfer buffer  
20% (v/v) methanol, 0.02 M Tris-HCl (pH 8.3), 0.15 M glycine, 0.1% (w/v) SDS 
 
Trypsin-EDTA solution 
0.05 g/l trypsin, 1 g/l EDTA in PBS without Mg2+ and Ca2+ (PAN, Aidenbach,        
  Germany) 
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5.3 Materials and chemicals 
 
 
Prestained protein weight marker 
Premixed Protein Molecular Weight Marker (‚Full range rainbow protein molecular 
weight marker’ 10 bis 250 kDa; Amersham, Buckinghamshire, UK) 
 
Polyvinylidenfluorid membrane (Immobilon-P; MILLIPORE) 
 
X-ray film (Hyperfilm ECL; Amersham, Buckinghamshire, UK) 
 
Vectashield ‚Mounting Medium’ (Vector Laboratories, Burlingame, CA, USA) 
 
Glass cover slips (Menzel-Gläser, Braunschweig, Germany) 
 
Perti dishes (Nunc, Roskilde, Denmark) 
 
Culture flasks (Falcon, BD Biosciences, CA, USA) 
 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)  
 
FuGENE 6 (Roche, Basel, Schwitzerland) 
 
 
 
5.4 Used kits 
 
Lowry Assay ‚DC Protein Assay’ (Bio-Rad, CA, USA) 
 
‚ECL PlusTM Western blotting detection system’ (Amersham, Buckinghamshire, UK) 
 
‚Mykoplasma Detektion Kit’ (Boehringer Mannheim, Germany) 
 
Bradford Assay Rothiquant (Roth, Karlsuhe, Germany) 
 
Qiagen kit (Qiagen, Hilden, Germany) 
 
DNA purification kit Easy pure (Biozym Diagnostik, Oldendorf, Germany) 
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5.5 Used apparatus 
 
 
Nucleofector from Amaxa (Köln, Germany) 
 
Elisa-Reader (ELX 800, Bio-Tek Instruments, Bad Friedrichshall, Germany)  
 
Z2 Coulter Counter (Beckman Coulter, Krefeld, Germany) 
 
Confocal laserscanning system Leica TCS  
Equipped with a DM IRBE inverted microscope (lens: PlanApo 63 × / 1.32 oil) and an 
argon/krypton laser; connected to a Märzhäuser computerised stage control SCAN 100 
× 100 
 
Tank-blot system ‚Mini Trans-Blot’ (Bio-Rad, Munich, Germany) 
 
SDS-PAGE system ‚Mini-Protean II’ (Bio-Rad, Munich, Germany) 
 
SN4 dosimeter (PTW Freiburg, Germany) 
 
X-ray generator Isovolt DS1, type IV320-13 (Seifert, Germany) 
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6 SUPPLEMENT 
 
 
6.1 To Sect. 2.2.1 Kinetics of  p21/PCNA foci formation 
 
 
                  A 
 
B 
 
 
           mock-irradiated 2 min post-irradiation  
C 
 
D 
 
E 
 
5 min post-irradiation 15 min post-irradiation 1 h post-irradiation 
Fig. 71 Early time course for p21 and PCNA accumulations in human fibroblasts after 
exposure to uranium ions. A: mock-irradiated; B–F: after irradiation with uranium ions. p21 
(green) and PCNA (red), DNA (blue). Unfortunately, the ToPro3 signal (blue) was hardly 
detectable in various samples, as in A and D. At all time-points, clear foci of both p21 and 
PCNA are detectable in the irradiated samples. 
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A B 
 
C 
 
mock-irradiated 30 min post-irradiation 1 h post-irradiation 
D E 
 
F 
 
2 h post-irradiation 3 h post-irradiation 5 h post-irradiation 
Fig. 72 Resolution of p21 and PCNA foci in human fibroblasts after irradiation with nickel 
ions. p21 (green) and PCNA (red) accumulate to foci at all taken time-points. The mock-irradiated 
cells do not show any protein accumulations (A). An induction of the p21 level 5 h post-irradiation 
is seen by the elevated green dispersed fluorescence in F. DNA visualized by ToPro3 (blue). 
 
Human fibroblasts irradiated with Ni ions and fixed 30 min, 1, 2, 3 or 5 h post-irradiation 
showed accumulations of p21 as well as PCNA (Fig. 72 B–F). Analysis showed, that within this 
chosen time frame, a maximum of cells showing p21 foci occurred 3 h post-irradiation (75%, n 
= 28). However, 5 hours after irradiation, still many nuclei showed visible p21 foci (60%, n = 
10), with less nuclei displaying PCNA foci (40%, n = 10). It must be noted that here the p21 
level was quite high compared to the earlier taken time-points due to an induction of the p21 
protein level and PCNA was hardly visible, making me only analyze 10 nuclei making it only 
being a preliminary result. 
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6.2 To Sect. 2.2.4 Recombinant p21T145D no longer interacts with 
PCNA 
 
 
Lane        1       2       3        4         5     Exposure 10 min 
 
 
 
 
PCNA 
 
 
 
Lane 
1 AG laemmli lysate  
2 Myc IP mouse Non-transfected HeLa cells 
3 Myc IP mouse HeLa cells transfected with wtp21 
4 Myc IP mouse HeLa cells transfected with p21T145D 
5 Molecular weight marker RPN 800 
Fig. 73 PCNA is not co-immunoprecipitated by anti-myc immunoprecipitation 
of p21T145D. Westernblot analysis of the anti-myc complexes from HeLa cells, non-
transfected (lane 2), transfected with the wtp21 plasmid (lane 3) or with the 
p21T145D plasmid (lane 4). Lane 1: Crude lysate from AG cells. Lane 5: 
Molecularweightmarker. 
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6.3 To 2.7.1 Ectopical expression of  a GFPp21 Fusion protein 
 
A 
 
  
mock-irradiated   
B 
 
C D 
 
GFPp21  γH2AX merge 
Fig. 74 Ectopically expressed GFPp21 in HeLa cells accumulates to HI induced foci. HeLa 
cells transfected with GFPp21 fusion protein and irradiated with Sm ions (3×106 p/cm2; 11.4 
MeV/u; 10290 V/μm) 24 h after transfection show clear GFPp21 foci 30 min post irradiation (B–
D). Fixed without extraction and stained for γH2AX (red). A: mock-irradiated. GFPp21: green. 
DNA: blue.  
 
HeLa cells transfected with the p21GFP construct and exposed to Sm ions (3×106 p/cm2; 11.4 
MeV/u; 10290 V/μm) also showed clear irradiation-induced p21GFP foci as displayed in Fig. 
74 B. Mock-irradiated cells show a heterogeneous expression level of the p21GFP protein (Fig. 
74 A). Non-transfected HeLa cells do not give any detectable green fluorescence signal (data not 
shown). 
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6.4 To Sect. 4.8.1 Establishment of  a method to immunoprecipitate a 
p21 complex 
 
 
Lane 1        2              3             4              5             6 Exposure time 1 min 
 
 
PCNA 
 
Lane 
1 Molecular weight marker RPN 800 
2 p21 AB3 pulldown HCT116p21-/-  
3 p21 AB 5 pulldown HCT116p21-/-  
4 p21 AB 3 pulldown HCT116p21+/+ 
5 p21 AB 5 pulldown HCT116p21+/+ 
6 HCT116p21-/- lysate 
 
Fig. 75 Comparison of two different antibodies for p21 pulldown in HCT116 cells. 
Western Blot analysis of p21 pulldown in HCT116p21+/+ and HCT116p21-/- cells. The 
pulldown was done either with a polyclonal rabbit or monoclonal mouse antibody against 
human p21 followed by Western Blot detection with PCNA mouse or rabbit, respectively. 
 
Fig. 75 displays the WB analysis of the p21 pulldown in both HCT116 cell lines using two 
different p21 antibodies. A slight difference between the used antibody was seen, as the 
detectable PCNA band is elevated with the use of the p21 polyclonal rabbit antibody (AB5) 
compared to the IP's done with the p21 monoclonal mouse antibody (AB3) (Fig. 75 lane 3 and 5 
versus lane 2 and 4). However, both cell lines gave a comparable PCNA signal with the same 
antibody used for the pulldown (Fig. 75; lane 2 versus 4 and lane 3 versus 5). As the AB5 p21 
antibody gave the best and clearest detectable PCNA band after WB analysis, this antibody was 
used for the further made IP's. The next approach was to check the non-specific binding of 
PCNA to the used IgG's, Western Blot analysis is shown in Fig. 76. 
 
 
Lane        1      2       3           4        5      6 Exposure time 1 min 
              
 
PCNA 
Lane 
1 HCT116 lysate 0.3 µg 
2 IgG mouse pulldown HCT116p21+/+  
3 IgG mouse pulldown HCT116p21-/-  
4 Molecular weight marker RPN 800 
5 IgG rabbit pulldown HCT116p21+/+ 
6 IgG rabbit pulldown HCT116p21-/-  
 
Fig. 76 IgG pulldown from HCT116 cell Dignam A lysates gives a detectable PCNA signal 
by Western Blot analysis. Western Blot analysis of IgG rabbit and mouse pulldown in HCT116 
cells. 
 
The pulldown with IgG mouse antibody in Dignam A buffer gave a detectable PCNA signal in 
both HCT116 cell lines as seen in Fig. 76, lane 2 and 3. Also with the IgG rabbit pulldown, a 
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clear PCNA band was detected, Fig. 76 lane 5 and 6. It is seen, that with the used IgG's a non-
specific binding of a PCNA complex is reached. Before the specific p21 precipitation however, 
the lysates are precleared with the appropriate IgG antibody. This means that the shown PCNA 
band in Fig. 76 should be cleared out of the sample before the specific p21 pulldown is carried 
out. Therefore, I assume that the detectable PCNA band after p21 pulldown in the HCT116p21-
/- cells is not a result of the unspecific binding of a PCNA complex to the used IgG's, but maybe 
caused by binding of a p21-like protein. If it is the case, possibly the binding affinity differ from 
the specific binding of p21. This made me try various protocols using different harsh buffers. It 
must be mentioned however, that the immunofluorescence analysis and WB analysis of 
HCT116p21-/- whole cell lysate did not give any positive p21 signal with the here used p21 
antibodies.  
 
I compared the results of IP's in RIPA and Dignam A buffer (RIPA contains a detergent, 
Dignam A not) and changed the waschbuffer from 0.1% SDS Babco buffer to 0.5% SDS Babco 
buffer. The WB analysis is shown below in Fig. 77. 
 
 
         Lane      1      2       3       4      5       6    Exposure 2 min 
  
 
PCNA 
Lane 
1 AG lysate 
2 Molecular weight marker RPN 800 
3 IgG rabbit pulldown in Dignam A lysate from HCT116p21-/- 
4 IgG rabbit pulldown in RIPA lysate from HCT116p21-/- 
5 p21 Ab5 rabbit pulldown in RIPA lysate from HCT116p21+/+ 
6 p21 Ab5 rabbit pulldown in Dignam A lysate from HCT116p21+/+ 
Fig. 77 Changed IP conditions clear out the former observed PCNA signal after IgG 
pulldown in HCT116p21-/-cell lysate. 
 
The change of the buffer in which the IP was carried out from Dignam A to Ripa buffer made a 
severe difference in the unspecific IgG pulldown from the HCT116p21-/- cells. The IP in 
Dignam A buffer with the IgG rabbit from the HCT116p21-/- cell lysate resulted in a clear 
PCNA band after WB analysis (Fig. 77 lane 3). However, if the RIPA buffer was used during 
this IP, a hardly detectable PCNA signal was observed (Fig. 77 lane 4). Also, the p21 pulldown 
with the p21 Ab5 antibody in HCT116p21+/+ cells showed a difference in the PCNA signal, 
depending on the used buffer. The detectable PCNA is clearly reduced by the usage of the 
RIPA buffer in stead of Dignam A buffer throughout the IP (Fig. 77 lane 5 versus 6).  
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